NCT ID,Acronym,Overall Status,Start Date,Conditions,Interventions,Locations,Primary Completion Date,Study First Post Date,Last Update Post Date,Study Type,Phases,Sponsor,Sponsor Type,Disease
NCT06153862,ARMS,ACTIVE_NOT_RECRUITING,2022-09-23,Malaria,Immuno analytical assay,Dodowa - Ghana,2024-09,2023-12-01,2023-12-01,INTERVENTIONAL,NA,University of Ghana,OTHER,malaria
NCT00868465,TRANSACT,COMPLETED,2009-04,Uncomplicated Malaria,"Artemether-Lumefantrine, Dihydroartemisinin-piperaquine","Mbita - Kenya, Moshi - Tanzania",2010-05,2009-03-25,2010-06-07,INTERVENTIONAL,NA,Radboud University Medical Center,OTHER,malaria
NCT05219565,Unknown,COMPLETED,2022-03-07,Malaria,Attractive Targeted Sugar Bait (ATSB),"Siaya - Kenya, Siaya - Kenya, Siaya - Kenya, Siaya - Kenya, Siaya - Kenya, Siaya - Kenya, Siaya - Kenya, Siaya - Kenya, Siaya - Kenya",2024-03-21,2022-02-02,2024-06-10,INTERVENTIONAL,NA,Liverpool School of Tropical Medicine,OTHER,malaria
NCT02458092,Unknown,COMPLETED,2008-04,Malaria,"Plasmodium falciparum Malaria Protein 010 (FMP010), Rabipur",No locations listed,2008-12,2015-05-29,2023-06-28,INTERVENTIONAL,PHASE1,U.S. Army Medical Research and Development Command,FED,malaria
NCT02786589,Unknown,RECRUITING,2016-06-27,"Lung Cancer, Nonsmall Cell",Blood-stage infection of P. vivax,Guangzhou - China,2020-07-01,2016-06-01,2023-06-22,INTERVENTIONAL,PHASE2,State Key Laboratory of Respiratory Disease,OTHER,malaria
NCT03084289,Unknown,COMPLETED,2017-03-28,Malaria,"ChAd63-METRAP, MVA ME-TRAP",Oxford - United Kingdom,2020-07-06,2017-03-20,2020-10-09,INTERVENTIONAL,PHASE1,University of Oxford,OTHER,malaria
NCT04238689,TB31F,COMPLETED,2020-02-14,"Malaria,Falciparum",TB31F,Nijmegen - Netherlands,2021-03-04,2020-01-23,2023-03-27,INTERVENTIONAL,PHASE1,Radboud University Medical Center,OTHER,malaria
NCT01351948,Unknown,COMPLETED,2011-06,Malaria,"AdCh63 AMA1 + MVA AMA1 + AMA1-C1/Alhydrogel®+ CPG 7909, AdCh63 AMA1 + AMA1-C1/Alhydrogel®+ CPG 7909, AdCh63 AMA1 + AMA1-C1/Alhydrogel®, AdCh63 AMA1 AMA1-C1/Alhydrogel®+ CPG 7909, AdCh63 AMA1 + MVA AMA1",Oxford - United Kingdom,2013-03,2011-05-11,2013-03-14,INTERVENTIONAL,PHASE1,University of Oxford,OTHER,malaria
NCT03454048,CHMI-trans2,COMPLETED,2018-05-07,"Malaria,Falciparum, Gametocytes, Controlled Human Malaria Infection, Transmission","Piperaquine (low dose), Piperaquine (high dose), Sulfadoxine pyrimethamine, Atovaquone Proguanil, malaria challenge infection, P. falciparum 3D7, Blood stage malaria challenge infection, P. falciparum 3D7",Nijmegen - Netherlands,2018-11-01,2018-03-05,2020-07-07,INTERVENTIONAL,NA,Radboud University Medical Center,OTHER,malaria
NCT06155448,PMCEffect,ACTIVE_NOT_RECRUITING,2023-08-08,Malaria,Perennial Malaria Chemoprevention effect,Oshogbo - Nigeria,2025-08-07,2023-12-04,2023-12-04,INTERVENTIONAL,NA,Malaria Consortium,OTHER,malaria
NCT02080026,BMGF1,COMPLETED,2014-06,Malaria,"CPS-immunization, Controlled Human Malaria Infection, chloroquine, atovaquone/proguanil",Nijmegen - Netherlands,2015-07,2014-03-06,2015-08-10,INTERVENTIONAL,NA,Radboud University Medical Center,OTHER,malaria
NCT04093765,MSAT,COMPLETED,2018-11-01,Plasmodium Falciparum Malaria,"Ultrasensitive Rapid Diagnostic Test (URDT), Antimalarials",Mae Sot - Thailand,2019-12-31,2019-09-18,2024-03-27,INTERVENTIONAL,NA,University of Oxford,OTHER,malaria
NCT00153491,Unknown,COMPLETED,2002-08,"Malaria, Uncomplicated",artemether-lumefantrine,Mkuranga - Tanzania,Unknown Date,2005-09-12,2005-09-12,OBSERVATIONAL,Not Available,Centers for Disease Control and Prevention,FED,malaria
NCT02015091,Unknown,COMPLETED,2013-12-12,Malaria,PfSPZ Vaccine,"Baltimore - United States, Bethesda - United States",2015-05-01,2013-12-19,2019-12-17,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT04160026,Unknown,COMPLETED,2019-11-11,"Malaria in Pregnancy, Adherence, Treatment","Monthly intermittent preventive treatment with dihydroartemisnin-piperaquine, Monthly intermittent preventive treatment with sulfadoxine-pyrimethamine, Monthly intermittent preventive treatment with dihydroartemisnin-piperaquine with targeted information transfer",Kisumu - Kenya,2020-07-31,2019-11-12,2021-04-15,INTERVENTIONAL,PHASE4,Liverpool School of Tropical Medicine,OTHER,malaria
NCT01024426,Unknown,COMPLETED,2010-12,Malaria,"Enhanced health facility-based care, Standard care",Kampala - Uganda,2013-04,2009-12-02,2013-11-01,INTERVENTIONAL,PHASE4,Uganda Malaria Surveillance Project,OTHER,malaria
NCT02259426,DAPPI,COMPLETED,2014-10,"Malaria, Asymptomatic Malaria, Plasmodium Falciparum","Dihydroartemisinin-piperaquine combination (Artekin), Primaquine",Mbita - Kenya,2015-09,2014-10-08,2016-01-14,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT01809873,Unknown,COMPLETED,2012-09,Malaria,Performance based incentives,Eldoret - Kenya,2013-11,2013-03-13,2015-03-10,INTERVENTIONAL,NA,Duke University,OTHER,malaria
NCT04675931,Unknown,RECRUITING,2022-03-07,Severe Malaria,"KAE609, IV Artesunate, Coartem","Burkina Faso - Burkina Faso, Ouagadougou - Burkina Faso, Kinsasha - Congo, The Democratic Republic of the, Abidjan - Côte D'Ivoire, Agboville - Côte D'Ivoire, Lambarene - Gabon, Raipur - India, Surat - India, Jaipur - India, Siaya - Kenya, Manhica - Mozambique, Ilorin - Nigeria, Kigali - Rwanda, Tororo - Uganda",2025-08-30,2020-12-19,2024-12-31,INTERVENTIONAL,PHASE2,Novartis Pharmaceuticals,INDUSTRY,malaria
NCT04201431,Unknown,COMPLETED,2020-01-24,"Malaria, Vivax",PvDBPII/Matrix-M1,Oxford - United Kingdom,2022-07-14,2019-12-17,2024-11-25,INTERVENTIONAL,PHASE2,University of Oxford,OTHER,malaria
NCT04130282,Unknown,TERMINATED,2019-09-27,"Malaria,Falciparum",Pfs25-IMX313/Matrix-M1,Oxford - United Kingdom,2020-09-22,2019-10-17,2020-09-29,INTERVENTIONAL,PHASE1,University of Oxford,OTHER,malaria
NCT03521973,Unknown,COMPLETED,2018-06-14,Malaria,"PfSPZ Vaccine, Normal Saline",Lambaréné - Gabon,2021-05-18,2018-05-11,2021-10-07,INTERVENTIONAL,PHASE2,Sanaria Inc.,INDUSTRY,malaria
NCT03931473,NNP,COMPLETED,2020-06-01,"Malaria, Anemia",Bed nets,Cove - Benin,2023-05-01,2019-04-30,2024-10-18,INTERVENTIONAL,NA,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT04301531,DetI-MTTT,COMPLETED,2020-03-01,Malaria Asymptomatic Parasitaemia,"Mass testing using RDTs, Treatment for all cases confirmed positive malaria cases with ACTs, Determination of Hb, Household survey, Community-base management of malaria",Accra - Ghana,2021-11-30,2020-03-10,2023-05-06,INTERVENTIONAL,NA,Noguchi Memorial Institute for Medical Research,OTHER,malaria
NCT04041973,PAL_Cambodia,COMPLETED,2020-03-11,Malaria,"Artemether-lumefantrine, Multivitamin","Pursat - Cambodia, Stung Treng - Cambodia",2021-03-17,2019-08-01,2024-03-20,INTERVENTIONAL,NA,University of Oxford,OTHER,malaria
NCT01955382,Unknown,COMPLETED,2013-09,"Malaria, Severe Malaria","Actidose Aqua, Artesunate, Amodiaquine",Bamako - Mali,2015-07,2013-10-07,2018-02-06,INTERVENTIONAL,PHASE2,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT00340431,Unknown,COMPLETED,2004-06-09,"Plasmodium Falciparum Malaria, Vaccines",MSP1(42)-FVO & MSP1(42)-3D7,Lenexa - United States,Unknown Date,2006-06-21,2017-07-02,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT06624631,PDMC-SL,NOT_YET_RECRUITING,2024-11,"Severe Malaria, Severe Anemia","Delivery strategy A, Delivery strategy B",No locations listed,2026-06,2024-10-03,2024-10-03,INTERVENTIONAL,PHASE4,Liverpool School of Tropical Medicine,OTHER,malaria
NCT03387631,TES2016,COMPLETED,2016-04,Uncomplicated Malaria,Artemether-Lumefantrine,No locations listed,2016-09,2018-01-02,2018-01-02,OBSERVATIONAL,Not Available,"National Institute for Medical Research, Tanzania",OTHER_GOV,malaria
NCT01663831,MalaResT,COMPLETED,2012-05,Malaria,Mosquito topical repellent,Banlung - Cambodia,2013-12,2012-08-13,2014-02-03,INTERVENTIONAL,NA,"Institute of Tropical Medicine, Belgium",OTHER,malaria
NCT01930331,Unknown,COMPLETED,2014-01-07,"Plasmodium Falciparum, Malaria, Falciparum","artemisinin/naphthoquine, dihydroartemisinin/piperaquine phosphate",Bagamoyo - Tanzania,2014-07-27,2013-08-28,2018-03-14,INTERVENTIONAL,PHASE4,Ifakara Health Institute,OTHER,malaria
NCT00317473,Unknown,COMPLETED,2003-06,Plasmodium Falciparum Malaria,"FMP1/AS02A Malaria vaccine, Imovax Rabies vaccine",Kombewa - Kenya,2004-07,2006-04-24,2017-10-02,INTERVENTIONAL,PHASE1,U.S. Army Medical Research and Development Command,FED,malaria
NCT00761020,Unknown,COMPLETED,2008-09,Malaria,"Mefloquine, Control",Silver Spring - United States,2009-04,2008-09-26,2021-04-19,INTERVENTIONAL,NA,U.S. Army Medical Research and Development Command,FED,malaria
NCT02694874,ROSI,COMPLETED,2016-02,Malaria,"Rosiglitazone, Placebo",Manhiça - Mozambique,2020-03,2016-03-01,2024-02-21,INTERVENTIONAL,NA,Centro de Investigacao em Saude de Manhica,OTHER,malaria
NCT02721420,PMC,UNKNOWN,2016-03-24,"Malaria, Severe Anemia","dihydroartemisinin-piperaquine, message(SMS) reminder, Health worker reminder, short message(SMS) reminder",Zomba - Malawi,2019-03,2016-03-29,2018-02-01,INTERVENTIONAL,PHASE3,Kamuzu University of Health Sciences,OTHER,malaria
NCT00340574,Unknown,COMPLETED,2005-03-08,"Healthy Volunteer, HV",AMA1-C1/Alhydrogel + CpG 7909,"Bethesda - United States, Rochester - United States",Unknown Date,2006-06-21,2017-07-02,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT03906474,Unknown,COMPLETED,2018-11-06,Malaria,Blood-stage controlled human P. falciparum malaria infection,Oxford - United Kingdom,2019-02-14,2019-04-08,2019-04-08,INTERVENTIONAL,NA,University of Oxford,OTHER,malaria
NCT04268420,Unknown,UNKNOWN,2020-03-20,Vaccine Reaction,"FMP013, ALFQ",Silver Spring - United States,2023-07,2020-02-13,2023-01-10,INTERVENTIONAL,PHASE1,U.S. Army Medical Research and Development Command,FED,malaria
NCT00399074,Unknown,COMPLETED,2006-10,"Sickle Cell Anemia, Malaria",sulfadoxine pyrimethamine,Kampala - Uganda,2007-02,2006-11-14,2009-07-02,INTERVENTIONAL,PHASE3,Makerere University,OTHER,malaria
NCT05070520,Unknown,COMPLETED,2020-09-01,MALARIA,Artemether-lumefantrine,Niamey - Niger,2020-09-30,2021-10-07,2021-10-07,INTERVENTIONAL,PHASE4,"Programme National de Lutte contre le Paludisme, Niger",OTHER_GOV,malaria
NCT01325974,Unknown,COMPLETED,2011-09,"Malaria, Falciparum",No interventions listed,"Kazo - Uganda, Mbarara - Uganda",2013-02,2011-03-30,2015-11-30,OBSERVATIONAL,Not Available,Epicentre,OTHER,malaria
NCT02605720,ECG-Lihir,COMPLETED,2015-09,Malaria,Dihydroartemisinin-piperaquine,Londolovit - Papua New Guinea,2016-01,2015-11-16,2016-03-03,INTERVENTIONAL,PHASE3,Lihir Medical Centre,OTHER,malaria
NCT02783820,Unknown,COMPLETED,2016-05,Malaria,"MMV390048 40 mg, Placebo to match MMV390048 40 mg, MMV390048 80 mg, Placebo to match MMV390048 80 mg, MMV390048 120 mg, Placebo to match MMV390048 120 mg",Herston - Australia,2016-12,2016-05-26,2020-06-11,INTERVENTIONAL,PHASE1,Medicines for Malaria Venture,OTHER,malaria
NCT02613520,Unknown,COMPLETED,2015-12,Malaria,"PfSPZ Vaccine, Normal Saline, PfSPZ Challenge (for CHMI)",Bagamoyo - Tanzania,2017-02,2015-11-24,2018-10-15,INTERVENTIONAL,PHASE1,Sanaria Inc.,INDUSTRY,malaria
NCT00290420,Unknown,WITHDRAWN,2006-03,Malaria,Chloroquine profilaxis,No locations listed,2007-11,2006-02-13,2013-05-22,INTERVENTIONAL,PHASE4,Institut de Recherche pour le Developpement,OTHER_GOV,malaria
NCT04704674,Unknown,ACTIVE_NOT_RECRUITING,2021-09-30,Malaria,No interventions listed,Fleh-la - Liberia,2025-02-28,2021-01-12,2025-02-28,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT00082576,Unknown,COMPLETED,2004-06,"Malaria, Falciparum","Azithromycin/Chloroquine, Mefloquine","Navrongo - Ghana, Bamako - Mali, Jinja - Uganda, Kampala - Uganda, Ndola - Zambia, No City - No Country",Unknown Date,2004-05-14,2011-05-11,INTERVENTIONAL,PHASE3,Pfizer,INDUSTRY,malaria
NCT00692627,PRiSM,COMPLETED,2008-07,Severe Falciparum Malaria,No interventions listed,Chittagong - Bangladesh,2008-12,2008-06-06,2015-01-22,OBSERVATIONAL,Not Available,University of Oxford,OTHER,malaria
NCT02313376,Unknown,COMPLETED,2014-12,Malaria,GAP3KO,Seattle - United States,2015-02,2014-12-10,2015-11-18,INTERVENTIONAL,PHASE1,Seattle Children's Hospital,OTHER,malaria
NCT03867331,Unknown,COMPLETED,2019-03-13,"Malaria,Falciparum","5 microgram VLPM01, 15 microgram VLPM01, 30 microgram VLPM01, Plasmodium falciparum challenge",Bethesda - United States,2020-05-21,2019-03-08,2021-04-08,INTERVENTIONAL,PHASE1,VLP Therapeutics,INDUSTRY,malaria
NCT00284973,Unknown,COMPLETED,2006-01,Prophylaxis Against Plasmodium Falciparum Malaria,Plasmodium falciparum Chimeric Prot. 2.9 - Montanide ISA 720,Shanghai - China,Unknown Date,2006-02-01,2015-04-14,INTERVENTIONAL,PHASE1,Shanghai Wanxing Bio-Pharmaceutical Co. Ltd.,INDUSTRY,malaria
NCT02687373,Unknown,COMPLETED,2016-07-21,Malaria,"PfSPZ Vaccine, Normal Saline",Kisian - Kenya,2018-08,2016-02-22,2019-04-19,INTERVENTIONAL,PHASE2,Sanaria Inc.,INDUSTRY,malaria
NCT03897673,OptiM,COMPLETED,2019-09-01,"Iron Deficiency Anemia, Iron-deficiency, Anemia, Iron Deficiency, Anemia, Anemia in Children, Malaria","Early Iron, Delayed Iron",Kampala - Uganda,2024-07-01,2019-04-01,2024-12-10,INTERVENTIONAL,NA,University of Minnesota,OTHER,malaria
NCT05913973,Unknown,ACTIVE_NOT_RECRUITING,2023-08-04,Malaria,Pvs230D1-EPA/Matrix-M,Bethesda - United States,2025-11-03,2023-06-22,2024-12-02,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT00443131,Unknown,COMPLETED,2007-03-26,Malaria,GSK Malaria vaccine 257049,Gent - Belgium,2007-07-01,2007-03-05,2017-04-25,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,malaria
NCT00993031,PROMOTE-PIs,COMPLETED,2009-12-15,"Malaria, HIV Infections","Lopinavir/ritonavir, Efavirenz, Zidovudine, Lamivudine",Tororo - Uganda,2013-07,2009-10-09,2019-05-14,INTERVENTIONAL,PHASE3,"University of California, San Francisco",OTHER,malaria
NCT05440773,Unknown,UNKNOWN,2023-04,Asymptomatic Malaria,"Artemisia afra tea infusions, Artemisia afra tea infusions, Artemisia afra tea infusions, Artemisia afra tea infusions, Artemisia afra tea infusions, Artemisia afra tea infusions, Flavored placebo infusions, Regular tea placebo",No locations listed,2023-06,2022-07-01,2022-07-01,INTERVENTIONAL,NA,Université Catholique de Louvain,OTHER,malaria
NCT04265573,Unknown,COMPLETED,2018-11-10,Malaria,No interventions listed,Ouagadougou - Burkina Faso,2020-12-01,2020-02-11,2022-03-25,OBSERVATIONAL,Not Available,Groupe de Recherche Action en Sante,OTHER,malaria
NCT01082731,PAACT-PF,TERMINATED,2010-11,Malaria,"Artemether-Lumefantrine, Mefloquine- Artesunate","Cruzeiro do Sul - Brazil, Porto Velho - Brazil",2012-01,2010-03-09,2012-04-13,INTERVENTIONAL,PHASE4,Centers for Disease Control and Prevention,FED,malaria
NCT01594931,Unknown,COMPLETED,2005-07,Plasmodium Falciparum Malaria,pyronaridine/artesunate,"Pailin - Cambodia, Farafenni - Gambia, Tomohon - Indonesia, Guediawaye - Senegal, Bangkok - Thailand, Mbarara - Uganda",2006-03,2012-05-09,2021-11-02,INTERVENTIONAL,PHASE2,Medicines for Malaria Venture,OTHER,malaria
NCT03765931,Unknown,COMPLETED,2016-07,Fever,"Doxycycline, Amoxicillin",Niakhar - Senegal,2017-01,2018-12-05,2018-12-05,INTERVENTIONAL,PHASE4,Institut de Recherche pour le Developpement,OTHER_GOV,malaria
NCT01810731,Unknown,WITHDRAWN,2014-04,"Influenza, Human, HIV, Malaria, Tetanus, Polio","Quadrivalent Inactivated Influenza Vaccine (QIV), Inactivated Polio Vaccine, Double Dose QIV",Siaya - Kenya,2014-04,2013-03-13,2014-04-10,INTERVENTIONAL,PHASE3,Centers for Disease Control and Prevention,FED,malaria
NCT05135273,Unknown,COMPLETED,2021-10-22,"Malaria,Falciparum","Pfs230D1-EPA/Matrix-M Vaccine, Verorab Rabies Vaccine",Bamako - Mali,2023-02-17,2021-11-26,2024-05-06,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT02661373,Unknown,COMPLETED,2016-03-01,Malaria,"SJ733, Cobicistat",Memphis - United States,2018-03-09,2016-01-22,2019-01-02,INTERVENTIONAL,PHASE1,St. Jude Children's Research Hospital,OTHER,malaria
NCT00529620,Unknown,COMPLETED,2007-09,Malaria,"sulfalene-pyrimethamine plus amodiaquine, dihydroartemisinin plus piperaquine, sulfadoxine pyrimethamine plus piperaquine",Dakar - Senegal,2007-12,2007-09-14,2010-05-27,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT01288820,ACTPQ,COMPLETED,2011-01,Vivax Malaria,"Dihydroartemisinin/piperaquine + primaquine, Artesunate-amodiaquine + primaquine",North Sumatra - Indonesia,2012-04,2011-02-02,2013-08-29,INTERVENTIONAL,PHASE3,University of Oxford,OTHER,malaria
NCT02389374,Unknown,COMPLETED,2014-08,Malaria,"chloroquine, Artemether-lumefantrine combination, Primaquine, Primaquine",No locations listed,2015-03,2015-03-17,2024-03-13,INTERVENTIONAL,PHASE4,Menzies School of Health Research,OTHER,malaria
NCT00158574,Unknown,COMPLETED,2005-01,Malaria,"sulphadoxine-pyrimethamine, mefloquine, Chlorproguanil-dapsone, Placebo, Sulphadoxine-pryrimethamine, IPTi mefloquine, Chlorproguanil dapsone",Tanga - Tanzania,2008-04,2005-09-12,2017-01-12,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT00338520,Unknown,COMPLETED,2007-10,Plasmodium Falciparum Malaria,No interventions listed,Dar es Salaam - Tanzania,2012-01,2006-06-20,2012-10-22,OBSERVATIONAL,Not Available,University of Utah,OTHER,malaria
NCT00699920,SMART-CURE,COMPLETED,2008-06,Malaria,"Coarsucam, Coartem",Kampala - Uganda,2010-06,2008-06-18,2010-06-29,INTERVENTIONAL,PHASE4,Sanofi,INDUSTRY,malaria
NCT00730782,Unknown,COMPLETED,2005-11,Plasmodium Falciparum Malaria,PfAMA-1-FVO[25-545],"Nijmegen - Netherlands, Rijswijk - Netherlands",2007-09,2008-08-08,2008-08-08,INTERVENTIONAL,PHASE1,European Vaccine Initiative,OTHER,malaria
NCT05535465,REACT-2,UNKNOWN,2021-12-01,Malaria,Public health intervention,"Bobo-Dioulasso - Burkina Faso, Bouaké - Côte D'Ivoire",2024-02-01,2022-09-10,2022-09-10,INTERVENTIONAL,NA,Institut de Recherche pour le Developpement,OTHER_GOV,malaria
NCT04709692,Unknown,COMPLETED,2021-04-14,"Malaria, Falciparum, Malaria, Vivax",(+)-SJ000557733 (SJ733),Iquitos - Peru,2022-04-15,2021-01-14,2023-12-04,INTERVENTIONAL,PHASE2,R. Kiplin Guy,OTHER,malaria
NCT04102592,Unknown,COMPLETED,2019-10-28,Malaria,"Permethrin-treated Lesu (baby wrap), Untreated Lesu (baby wrap)",Bugoye - Uganda,2020-03-04,2019-09-25,2021-03-17,INTERVENTIONAL,NA,"University of North Carolina, Chapel Hill",OTHER,malaria
NCT00371189,Unknown,COMPLETED,2007-01,Plasmodium Falciparum Infection,"Placebo, Ad35.CS.01 Circumsporozoite Malaria Vaccine","Stanford - United States, Nashville - United States",2014-06,2006-09-01,2014-09-22,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT01157689,Unknown,COMPLETED,2010-03,Malaria,No interventions listed,Bissau - Guinea-Bissau,2012-12,2010-07-07,2021-05-19,OBSERVATIONAL,Not Available,Bandim Health Project,OTHER,malaria
NCT00084240,Unknown,TERMINATED,2004-03,"Malaria, Falciparum","Azithromycin/Chloroquine, Sulfadoxine-Pyrimethamine/Chloroquine",No locations listed,Unknown Date,2004-06-11,2008-11-02,INTERVENTIONAL,PHASE3,Pfizer,INDUSTRY,malaria
NCT00944840,Unknown,COMPLETED,2008-09,Malaria,"SP plus amodiaquine, SP placebo plus amodiaquine placebo",Farafenni - Gambia,2009-07,2009-07-23,2017-01-26,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT00466557,Unknown,COMPLETED,2007-06,"Malaria, Plasmodium Falciparum Malaria",No interventions listed,West Africa - Burkina Faso,2012-04-30,2007-04-27,2019-01-31,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT03300648,TBS,COMPLETED,2018-01-08,"Malaria, Cerebral","Mechanical ventilation, Hypertonic saline",Blantyre - Malawi,2023-12-31,2017-10-03,2024-01-31,INTERVENTIONAL,PHASE3,Michigan State University,OTHER,malaria
NCT00373048,Unknown,COMPLETED,2005-10,HIV Infections,"mefloquine, placebo",Ndola - Zambia,2007-12,2006-09-07,2011-05-24,INTERVENTIONAL,NA,"Institute of Tropical Medicine, Belgium",OTHER,malaria
NCT05149157,SCRIPT,ACTIVE_NOT_RECRUITING,2022-08-02,Malaria,Symptomatic malaria,London - United Kingdom,2026-01-05,2021-12-08,2025-02-19,OBSERVATIONAL,Not Available,Imperial College London,OTHER,malaria
NCT01771848,Unknown,COMPLETED,2012-12,Malaria,PfSPZ Challenge,"Barcelona - Spain, Barcelona - Spain",2013-05,2013-01-18,2016-04-04,INTERVENTIONAL,PHASE1,Sanaria Inc.,INDUSTRY,malaria
NCT00132548,Unknown,COMPLETED,2004-06,Malaria,"Pyrimethamine/sulfadoxine, Amodiaquine, Artesunate",Dakar - Senegal,Unknown Date,2005-08-22,2017-01-12,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT02573857,DSMOZ-2,TERMINATED,2015-10,Malaria,"DSM265, OZ439",Herston - Australia,2016-05,2015-10-12,2020-06-05,INTERVENTIONAL,PHASE2,Medicines for Malaria Venture,OTHER,malaria
NCT06408857,Unknown,NOT_YET_RECRUITING,2025-03,Healthy Volunteers,"MAM01 300 mg SC, MAM01 300 mg IM, MAM01 2000 mg IV, MAM01 190 mg SC, MAM01 225 mg SC, MAM01 150 mg SC, MAM01 100 mg SC, MAM01 150 mg IM, MAM01 150 mg IV, Placebo SC, Placebo IV, Placebo IM","Kampala - Uganda, Tororo - Uganda",2026-01,2024-05-10,2025-03-12,INTERVENTIONAL,PHASE1,Bill & Melinda Gates Medical Research Institute,OTHER,malaria
NCT01623557,VAC045,COMPLETED,2012-04,Plasmodium Falciparum Malaria,"ChAd63-MVA CS, ChAd63-MVA ME-TRAP, Controlled Human Malaria Infection Administered by Mosquito Bite","Oxford - United Kingdom, London - United Kingdom, Southampton - United Kingdom",2012-11,2012-06-20,2015-02-16,INTERVENTIONAL,PHASE2,University of Oxford,OTHER,malaria
NCT03806465,MVPE,COMPLETED,2019-02-25,"Malaria,Falciparum, Feasibility, Safety, Mortality","Feasibility survey, Sentinel hospital surveillance, Community mortality surveillance","Kintampo - Ghana, Kisumu - Kenya, Blantyre - Malawi",2023-07-31,2019-01-16,2024-12-17,OBSERVATIONAL,Not Available,Rafiq OKINE,OTHER,malaria
NCT04419766,REPELMALARIA,ACTIVE_NOT_RECRUITING,2021-04-28,Malaria,IR3535 (3-(N-acetyl-N-butyl) aminopropionic acid ethyl ester) house spraying,Beira - Mozambique,2024-06-30,2020-06-05,2023-12-14,INTERVENTIONAL,NA,Universidade Nova de Lisboa,OTHER,malaria
NCT04877626,UNAL MALARIA,COMPLETED,2008-09,P. Falciparum Malaria,Artemeter plus lumefantrina vs artesunato plus amodiquina,Quibdó - Colombia,2009-10,2021-05-07,2021-05-07,INTERVENTIONAL,PHASE4,Universidad Nacional de Colombia,OTHER,malaria
NCT02878265,Unknown,COMPLETED,2011-11,Malaria,"Vitamin A, Vitamin A and ZInc, Vitamin A , Zinc and Multivitamin",Accra - Ghana,2012-05,2016-08-25,2016-08-25,INTERVENTIONAL,PHASE3,University of Ghana,OTHER,malaria
NCT00137566,Unknown,UNKNOWN,2004-05,"Malaria, Falciparum","acetaminophen (paracetamol), Placebo",Apartado 861 - Guinea-Bissau,2006-11,2005-08-30,2010-07-07,INTERVENTIONAL,PHASE4,Bandim Health Project,OTHER,malaria
NCT00673166,Unknown,COMPLETED,2008-01,"Hospital Mortality, Malaria","Staff incentive & supervision, Staff motivation",Bissau - Guinea-Bissau,2008-12,2008-05-07,2017-01-26,INTERVENTIONAL,NA,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT02604966,Unknown,UNKNOWN,2015-04,Drug Resistant Malaria Due to Plasmodium Falciparum,"Artesunate (AS) group, DHA - PPQ group",Pleiku - Vietnam,2016-09,2015-11-16,2015-12-21,INTERVENTIONAL,PHASE4,"National Institute of Malariology, Parasitology and Entomology, Vietnam",OTHER_GOV,malaria
NCT01142765,Unknown,COMPLETED,2010-06,Malaria,"AdCh63 MSP1, MVA MSP1, challenge, AdCh63 AMA1, MVA AMA1, challenge, AdCh63 AMA1, AdCh63 MSP1, MVA AMA1, MVA MSP1, challenge, AdCh63 MSP1, AdCh63 ME-TRAP, MVA MSP1, MVA ME-TRAP, challenge, Sporozoite challenge","London - United Kingdom, Oxford - United Kingdom, Southampton - United Kingdom",2011-03,2010-06-11,2011-03-28,INTERVENTIONAL,PHASE2,University of Oxford,OTHER,malaria
NCT01936766,DRIPICCO,COMPLETED,2013-05,"Malaria, Sepsis",No interventions listed,Chittagong - Bangladesh,2017-12,2013-09-06,2018-08-16,OBSERVATIONAL,Not Available,University of Oxford,OTHER,malaria
NCT04577066,Unknown,COMPLETED,2021-09-27,Plasmodium Falciparum Malaria,"GA2, GA1, Placebo",Leiden - Netherlands,2022-05-30,2020-10-06,2023-01-13,INTERVENTIONAL,PHASE2,Leiden University Medical Center,OTHER,malaria
NCT04944966,MALHERBAL,COMPLETED,2021-06-02,Malaria,Maytenus Senegalensis,Bagamoyo - Tanzania,2022-09-25,2021-06-30,2023-07-18,INTERVENTIONAL,PHASE2,Ifakara Health Institute,OTHER,malaria
NCT00465257,Unknown,SUSPENDED,2007-05,Malaria,artesunate + amodiaquine,Kivunge - Tanzania,Unknown Date,2007-04-24,2008-05-20,INTERVENTIONAL,PHASE4,Karolinska University Hospital,OTHER,malaria
NCT05285657,e-MANIC,COMPLETED,2022-02-28,Antimicrobial Resistance,"Two-step malaria RDT detecting PfHRP2/pLDH (SD Ag Bioline Malaria Ag P.f/Pan: Standard Diagnostics, Hagal-Dong, Korea)","Nanoro - Burkina Faso, Nanoro - Burkina Faso",2022-02-28,2022-03-17,2024-06-17,INTERVENTIONAL,NA,"Institut de Recherche en Sciences de la Sante, Burkina Faso",OTHER_GOV,malaria
NCT00393757,Unknown,COMPLETED,2006-10,Plasmodium Falciparum Malaria,No interventions listed,Kisumu - Kenya,2011-01-31,2006-10-29,2019-02-01,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT02698748,Cloroquina,COMPLETED,2015-01,Malaria,"Chloroquine, Placebo",Manhiça - Mozambique,2015-04,2016-03-04,2018-02-07,INTERVENTIONAL,PHASE3,Centro de Investigacao em Saude de Manhica,OTHER,malaria
NCT01878357,Unknown,COMPLETED,2013-06,Malaria,"dihydroartemisinin-piperaquine, primaquine",Betun - Indonesia,2013-11,2013-06-14,2014-01-24,INTERVENTIONAL,PHASE4,Indonesia University,OTHER,malaria
NCT06141057,Unknown,ACTIVE_NOT_RECRUITING,2023-06-06,"Malaria, Malaria,Falciparum, Protozoan Infections, Parasitic Disease, Infections, Vector Borne Diseases",Matrix M with RH5.1,Sheffield - United Kingdom,2025-07,2023-11-21,2024-10-04,INTERVENTIONAL,PHASE1,University of Oxford,OTHER,malaria
NCT00137657,Unknown,COMPLETED,2002-02,"HIV, Malaria, Diarrhea, Pneumonia, Opportunistic Infections",Cotrimoxazole (trimethoprim sulfamethoxazole),Kisumu - Kenya,Unknown Date,2005-08-30,2005-12-13,INTERVENTIONAL,PHASE4,Centers for Disease Control and Prevention,FED,malaria
NCT01464125,JP011,UNKNOWN,2008-11,Malaria,"Fosmidomycin, Azithromycin",Bangkok - Thailand,2009-10,2011-11-03,2011-11-03,INTERVENTIONAL,PHASE2,Jomaa Pharma GmbH,INDUSTRY,malaria
NCT05605925,IVIME,UNKNOWN,2022-08-04,Malaria,"Artemether/lumefantrine, Ivermectin",Kasese - Uganda,2022-12-31,2022-11-04,2022-11-04,INTERVENTIONAL,PHASE4,Makerere University,OTHER,malaria
NCT00355225,Unknown,COMPLETED,Unknown Date,Malaria,ITN distribution channel,No locations listed,Unknown Date,2006-07-21,2006-10-09,INTERVENTIONAL,NA,Heidelberg University,OTHER,malaria
NCT00378625,Unknown,COMPLETED,2000-04,"Malaria,Falciparum, Malaria, Antimalarials",Artesunate,Quibdo - Colombia,Unknown Date,2006-09-20,2006-09-20,INTERVENTIONAL,PHASE3,Centro Internacional de Entrenamiento e Investigaciones Médicas,OTHER,malaria
NCT03474822,Unknown,RECRUITING,2018-08-10,"Advanced Breast Cancer, Advanced Liver Cancer",Blood-stage infection of P.vivax,Guangzhou - China,2023-06-30,2018-03-23,2024-02-20,INTERVENTIONAL,PHASE2,"CAS Lamvac Biotech Co., Ltd.",INDUSTRY,malaria
NCT01640574,Unknown,COMPLETED,2012-02,Vivax Malaria,"Dihydroartemisinin-Piperaquine, Dihydroartemisinin-Piperaquine, Chloroquine, Chloroquine",Mae Sot - Thailand,2015-07,2012-07-13,2016-04-28,INTERVENTIONAL,PHASE3,University of Oxford,OTHER,malaria
NCT04223674,SSAT,UNKNOWN,2022-02-09,"Malaria, Vivax",Serological screen and treat,Tanjung Tiram - Indonesia,2023-05-30,2020-01-10,2023-03-07,INTERVENTIONAL,NA,Indonesia University,OTHER,malaria
NCT01658774,Unknown,COMPLETED,2013-01,"Intestinal Helminthiasis, Ascariasis, Hookworm, Malaria","Albendazole, Vitamin C",Nairobi - Kenya,2015-01,2012-08-07,2015-04-10,INTERVENTIONAL,NA,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT05270265,Unknown,TERMINATED,2022-02-09,"Malaria, Vivax",Pvs25-IMX313/Matrix-M1,Oxford - United Kingdom,2023-07-31,2022-03-08,2024-08-09,INTERVENTIONAL,PHASE1,University of Oxford,OTHER,malaria
NCT01540474,Unknown,COMPLETED,2012-02,Malaria,"Group 1: 10 ug FMP012 with 2 ug GLA-SE, Group 2: 10 ug FMP012 with 5 ug GLA-SE, 50 ug FMP012 with 5 ug GLA-SE or 2 ug GLA-SE, Controlled group-Challenged Only: no vaccination",Silver Spring - United States,2012-10,2012-02-28,2021-06-08,INTERVENTIONAL,PHASE1,U.S. Army Medical Research and Development Command,FED,malaria
NCT01374126,Unknown,COMPLETED,2011-07,Falciparum Malaria,"Artesunate, Azithromycin + Artesunate",Bandarban - Bangladesh,2012-11,2011-06-15,2013-08-23,INTERVENTIONAL,PHASE2,Medical University of Vienna,OTHER,malaria
NCT04050566,MBC,RECRUITING,2019-04-08,Malaria,No interventions listed,Agogo - Ghana,2025-04,2019-08-08,2021-09-01,OBSERVATIONAL,Not Available,Bernhard Nocht Institute for Tropical Medicine,OTHER_GOV,malaria
NCT02458066,Unknown,COMPLETED,2014-02,Malaria,"IRS: bendiocarb, IRS: deltamethrin",No locations listed,2014-09,2015-05-29,2015-05-29,INTERVENTIONAL,NA,"Medical Care Development, Inc.",OTHER,malaria
NCT00471666,Unknown,COMPLETED,2007-05-07,"Malaria, Filariasis",No interventions listed,Bamako - Mali,Unknown Date,2007-05-10,2017-07-02,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT00116766,Unknown,COMPLETED,2005-07,"Malaria, Arbovirus Infections",anti-mosquito plant use,No locations listed,Unknown Date,2005-07-01,2016-09-02,INTERVENTIONAL,PHASE2,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT01652365,Unknown,COMPLETED,2011-03,Malaria,"RDT Training and Subsidy Offered, Information/Education Campaign","Kampala - Uganda, Kampala - Uganda",2012-06,2012-07-30,2012-07-30,INTERVENTIONAL,NA,Harvard School of Public Health (HSPH),OTHER,malaria
NCT01002066,RDTACT,COMPLETED,2010-05,"Fever, Malaria",No interventions listed,Kivunge and Micheweni - Tanzania,2010-10,2009-10-27,2011-11-15,OBSERVATIONAL,Not Available,Karolinska University Hospital,OTHER,malaria
NCT04167566,Unknown,COMPLETED,2017-07-01,"Malaria, Malaria, Asymptomatic Parasitaemia",Artemisinin Combination Therapy ACTs,Accra - Ghana,2019-07-30,2019-11-19,2019-11-19,INTERVENTIONAL,NA,Noguchi Memorial Institute for Medical Research,OTHER,malaria
NCT01213966,Unknown,COMPLETED,2010-10,"Malaria, Falciparum, Malaria, Vivax",OZ439,No locations listed,2012-05,2010-10-04,2014-12-03,INTERVENTIONAL,PHASE2,Medicines for Malaria Venture,OTHER,malaria
NCT05192265,Unknown,COMPLETED,2019-05-20,"Malaria Fever, Plasmodium Falciparum Malaria, Uncomplicated Malaria","Antimalarials, pyronaridine-artesunate, Antimalarials, Artemether + Lumefantrine",Ibadan - Nigeria,2020-12-23,2022-01-14,2022-04-07,INTERVENTIONAL,PHASE3,University of Ibadan,OTHER,malaria
NCT01994525,IMRAS,COMPLETED,2014-01-24,Malaria,"PfRAS, Placebo, Challenge",Bethesda - United States,2016-12-20,2013-11-25,2019-09-17,INTERVENTIONAL,PHASE1,U.S. Army Medical Research and Development Command,FED,malaria
NCT01053325,Unknown,COMPLETED,2010-09,"Malaria in Pregnancy, HIV Infections","Cotrimoxazole prophylaxis, SP IPT",Kabuta - Zambia,2012-12,2010-01-21,2013-10-24,INTERVENTIONAL,PHASE3,"Institute of Tropical Medicine, Belgium",OTHER,malaria
NCT00360230,Unknown,COMPLETED,2006-08-30,Malaria,"GSK Biologicals' candidate Plasmodium falciparum malaria vaccine 257049, Rabipur","Kintampo - Ghana, Kumasi - Ghana",2007-08-25,2006-08-04,2018-02-19,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,malaria
NCT04182126,Unknown,COMPLETED,2019-12-01,"LLIN, PBO LLIN, IRS, Larviciding","Regular long-lasting insecticidal nets, LLIN plus Piperonyl butoxide-treated LLIN, Long-lasting microbial larvicide, Indoor residual spraying with micro-encapsulated pirimiphos-methyl or other insecticides","Irvine - United States, Homa Bay - Kenya",2024-08-31,2019-12-02,2024-10-15,INTERVENTIONAL,NA,"University of California, Irvine",OTHER,malaria
NCT01058226,Unknown,COMPLETED,2010-02,Healthy,Malaria challenge (wild-type NF54 strain Plasmodium falciparum sporozoites),Seattle - United States,2010-05,2010-01-28,2011-03-31,INTERVENTIONAL,PHASE1,Seattle Children's Hospital,OTHER,malaria
NCT02092766,DHART,COMPLETED,2014-06,Anaemia,"artesunate, quinine","Kinshasa - Congo, The Democratic Republic of the",2015-04,2014-03-20,2015-06-01,INTERVENTIONAL,PHASE4,University of Oxford,OTHER,malaria
NCT01283165,Zimworms,COMPLETED,2003-04,Integrated Control of Malaria and Polyparasitism,Health education intervention,Harare - Zimbabwe,2006-06,2011-01-25,2011-11-10,OBSERVATIONAL,Not Available,University of Zimbabwe,OTHER,malaria
NCT00646126,Unknown,COMPLETED,2005-08,"Plasmodium Falciparum, Asymptomatic Parataemia, Sub Patent Parasitaemia","Sulfadoxine / Pyrimethamine (SP) plus artesunate (AS), placebo tablet similar to active drug in shape and size",Khartoum - Sudan,Unknown Date,2008-03-28,2008-03-28,INTERVENTIONAL,PHASE3,Tropical Medicine Research Institute,OTHER,malaria
NCT01666925,Unknown,COMPLETED,2012-03,Malaria,"ChAd63 ME-TRAP / MVA ME-TRAP prime-boost immunisation, Rabies vaccine",Kilifi - Kenya,2012-08,2012-08-16,2013-12-12,INTERVENTIONAL,PHASE2,University of Oxford,OTHER,malaria
NCT00323622,Unknown,COMPLETED,2005-04,Malaria,"GSK Biologicals' candidate Plasmodium falciparum malaria vaccine 257049, Engerix™-B, Hiberix®, Prevnar™, sulfadoxine-pyrimethamine, amodiaquine",Maputo - Mozambique,2007-05,2006-05-09,2016-12-09,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,malaria
NCT03923725,DeTACT-Africa,RECRUITING,2020-09-01,Plasmodium Falciparum Malaria (Uncomplicated),"Artemether-lumefantrine+ Amodiaquine (AL+AQ), Artemether-lumefantrine + placebo (AL+PBO), Artesunate-mefloquine+piperaquine (AS-MQ+PPQ), Artesunate-mefloquine+placebo (AS-MQ+PBO)","Bobo-Dioulasso 01 - Burkina Faso, Kinshasa - Congo, The Democratic Republic of the, Fajara - Gambia, Conakry - Guinea, Ilorin - Nigeria, Niamey - Niger, Kigali - Rwanda, Tanga - Tanzania",2024-03-15,2019-04-23,2024-03-27,INTERVENTIONAL,PHASE3,University of Oxford,OTHER,malaria
NCT03754322,LAMPREG,COMPLETED,2021-06-18,"Malaria, Pregnancy Malaria, Malaria in Pregnancy","LAMP, Microscopy/RDT","Calgary - Canada, Bahir Dar - Ethiopia, Jimma - Ethiopia, Addis Ababa - Ethiopia",2023-11-20,2018-11-27,2024-12-04,INTERVENTIONAL,NA,University of Calgary,OTHER,malaria
NCT02557425,PROTECT,COMPLETED,2015-10,Neurobehavioral Manifestations,No intervention in PROTECT,Tororo - Uganda,2021-08-05,2015-09-23,2021-08-25,OBSERVATIONAL,Not Available,Indiana University,OTHER,malaria
NCT02793622,PROMOTE-BC3,COMPLETED,2016-09,Malaria,"Monthly Sulfadoxine-Pyrimethamine (SP) During Pregnancy, Monthly Dihydroartemisinin-Piperaquine (DP) During Pregnancy",Tororo - Uganda,2018-12-04,2016-06-08,2021-04-14,INTERVENTIONAL,PHASE3,"University of California, San Francisco",OTHER,malaria
NCT01976325,OMDA,UNKNOWN,2014-01,Malaria,Ottawa Malaria Decision Aid,"Ottawa - Canada, Ottawa - Canada, Toronto - Canada",2015-11,2013-11-05,2015-04-16,INTERVENTIONAL,NA,Ottawa Hospital Research Institute,OTHER,malaria
NCT00460525,Unknown,COMPLETED,2007-05,Plasmodium Falciparum Malaria,"FMP2.1/AS02A, Rabies Vaccine",Bamako - Mali,2009-07,2007-04-16,2018-11-09,INTERVENTIONAL,PHASE2,U.S. Army Medical Research and Development Command,FED,malaria
NCT02536222,Unknown,COMPLETED,2015-09,Malaria,Case investigation of malaria passively detected cases with FT/FDA,"Oudallaye, Mbem-Mbem, Salalatou, Doundé, Nianghana, Gassane - Senegal",2016-07,2015-08-31,2016-09-15,INTERVENTIONAL,PHASE4,PATH,OTHER,malaria
NCT05012280,Palu-COVID,TERMINATED,2021-09-04,"Covid19, Paludism",No interventions listed,"Kinshasa - Congo, The Democratic Republic of the",2022-08-17,2021-08-19,2024-10-17,OBSERVATIONAL,Not Available,"Institute of Tropical Medicine, Belgium",OTHER,malaria
NCT00294580,Unknown,COMPLETED,1982-04,Malaria,Maloprim,Farafenni - Gambia,Unknown Date,2006-02-22,2023-10-03,INTERVENTIONAL,PHASE4,Imperial College London,OTHER,malaria
NCT00367380,Unknown,COMPLETED,2006-12,"MALARIA, FEVER, Sweating Fever, Chills, ANEMIA","413ABM, 414WRR, 418JAL",Cali - Colombia,2006-12,2006-08-22,2021-03-22,INTERVENTIONAL,PHASE2,Malaria Vaccine and Drug Development Center,OTHER,malaria
NCT04336189,Unknown,COMPLETED,2020-12-28,Malaria,"Sulfadoxine-pyrimethamine (SP), Dihydroartemisinin-piperaquine (DP)",Masafu - Uganda,2024-07-28,2020-04-07,2024-08-20,INTERVENTIONAL,PHASE3,"Grant Dorsey, M.D, Ph.D.",OTHER,malaria
NCT01500980,ITV,COMPLETED,2011-12,Malaria,"P. falciparum infection, Chloroquine, Primaquine, Primaquine",Seattle - United States,2012-07,2011-12-29,2012-12-13,INTERVENTIONAL,PHASE1,Seattle Children's Hospital,OTHER,malaria
NCT04176029,LUSiSM,COMPLETED,2019-12-09,Severe Malaria,lung ultrasound,"Kinshasa - Congo, The Democratic Republic of the",2021-10-01,2019-11-25,2022-06-22,OBSERVATIONAL,Not Available,University of Oxford,OTHER,malaria
NCT02211729,SMCAZ,COMPLETED,2014-05,"Malaria, Respiratory Infections","Sulphadoxine-Pyrimethamine+ Amodiaquine+ Azithromycin, Sulphadoxine-pyrimethamine + amodiaquine + placebo azithromycin","Hounde - Burkina Faso, Bougouni - Mali",2017-12-31,2014-08-07,2018-03-07,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT05357560,Unknown,RECRUITING,2023-07-10,"Malaria, Plasmodium Falciparum",Matrix-M with RH5.2 VLP and/or R21,Banjul - Gambia,2025-07,2022-05-03,2023-07-25,INTERVENTIONAL,PHASE1,University of Oxford,OTHER,malaria
NCT02353494,Unknown,COMPLETED,2015-03,"Plasmodium Falciparum Infection, Plasmodium Vivax Infection",Dihydroartemisinin-Piperaquine,Timika - Indonesia,2016-05,2015-02-02,2017-02-01,OBSERVATIONAL,Not Available,Menzies School of Health Research,OTHER,malaria
NCT05788094,ACTQ,RECRUITING,2023-06-26,"Malaria, Malaria, Vivax, Plasmodium Vivax Malaria","Dihydroartemisinin-piperaquine plus tafenoquine (450 mg adult dose), Chloroquine plus Tafenoquine (450 mg adult dose), Artemether-Lumefantrine plus Tafenoquine (450 mg adult dose)",Mae Sot - Thailand,2025-02-28,2023-03-28,2024-12-03,INTERVENTIONAL,PHASE4,Shoklo Malaria Research Unit,OTHER,malaria
NCT04157894,Unknown,COMPLETED,2019-07-07,Malaria,"Standard long-lasting insecticidal net, Chlorfenapyr insecticide treated net, Piperonyl butoxide long-lasting insecticidal net",Ouagadougou - Burkina Faso,2022-07-06,2019-11-08,2022-12-13,OBSERVATIONAL,Not Available,PATH,OTHER,malaria
NCT06666491,Unknown,RECRUITING,2024-11-13,"Malaria, Vivax","Tafenoquine, Primaquine, Chloroquine","Mumbai - India, Surat - India",2026-07-06,2024-10-30,2024-12-13,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,malaria
NCT03304691,Unknown,COMPLETED,2021-06-30,Malaria,No interventions listed,"Bamako - Mali, Bandiagara - Mali",2023-03-01,2017-10-09,2023-10-31,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT00131794,Unknown,COMPLETED,2003-01,Malaria,BCG,Bissau - Guinea-Bissau,Unknown Date,2005-08-19,2016-09-02,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT01716260,Unknown,COMPLETED,2013-01,Vivax Malaria,"Chloroquine, Primaquine",Gelephu - Bhutan,2015-10,2012-10-29,2016-05-27,OBSERVATIONAL,Not Available,Menzies School of Health Research,OTHER,malaria
NCT04094727,Unknown,COMPLETED,2019-10-31,Malaria,"Presumptive treatment with Artemether-lumefantrine (AL), Enhanced vector control",Windhoek - Namibia,2020-06-30,2019-09-19,2020-11-03,INTERVENTIONAL,PHASE4,"University of California, San Francisco",OTHER,malaria
NCT03764527,AcoI,COMPLETED,2002-11-01,Plasmodium Falciparum Malaria,"Artemether-lumefantrine, Coadministered Artesunate plus Amodiaquine",No locations listed,2003-02-17,2018-12-05,2018-12-06,INTERVENTIONAL,PHASE4,Professor Anders Björkman,OTHER,malaria
NCT01214876,Unknown,COMPLETED,2010-08,"Malaria, Schistosomiasis, Hiv Infection",No interventions listed,Kampala - Uganda,2011-03,2010-10-05,2011-03-04,OBSERVATIONAL,Not Available,Radboud University Medical Center,OTHER,malaria
NCT02014727,AMA1-DiCo,COMPLETED,2014-01,"Malaria, Falciparum","Group A1 : 50µg AMA1-DiCo + Alhydrogel, Group A2 : 50 µg AMA1-DiCo+ GLA-SE, Group B2 : Placebo","Ouagadougou - Burkina Faso, Hôpital Cochin Bâtiment Lavoisier 27 rue du faubourg St Jacqu - France",2015-03,2013-12-18,2016-02-02,INTERVENTIONAL,PHASE1,"Institut National de la Santé Et de la Recherche Médicale, France",OTHER_GOV,malaria
NCT05232227,Unknown,WITHDRAWN,2023-01-20,"Malaria, Vivax, Relapse","Primaquine double dose over 14 days, Primaquine single dose over 14 days",No locations listed,2023-06-05,2022-02-09,2023-05-11,INTERVENTIONAL,PHASE3,"University of California, San Francisco",OTHER,malaria
NCT00084227,Unknown,COMPLETED,2004-07,"Malaria, Falciparum","Azithromycin/Chloroquine, Atovaquone/Proguanil",No locations listed,Unknown Date,2004-06-11,2011-05-11,INTERVENTIONAL,PHASE3,Pfizer,INDUSTRY,malaria
NCT01843491,AdBa,WITHDRAWN,2013-06,"Healthy, Malaria",Ad-PfCA,Bethesda - United States,2014-06,2013-04-30,2015-04-30,INTERVENTIONAL,PHASE1,U.S. Army Medical Research and Development Command,FED,malaria
NCT01632891,Unknown,COMPLETED,2014-01-10,"HIV-1 Infection, Pf Subclinical Parasitemia","Lopinavir/ritonavir, Emtricitabine/tenofovir disoproxil fumarate, Efavirenz, Nevirapine, Trimethoprim/sulfamethoxazole","Eldoret - Kenya, Kericho - Kenya, Kisumu - Kenya, Blantyre - Malawi, Kampala - Uganda",2016-06-19,2012-07-03,2019-08-06,INTERVENTIONAL,PHASE2,Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections,NETWORK,malaria
NCT06064591,IMMETASEX,RECRUITING,2023-12-13,"Severe Malaria, Uncomplicated Malaria, Asyptomatic Plasmodium Infection",No interventions listed,"Antwerp - Belgium, Nanoro - Burkina Faso, Maputo - Mozambique",2025-12,2023-10-03,2024-02-01,OBSERVATIONAL,Not Available,"Institute of Tropical Medicine, Belgium",OTHER,malaria
NCT00694694,CAZAMS,COMPLETED,2008-06,Malaria,"azithromycin + artesunate, artemether-lumefantrine",Muheza - Tanzania,2008-12,2008-06-10,2016-10-20,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT00486694,Unknown,COMPLETED,2004-03,"Malaria, Vivax","Sulfadoxine-pyrimethamine + artesunate, Chloroquine",No locations listed,Unknown Date,2007-06-15,2007-06-15,INTERVENTIONAL,PHASE2,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT03056391,PACKNOW,COMPLETED,2016-10,Malaria,Paracetamol,"Keningau - Malaysia, Kota Kinabalu - Malaysia, Kota Marudu - Malaysia, Ranau - Malaysia",2018-02-01,2017-02-17,2019-12-19,INTERVENTIONAL,PHASE3,Menzies School of Health Research,OTHER,malaria
NCT01708876,ACT KNOW,COMPLETED,2012-10,Uncomplicated Plasmodium Knowlesi Malaria,"Artesunate-mefloquine, Chloroquine, Primaquine","Kota Marudu - Malaysia, Kudat - Malaysia, Pitas - Malaysia",2014-12,2012-10-17,2015-04-09,INTERVENTIONAL,PHASE3,Menzies School of Health Research,OTHER,malaria
NCT05924776,Unknown,NOT_YET_RECRUITING,2024-07-20,Advanced Ovarian Cancer,Plasmodium immunotherapy,Guangzhou - China,2026-11-30,2023-06-29,2024-07-22,INTERVENTIONAL,PHASE3,"CAS Lamvac (Guangzhou) Biomedical Technology Co., Ltd.",INDUSTRY,malaria
NCT00118027,Unknown,COMPLETED,2003-05,"Malaria, Pregnancy, Anemia",sulphadoxine-pyrimethamine intermittent preventive treatment,Mukono - Uganda,Unknown Date,2005-07-11,2017-01-12,INTERVENTIONAL,NA,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT02590627,WB-Malaria,COMPLETED,2014-05,Malaria,"Artemether-lumefantrine, Dihydroartemisinin-piperaquine","Ujiji - Tanzania, Muheza - Tanzania",2015-12,2015-10-29,2017-12-26,INTERVENTIONAL,PHASE4,"National Institute for Medical Research, Tanzania",OTHER_GOV,malaria
NCT02411994,PAAL,COMPLETED,2015-10,Malaria,"Pyronaridine-artesunate, Artemether-lumefantrine combination",Mbita - Kenya,2017-08,2015-04-08,2017-11-27,INTERVENTIONAL,PHASE3,Royal Tropical Institute,OTHER,malaria
NCT02894294,Unknown,COMPLETED,2014-07,"Malaria, Anemia",implementation of seasonal malaria chemoprevention,No locations listed,2015-03,2016-09-09,2016-09-14,OBSERVATIONAL,Not Available,University of Bamako,OTHER,malaria
NCT00499876,Unknown,COMPLETED,2007-10,"HIV Infections, Malaria","mefloquine, placebo",Kumasi - Ghana,2008-10,2007-07-12,2017-01-26,INTERVENTIONAL,NA,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT03394976,Unknown,WITHDRAWN,2022-01-31,Human African Trypanosomiasis,No intervention,No locations listed,2022-12-31,2018-01-09,2024-01-09,OBSERVATIONAL,Not Available,"Foundation for Innovative New Diagnostics, Switzerland",OTHER,malaria
NCT06182176,MALHELMIN,NOT_YET_RECRUITING,2024-05-27,"Malaria, Soil Transmitted Helminths, Schistosomiasis, Seasonal Malaria Chemoprevention, Mass Drug Administration With Anthelminthic Drugs",Sulphadoxine-pyrimethamine and Amodiaquine,No locations listed,2024-11-29,2023-12-26,2024-03-20,INTERVENTIONAL,NA,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT00209794,Unknown,UNKNOWN,2002-09,Malaria,Sulfadoxine-Pyrimethamine (Fansidar),Manhiça - Mozambique,Unknown Date,2005-09-21,2006-11-16,INTERVENTIONAL,PHASE2,Hospital Clinic of Barcelona,OTHER,malaria
NCT03589794,Unknown,COMPLETED,2018-12-21,Plasmodium Falciparum Infection,"AP10-602, Malaria challenge, rCSP",Baltimore - United States,2022-07-05,2018-07-18,2023-07-10,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT00890760,Unknown,COMPLETED,2009-03,Malaria,"AdCh63 ME-TRAP, MVA ME-TRAP, Sporozoite challenge, Mixture of AdCh63 ME-TRAP and MVA ME-TRAP intramuscularly",Oxford - United Kingdom,2010-02,2009-04-30,2012-11-29,INTERVENTIONAL,PHASE2,University of Oxford,OTHER,malaria
NCT00550160,KNUST-COMDIS,COMPLETED,2007-04,Malaria,Amodiaquine plus Artesunate co-administration,Ejisu - Ghana,2008-05,2007-10-29,2015-09-18,INTERVENTIONAL,PHASE4,Kwame Nkrumah University of Science and Technology,OTHER,malaria
NCT06148792,TADORE,RECRUITING,2024-05-10,Vivax Malaria,"Tafenoquine, Primaquine","Manaus - Brazil, Arba Minch - Ethiopia, Timika - Indonesia, Alexishafen - Papua New Guinea",2027-03-01,2023-11-28,2024-08-29,INTERVENTIONAL,PHASE3,Menzies School of Health Research,OTHER,malaria
NCT05790889,Unknown,RECRUITING,2023-04-03,"Malaria,Falciparum","Rabies vaccine, RH5.1 10μg adjuvated with 50μg Matrix-M, RH5.2 5μg adjuvated with 50μg Matrix-M",Sigle - Burkina Faso,2026-05-30,2023-03-30,2025-03-07,INTERVENTIONAL,PHASE2,University of Oxford,OTHER,malaria
NCT03797989,Unknown,UNKNOWN,2019-01-10,"Malaria, Vivax",P. vivax infected inoculum (parasitised red blood cells),Oxford - United Kingdom,2022-12-31,2019-01-09,2022-08-17,INTERVENTIONAL,PHASE1,University of Oxford,OTHER,malaria
NCT01546389,Unknown,COMPLETED,2012-04,Malaria,"Sanaria™ PfSPZ Vaccine, Chloroquine",Baltimore - United States,2013-04,2012-03-07,2013-09-13,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT01397227,Unknown,COMPLETED,2011-06,Malaria,"Ad35.CS.01/Ad26.CS.01 low dose (1 x 10^10 vp), Ad 35.CS.01/Ad 26.CS.01 high dose (5 x 10^10 vp), Placebo",Seattle - United States,2012-05,2011-07-19,2012-09-07,INTERVENTIONAL,PHASE2,Crucell Holland BV,INDUSTRY,malaria
NCT05186363,Unknown,ACTIVE_NOT_RECRUITING,2022-01-08,Malaria,"Chemopreventive Agent - SPAQ, Control Test - no drugs given","Nampula - Mozambique, Nampula - Mozambique",2022-06-21,2022-01-11,2023-11-02,INTERVENTIONAL,PHASE4,Malaria Consortium,OTHER,malaria
NCT02237586,Unknown,COMPLETED,2014-07,"Plasmodium Falciparum Malaria, Malaria",PfSPZ Challenge,Lambaréné - Gabon,2014-09,2014-09-11,2015-04-23,INTERVENTIONAL,PHASE1,Sanaria Inc.,INDUSTRY,malaria
NCT04695886,Unknown,UNKNOWN,2021-01,Malaria,Community-delivered Integrated Malaria Elimination (CIME) intervention model,No locations listed,2021-07,2021-01-05,2021-01-05,INTERVENTIONAL,NA,Macfarlane Burnet Institute for Medical Research and Public Health Ltd,OTHER,malaria
NCT00426439,Unknown,COMPLETED,2006-12,"Malaria, Falciparum","Chloroquine, Artemether-lumefantrine (Coartem)",Apartado 861 - Guinea-Bissau,2008-11,2007-01-24,2011-01-04,INTERVENTIONAL,PHASE4,Bandim Health Project,OTHER,malaria
NCT01062386,Unknown,COMPLETED,2010-01,Malaria,No interventions listed,Mbarara - Uganda,2010-02,2010-02-04,2011-08-12,OBSERVATIONAL,Not Available,Epicentre,OTHER,malaria
NCT03432039,Unknown,COMPLETED,2018-01-09,Malaria,"Psychoeducation, Behavioral",Kampala - Uganda,2019-07-31,2018-02-13,2020-09-04,INTERVENTIONAL,NA,Makerere University,OTHER,malaria
NCT00206739,Unknown,COMPLETED,2003-01,"Malaria, Anemia",Sulfadoxine (12.5 mg)/Pyrimethamine (250 mg),Kumasi - Ghana,2005-09,2005-09-21,2010-03-30,INTERVENTIONAL,PHASE4,Bernhard Nocht Institute for Tropical Medicine,OTHER_GOV,malaria
NCT02721186,MaDrAZ,COMPLETED,2016-04-30,"Malaria, Plasmodium Infections",MDA with DHAp and SLD Primaquine,Mwanakwerekwe - Tanzania,2016-12-31,2016-03-29,2017-10-05,INTERVENTIONAL,NA,Ulrika Morris,OTHER,malaria
NCT02610686,Unknown,UNKNOWN,2015-03,Plasmodium Vivax,Chloroquine,Pleiku - Vietnam,2016-10,2015-11-20,2016-03-23,INTERVENTIONAL,PHASE4,"National Institute of Malariology, Parasitology and Entomology, Vietnam",OTHER_GOV,malaria
NCT00984763,Unknown,COMPLETED,2010-01,Malaria,AMA1-C1/Alhydrogel® + CPG 7909,"Oxford, Headington - United Kingdom",2010-09,2009-09-25,2015-05-28,INTERVENTIONAL,PHASE2,University of Oxford,OTHER,malaria
NCT00312663,Unknown,COMPLETED,2006-04,Plasmodium Falciparum Malaria,Falciparum Malaria Protein 11 with AS01B adjuvant.,Silver Spring - United States,2006-10,2006-04-10,2018-11-26,INTERVENTIONAL,PHASE2,U.S. Army Medical Research and Development Command,FED,malaria
NCT00386763,Unknown,COMPLETED,2006-08,"Malaria, Falciparum",Artemether-lumefantrine,"Benin - Benin, Kenya - Kenya, Mali - Mali, Mozambique - Mozambique, Tanzania - Tanzania",Unknown Date,2006-10-12,2009-03-12,INTERVENTIONAL,PHASE3,Novartis,INDUSTRY,malaria
NCT01027663,Unknown,COMPLETED,2009-11,"Iron Deficiency Anemia, Malaria",Iron Supplement,Chapel Hill - United States,2015-01,2009-12-09,2016-08-08,INTERVENTIONAL,NA,"University of North Carolina, Chapel Hill",OTHER,malaria
NCT00082563,Unknown,TERMINATED,2004-08,"Malaria, Falciparum","Azithromycin/Chloroquine, Chloroquine",No locations listed,Unknown Date,2004-05-14,2011-04-26,INTERVENTIONAL,PHASE2,Pfizer,INDUSTRY,malaria
NCT02739763,CHMI-SIKA,UNKNOWN,2016-05,Malaria,Plasmodium falciparum sporozoite (PfSPZ),"Kilifi - Kenya, Nairobi - Kenya",2020-01,2016-04-15,2016-05-30,INTERVENTIONAL,PHASE1,University of Oxford,OTHER,malaria
NCT06172686,Unknown,NOT_YET_RECRUITING,2024-01-09,"Controlled Human Malaria Infection, Induced Blood Stage Malaria Infection, Malaria Transmission, Malaria Challenge","Piperaquine tablets , which will be administered orally as a single dose of 480mg (320mg+160mg)., Doxycycline (100mg tablets strength as Doxycycline Hyclate) will also be administered orally and will be given as 1 tablet (100mg) Once daily for 7 days.",Pwani - Tanzania,2024-02-13,2023-12-15,2023-12-15,INTERVENTIONAL,PHASE1,Ifakara Health Institute,OTHER,malaria
NCT01108939,Unknown,COMPLETED,2009-02,"Malaria, Falciparum","Antimalarial treatment, Observation",Natitingou - Benin,2009-09,2010-04-22,2013-06-07,INTERVENTIONAL,PHASE1,Swiss Federal Institute of Technology,OTHER,malaria
NCT02389439,Unknown,COMPLETED,2015-03-01,"Malaria, Falciparum",Pyronaridine-artesunate,"Battambang - Cambodia, Pailin - Cambodia, Pursat) - Cambodia",2015-12-01,2015-03-17,2018-09-20,INTERVENTIONAL,PHASE2,University of Oxford,OTHER,malaria
NCT02461186,Unknown,WITHDRAWN,2015-06,"Uncomplicated Falciparum Malaria, Artemisinin-resistant","Arterolane maleate-piperaquine phosphate (Synriam), Dihydroartemisinin-piperaquine phosphate (Duocotexin)",No locations listed,2017-06,2015-06-03,2015-11-03,INTERVENTIONAL,PHASE3,University of Oxford,OTHER,malaria
NCT00344539,Unknown,COMPLETED,2005-05,Plasmodium Falciparum Malaria,"AMA1-C1/Alhydrogel®, CPG 7909 Oligodeoxynucleotide (VaxImmune®)",Rochester - United States,2007-01,2006-06-26,2013-06-03,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT06293339,Unknown,NOT_YET_RECRUITING,2025-03-01,"Malaria,Falciparum",CHMI with 3D7 malaria,No locations listed,2025-07-01,2024-03-05,2024-12-27,INTERVENTIONAL,PHASE1,Leiden University Medical Center,OTHER,malaria
NCT01115439,ASPF,COMPLETED,2010-03,Falciparum Malaria,artesunate plus sulfadoxine-pyrimethamine (AS+SP),"Maimana - Afghanistan, Asadabad - Afghanistan, Jalalabad - Afghanistan, Taloqan - Afghanistan",2011-04,2010-05-04,2012-07-12,OBSERVATIONAL,Not Available,University of Oxford,OTHER,malaria
NCT03660839,Unknown,COMPLETED,2018-09-11,Plasmodium Falciparum Infection,"Artefenomel (OZ439), Ferroquine (SSR97193)","Cotonou - Benin, Banfora - Burkina Faso, Ouagadougou - Burkina Faso, Lambarene - Gabon, Libreville - Gabon, Siaya - Kenya, Tororo - Uganda",2019-11-06,2018-09-07,2022-03-21,INTERVENTIONAL,PHASE2,Sanofi,INDUSTRY,malaria
NCT00167739,Unknown,COMPLETED,2003-04,Malaria,Quinine plus sulfadoxine-pyrimethamine,Lambaréné - Gabon,Unknown Date,2005-09-14,2005-09-21,INTERVENTIONAL,PHASE4,Albert Schweitzer Hospital,OTHER,malaria
NCT01443130,Unknown,COMPLETED,2012-02,Malaria,"Chloroquine, Sulfadoxine-pyrimethamine",Blantryre - Malawi,2014-10,2011-09-29,2016-12-28,INTERVENTIONAL,PHASE3,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT04704830,Unknown,ACTIVE_NOT_RECRUITING,2021-04-29,Malaria,"R21/Matrix-M, Rabies vaccine or Hepatitis A vaccine",Oxford - United Kingdom,2023-03-21,2021-01-12,2024-05-17,INTERVENTIONAL,PHASE3,University of Oxford,OTHER,malaria
NCT01319448,Unknown,COMPLETED,2011-09,"Malaria, Sickle Cell Crisis","Proguanil, mefloquine plus artesunate, Sulfadoxine-pyrimethamine plus amodiaquine",Ilorin - Nigeria,2013-04,2011-03-21,2014-03-21,INTERVENTIONAL,PHASE2,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT02389348,OZ/DSMCombo,COMPLETED,2015-02,Malaria,"DSM265, OZ439",Herston - Australia,2015-06,2015-03-17,2015-10-07,INTERVENTIONAL,PHASE2,Medicines for Malaria Venture,OTHER,malaria
NCT06036030,MCMPFPB,COMPLETED,2019-01-11,"Malaria,Falciparum, Malaria, Vivax, Malaria, Infections, Uncomplicated Malaria, Uncomplicated Plasmodium Falciparum","Dihydroartemisinin, Piperaquine, Primaquine, Momordica Charantia Extract",Manokwari - Indonesia,2019-04-16,2023-09-13,2023-09-13,INTERVENTIONAL,PHASE2,"Syamsudin Abdillah,Ph.D, Pharm D",OTHER,malaria
NCT01379430,Unknown,COMPLETED,2010-06,Malaria,"AdCh63 ME-TRAP followed by MVA ME-TRAP, AdCh63 ME-TRAP followed by MVA ME-TRAP",Kilifi - Kenya,2011-05,2011-06-23,2012-10-03,INTERVENTIONAL,PHASE1,University of Oxford,OTHER,malaria
NCT00270530,Unknown,COMPLETED,2002-11,"Placental Malaria Infection, HIV Infections, Stillbirth, Prematurity, Neonatal Deaths",Sulfadoxine-pyrimethamine (Fansidar),Ndola - Zambia,Unknown Date,2005-12-28,2006-01-31,INTERVENTIONAL,PHASE4,Center for International Health and Development,OTHER,malaria
NCT06068530,MVDA,RECRUITING,2025-02-15,Plasmodium Falciparum Malaria,"DHA/piperaquine and a SLD-PQ, Study vaccine R21/Matrix-M™","Bāndarban - Bangladesh, Lama - Bangladesh",2028-02-01,2023-10-05,2025-02-24,INTERVENTIONAL,PHASE4,University of Oxford,OTHER,malaria
NCT02020330,AL3vs5,COMPLETED,2013-11-25,Plasmodium Falciparum Infection,"Artemether-lumefantrine 3 days, Artemether-lumefantrine 5 days",Yangon - Myanmar,2015-02-04,2013-12-24,2018-09-20,INTERVENTIONAL,PHASE3,University of Oxford,OTHER,malaria
NCT05391230,Unknown,ACTIVE_NOT_RECRUITING,2022-06-03,"Malaria, P. Falciparum","Permethrin-treated lesu, Untreated lesu",Mbarara - Uganda,2025-06,2022-05-25,2025-01-30,INTERVENTIONAL,NA,"University of North Carolina, Chapel Hill",OTHER,malaria
NCT05816330,Unknown,COMPLETED,2023-05-25,"Plasmodium Falciparum Infection, Malaria","L9LS (VRC-MALMAB0114-00-AB), Normal Saline","Faladje - Mali, Kalifabougou - Mali, Torodo - Mali",2024-02-11,2023-04-18,2024-04-17,INTERVENTIONAL,PHASE2,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT04289558,Unknown,WITHDRAWN,2021-06-01,Falciparum Malaria,Sodium Nitrite,Dar es Salaam - Tanzania,2021-10-01,2020-02-28,2021-03-16,INTERVENTIONAL,PHASE1,Duke University,OTHER,malaria
NCT00371735,Unknown,COMPLETED,2006-04,"Malaria, Falciparum","chlorproguanil-dapsone-artesunate, chlorproguanil-dapsone","Ouagadougou - Burkina Faso, Kumasi - Ghana, Bamako - Mali, Ile-Ife - Nigeria, Jos - Nigeria, Lagos - Nigeria, Maiduguri - Nigeria",2007-05,2006-09-04,2016-12-05,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,malaria
NCT06472258,Unknown,COMPLETED,2023-03-01,Malaria,"IV Artesunate, IV Quinine Hydrochloride",Dera Ghazi Khan - Pakistan,2023-06-30,2024-06-25,2024-06-26,INTERVENTIONAL,NA,"RESnTEC, Institute of Research",OTHER,malaria
NCT00261222,Unknown,COMPLETED,2005-09,Malaria,Amodiaquine,Nouna - Burkina Faso,Unknown Date,2005-12-02,2010-02-03,INTERVENTIONAL,PHASE2,Heidelberg University,OTHER,malaria
NCT04940130,Unknown,COMPLETED,2022-04-01,"Malaria, Malaria,Falciparum","Sanaria® PfSPZ Vaccine, Normal Saline",Bamako - Mali,2022-12-10,2021-06-25,2024-02-07,INTERVENTIONAL,PHASE2,Sanaria Inc.,INDUSTRY,malaria
NCT02394522,SR-M-ZM,WITHDRAWN,2016-03,Malaria,"Spatial Repellent product with active ingredient (SHIELD), Active Ingredient, Spatial Repellent product without active ingredient (SHIELD)",Macha - Zambia,2016-04,2015-03-20,2016-10-06,INTERVENTIONAL,NA,University of Notre Dame,OTHER,malaria
NCT00304980,Unknown,TERMINATED,2003-03,Plasmodium Falciparum Malaria,ARTEMETHER + LUMEFANTRINE VS. SULFADOXINE + PYRIMETHAMINE,Ndola - Zambia,Unknown Date,2006-03-21,2010-09-14,INTERVENTIONAL,NA,"Institute of Tropical Medicine, Belgium",OTHER,malaria
NCT00666380,Unknown,COMPLETED,2008-04,Malaria,Plasmodium falciparum Malaria Protein 010 (FMP010),"Silver Spring - United States, Kombewa, Kisumu - Kenya",2008-12,2008-04-24,2015-05-29,INTERVENTIONAL,PHASE1,U.S. Army Medical Research and Development Command,FED,malaria
NCT00125489,Unknown,COMPLETED,2005-05,"Malaria, Plasmodium Falciparum Malaria","chloroquine sulfate, sulfadoxine/pyrimethamine",Blantyre - Malawi,Unknown Date,2005-08-01,2010-08-27,INTERVENTIONAL,PHASE4,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT00138489,Unknown,TERMINATED,2004-02-10,Plasmodium Vivax Malaria,No interventions listed,Goroka - Papua New Guinea,Unknown Date,2005-08-30,2019-02-04,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT05471544,Unknown,ACTIVE_NOT_RECRUITING,2022-07-18,Malaria,"Sulfadoxine pyrimethamine, Amodiaquine",Aweil - South Sudan,2024-12-15,2022-07-25,2024-03-25,INTERVENTIONAL,PHASE3,Malaria Consortium,OTHER,malaria
NCT00424944,Unknown,UNKNOWN,2007-06,Malaria,"GMZ2 (malaria vaccine), GMZ2 malaria vaccine, Verorab vaccine",Lambarene - Gabon,2008-07,2007-01-22,2008-04-03,INTERVENTIONAL,PHASE1,African Malaria Network Trust,NETWORK,malaria
NCT04864444,Unknown,COMPLETED,2021-06-19,"Malaria,Falciparum, Malaria","Dihydroartemisinin-piperaquine, Primaquine",Tambacounda - Senegal,2022-12-31,2021-04-28,2024-06-24,INTERVENTIONAL,NA,"University of California, San Francisco",OTHER,malaria
NCT01775592,Unknown,COMPLETED,2012-09,Plasmodium Falciparum,Arterakin (DHA-PPQ),Tra Leng - Vietnam,2013-01,2013-01-25,2013-01-28,INTERVENTIONAL,PHASE4,"National Institute of Malariology, Parasitology and Entomology, Vietnam",OTHER_GOV,malaria
NCT02281344,Unknown,TERMINATED,2014-10,"Malaria, Falciparum",MMV390048 20mg,Brisbane - Australia,2014-12-19,2014-11-02,2020-06-09,INTERVENTIONAL,PHASE1,Medicines for Malaria Venture,OTHER,malaria
NCT01345240,Unknown,COMPLETED,2011-11-17,"Malaria, Malaria Vaccines","GlaxoSmithKline (GSK) Biologicals' candidate Plasmodium falciparum malaria vaccine 257049, Engerix-B™ vaccine, Infanrix/Hib™ vaccine, Polio Sabin™ vaccine, Rotarix™ vaccine, Synflorix™ vaccine, Measles vaccine, Yellow fever vaccine","Ouagadougou 01 - Burkina Faso, Kumasi - Ghana",2013-01-09,2011-05-02,2019-07-18,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,malaria
NCT01043744,Unknown,COMPLETED,2010-01,"Malaria, Non-malarial Febrile Illness",Artemether-Lumefantrine,"Miono - Tanzania, Msata - Tanzania",2011-12,2010-01-07,2013-03-11,INTERVENTIONAL,NA,Centers for Disease Control and Prevention,FED,malaria
NCT00146692,Unknown,COMPLETED,2004-04,Malaria,Free medical treatment,Dodowa - Ghana,Unknown Date,2005-09-07,2017-01-12,INTERVENTIONAL,PHASE4,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT01837992,Unknown,UNKNOWN,2013-05,Malaria,"Primaquine, delayed primaquine","Honiara - Solomon Islands, Auki - Solomon Islands, Luganville - Vanuatu, Port Vila - Vanuatu",2014-05,2013-04-23,2013-11-08,INTERVENTIONAL,NA,Menzies School of Health Research,OTHER,malaria
NCT04189744,Unknown,COMPLETED,2019-12-15,"Pregnancy Malaria, Bacterial Vaginoses, Trichomonas Vaginitis","IPTp-sulphadoxine-pyrimethamine plus metronidazole, IPTp-dihydroartemisinin-piperaquine plus metronidazole, IPTp-sulphadoxine-pyrimethamine",Nchelenge - Zambia,2022-10-21,2019-12-06,2023-05-22,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT06572644,HS-RDT-MiP,COMPLETED,2022-10-11,"Malaria,Falciparum",No interventions listed,Bobo-Dioulasso - Burkina Faso,2022-12-16,2024-08-27,2024-08-28,OBSERVATIONAL,Not Available,Centre MURAZ/Institut National de Santé Publique,OTHER_GOV,malaria
NCT02298140,(PCMT),UNKNOWN,2014-11,Malaria,SMS reminders,Rufiji - Tanzania,2015-12,2014-11-21,2015-08-03,INTERVENTIONAL,NA,Ifakara Health Institute,OTHER,malaria
NCT02252640,Unknown,COMPLETED,2015-01,Plasmodium Falciparum Malaria,"RTS,S/AS01B (50mcg of RTS,S and standard adult dose of AS01), RTS,S/AS01B (10mcg of RTS,S and one fifth of the standard dose of AS01), ChAd63 ME-TRAP (5 x 10^10 vp), MVA ME-TRAP (2 x 10^8 pfu)","Southampton - United Kingdom, Oxford - United Kingdom, Guildford - United Kingdom, London - United Kingdom",2015-10,2014-09-30,2015-12-03,INTERVENTIONAL,PHASE2,University of Oxford,OTHER,malaria
NCT01150344,MalaRia,COMPLETED,2010-07,Malaria,"Malarone (atovaquone + proguanil combination), RIAMET (artemether + LUMEFANTRIN combination)",Bobigny - France,2014-04,2010-06-24,2015-12-09,INTERVENTIONAL,PHASE4,Assistance Publique - Hôpitaux de Paris,OTHER,malaria
NCT01210040,PALUFER,COMPLETED,2011-04,Malaria,"Folic Acid, Folic Acid and Iron",Bobo-Dioulasso 01 - Burkina Faso,2013-11,2010-09-28,2014-03-19,INTERVENTIONAL,NA,Liverpool School of Tropical Medicine,OTHER,malaria
NCT01228344,Unknown,COMPLETED,2010-05-01,Malaria,Artemether-lumefantrine,Atlanta - United States,2015-09-30,2010-10-26,2017-04-07,OBSERVATIONAL,Not Available,Novartis Pharmaceuticals,INDUSTRY,malaria
NCT02524444,Unknown,COMPLETED,2015-09,Malaria in Pregnant HIV + Patients,"Mefloquine, Sulphadoxine-Pyrimethamine",Ibadan - Nigeria,2016-08,2015-08-14,2017-12-11,INTERVENTIONAL,PHASE1,ORIYOMI OMOTOYOSI AKINYOTU,OTHER,malaria
NCT03568344,CARAMAL,COMPLETED,2018-06-15,Malaria,No interventions listed,"Kinshasa - Congo, The Democratic Republic of the, Abuja - Nigeria, Kampala - Uganda",2020-08-31,2018-06-26,2022-02-17,OBSERVATIONAL,Not Available,Swiss Tropical & Public Health Institute,OTHER,malaria
NCT04788862,Unknown,COMPLETED,2022-07-18,"Malaria, Plasmodium Falciparum",P. falciparum infected erythrocytes,Bagamoyo - Tanzania,2023-02-24,2021-03-09,2023-05-24,INTERVENTIONAL,NA,University of Oxford,OTHER,malaria
NCT05019729,VRC 614,COMPLETED,2021-09-13,Malaria,"VRC-MALMAB0114-00-AB, Plasmodium falciparum (P. falciparum) sporozoite challenge",Bethesda - United States,2022-09-19,2021-08-25,2024-08-14,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT01231880,SBMC,COMPLETED,2011-02,Malaria,"Four monthly IPT with dihydroartemisinin Piperaquine (DP), Monthly IPT using DP, Placebo given every month",Tororo - Uganda,2012-09,2010-11-01,2013-05-23,INTERVENTIONAL,PHASE3,Makerere University,OTHER,malaria
NCT04319380,RTSS-SMC,COMPLETED,2020-04-01,"Malaria,Falciparum, Child, Only","Tetanus/diphtheria toxoids, SMC with SP+AQ, RTS,S/AS01, SMC placebo","Ouagadougou - Burkina Faso, Bamako - Mali",2022-03-31,2020-03-24,2024-09-20,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT02083380,Unknown,COMPLETED,2014-07,Uncomplicated Plasmodium Falciparum Malaria,"Artefenomel 800mg: piperaquine 640mg, Artefenomel 800mg: piperaquine 960mg, Artefenomel 800mg: piperaquine 1440mg","Cotonou - Benin, Ouagadougou - Burkina Faso, Ouagadougou - Burkina Faso, Kinshasa - Congo, The Democratic Republic of the, Lambarene - Gabon, Libreville - Gabon, Chefe Maputa - Mozambique, Tororo - Uganda, Hanoi - Vietnam",2015-10,2014-03-11,2017-03-10,INTERVENTIONAL,PHASE3,Medicines for Malaria Venture,OTHER,malaria
NCT01450280,Unknown,COMPLETED,2011-12,Malaria,"ChAd63 CS, ChAd63 CS, MVA CS, ChAd63 CS, ChAd63, MVA CS",Dublin - Ireland,2012-10,2011-10-12,2012-11-29,INTERVENTIONAL,PHASE1,University of Oxford,OTHER,malaria
NCT00285662,Unknown,COMPLETED,2006-06,"Malaria, Anemia","Amodiaquine/sulphadoxine-pyrimethamine, Artesunate/sulphadoxine-pyrimethamine or placebo",Goroka - Papua New Guinea,2010-05,2006-02-02,2011-07-25,INTERVENTIONAL,NA,Papua New Guinea Institute of Medical Research,OTHER_GOV,malaria
NCT01280162,Unknown,COMPLETED,2010-09,Malaria,Dihydroartemisinin piperaquine,Anlong Veng - Cambodia,2011-02,2011-01-20,2021-03-03,INTERVENTIONAL,NA,"Armed Forces Research Institute of Medical Sciences, Thailand",OTHER_GOV,malaria
NCT02488980,Unknown,COMPLETED,2000-05,Falciparum Parasitaemia,"Tafenoquine, Mefloquine, Placebo",No locations listed,2000-10,2015-07-02,2017-05-30,INTERVENTIONAL,PHASE2,U.S. Army Medical Research and Development Command,FED,malaria
NCT00354380,Unknown,COMPLETED,2006-09,Malaria,"Methylene blue, Artesunate, Amodiaquine",Nouna - Burkina Faso,Unknown Date,2006-07-20,2006-10-24,INTERVENTIONAL,PHASE2,Heidelberg University,OTHER,malaria
NCT01160562,Unknown,COMPLETED,2010-06-23,"Malaria, Falciparum, Plasmodium Falciparum",No interventions listed,Bamako - Mali,Unknown Date,2010-07-12,2019-12-17,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT03490162,Unknown,TERMINATED,2018-07-31,Malaria,"DM1157, Placebo",Durham - United States,2019-09-06,2018-04-06,2021-07-23,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT02418962,Unknown,COMPLETED,2015-03,"Malaria, Plasmodium Falciparum","PfSPZ Vaccine, Normal Saline",Malabo - Equatorial Guinea,2015-09,2015-04-17,2016-03-02,INTERVENTIONAL,PHASE1,Sanaria Inc.,INDUSTRY,malaria
NCT00118794,Unknown,COMPLETED,2004-09,Malaria,"Chlorproguanil-dapsone (Lapdap), Lumefantrine-artemether (Coartemether )",Banjul - Gambia,Unknown Date,2005-07-12,2006-02-01,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT05950191,Unknown,RECRUITING,2023-11-27,Malaria,"long lasting insecticidal nets with chlorfenapyr-pyrethroid (PermaNet Dual), long lasting insecticidal nets with PBO-pyrethroid (PermaNet), Social Behavior Change Communication",Kampala - Uganda,2025-12-31,2023-07-18,2024-12-27,INTERVENTIONAL,NA,"University of California, San Francisco",OTHER,malaria
NCT03600844,TIPTOP,COMPLETED,2018-04-02,Malaria in Pregnancy,Community distribution of SP for IPTp,"Kenge - Congo, The Democratic Republic of the, Bulungu - Congo, The Democratic Republic of the, Kunda - Congo, The Democratic Republic of the, Mananjary - Madagascar, Toliary 2 - Madagascar, Vohipeno - Madagascar, Meconta - Mozambique, Murrupula - Mozambique, Nhamatanda - Mozambique, Ohaukwu District - Nigeria, Bosso - Nigeria, Akure South - Nigeria",2021-10-31,2018-07-26,2022-03-31,INTERVENTIONAL,NA,Jhpiego,OTHER,malaria
NCT06069544,Unknown,ACTIVE_NOT_RECRUITING,2023-11-13,Malaria,"BNT165e, Placebo","Tempe - United States, Baltimore - United States, Las Vegas - United States, Knoxville - United States, San Antonio - United States",2025-09,2023-10-06,2024-11-07,INTERVENTIONAL,PHASE2,BioNTech SE,INDUSTRY,malaria
NCT06870344,IGHID12334,RECRUITING,2025-03-12,"Malaria Infection, Malaria Falciparum","Dihydroartemisinin piperaquine, Dihydroartemisinin piperaquine + Bacillus thuringiensis israelensis, Long-lasting Insecticidal Net",Mbarara - Uganda,2030-03,2025-03-11,2025-03-12,INTERVENTIONAL,NA,"University of North Carolina, Chapel Hill",OTHER,malaria
NCT02647489,PAMVAC,COMPLETED,2016-05,"Malaria, Antepartum","PAMVAC, Alhydrogel, GLA-SE, GLA-LSQ, Placebo",Abomey-Calavi - Benin,2017-11-10,2016-01-06,2018-06-26,INTERVENTIONAL,PHASE1,University Hospital Tuebingen,OTHER,malaria
NCT01860989,Unknown,COMPLETED,2013-07,Cure Rate,"KAE609, KAE609, KAE609, KAE609","Ratchabari - Thailand, Srisaket - Thailand, Tak - Thailand, Hanoi - Vietnam",2014-08,2013-05-23,2015-09-10,INTERVENTIONAL,PHASE2,Novartis Pharmaceuticals,INDUSTRY,malaria
NCT03241901,ALU-PQ,COMPLETED,2017-07-27,"Malaria,Falciparum","Artemether-Lumefantrine Tab 20-120mg, Primaquine Phosphate 0.25 mg/kg, Placebo","Bagamoyo - Tanzania, Bagamoyo - Tanzania",2017-12-28,2017-08-08,2018-03-27,INTERVENTIONAL,PHASE4,Muhimbili University of Health and Allied Sciences,OTHER,malaria
NCT01048801,ACTUGA2,COMPLETED,2010-03,"Fever, Malaria","Rapid diagnostic test, presumptive malaria treatment",Rukungiri - Uganda,2012-07,2010-01-14,2012-10-12,INTERVENTIONAL,NA,DBL -Institute for Health Research and Development,OTHER,malaria
NCT02802501,Unknown,COMPLETED,2018-04-08,"Malaria, Vivax","Tafenoquine, Matched-Placebo for Tafenoquine, Primaquine, Matched-Placebo for Primaquine, Dihydroartemisinin-piperaquine (DHA-PQP), ACT plus PQ (Rescue medication), PQ (End of study treatment)",Jakarta - Indonesia,2019-08-19,2016-06-16,2020-07-24,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,malaria
NCT01341704,MSP3-POC,COMPLETED,2011-05,Malaria,"MSP3-LSP/AlOH, Verorab Vaccine, 0.9% NaCl/Normal Saline",Bamako - Mali,2011-12,2011-04-26,2015-08-31,INTERVENTIONAL,PHASE2,Vac4All,INDUSTRY,malaria
NCT03304704,Unknown,COMPLETED,2018-01-28,Malaria,No interventions listed,"Bamako - Mali, Bamako - Mali, Doneguebougou - Mali",2020-07-12,2017-10-09,2025-02-10,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT02451904,Unknown,COMPLETED,2015-06,Severe Malaria,Observation,Chittagong - Bangladesh,2017-09,2015-05-22,2018-06-20,OBSERVATIONAL,Not Available,University of Oxford,OTHER,malaria
NCT00316329,Unknown,COMPLETED,2006-03,Malaria,Artesunate + Amodiaquine,"Yaounde - Cameroon, Tsiroanomandidy - Madagascar, Bancoumana - Mali, Keur Socé - Senegal, Oussouye - Senegal",Unknown Date,2006-04-20,2008-04-22,INTERVENTIONAL,PHASE3,Sanofi,INDUSTRY,malaria
NCT01641289,Unknown,COMPLETED,2012-07-10,Malaria,"Paracetamol, No Paracetamol","Chittagong - Bangladesh, Ramu - Bangladesh",2014-09-13,2012-07-16,2018-06-14,INTERVENTIONAL,NA,University of Oxford,OTHER,malaria
NCT03138096,PbVac,COMPLETED,2017-05-29,"Malaria,Falciparum, Plasmodium Falciparum, Plasmodium Berghei, Controlled Human Malaria Infection (CHMI)","Pb(PfCS@UIS4)-infected mosquitoes, Challenge infection P. falciparum","Nijmegen - Netherlands, Rotterdam - Netherlands",2018-03-28,2017-05-03,2022-03-04,INTERVENTIONAL,PHASE2,Radboud University Medical Center,OTHER,malaria
NCT03814616,Unknown,UNKNOWN,2018-10-03,"Malaria,Falciparum",Pyronaridine tetraphosphate 180mg:artesunate 60mg,"Fajara, - Gambia, Ndola - Zambia",2019-10,2019-01-24,2019-09-30,INTERVENTIONAL,PHASE2,Shin Poong Pharmaceutical Co. Ltd.,INDUSTRY,malaria
NCT05567016,Unknown,ACTIVE_NOT_RECRUITING,2023-07-18,"Malaria,Falciparum, Malaria","Active case detection using molecular testing (ACDm), Passive case detection using molecular testing (PCDm), Control (standard of care)",Bagamoyo - Tanzania,2025-11-28,2022-10-05,2025-02-03,INTERVENTIONAL,NA,"University of California, San Francisco",OTHER,malaria
NCT03988296,Unknown,COMPLETED,2019-06-11,Plasmodium Knowlesi Infection,No interventions listed,"Kapit - Malaysia, Sarikei - Malaysia, Sibu - Malaysia",2019-08-22,2019-06-17,2019-10-02,OBSERVATIONAL,Not Available,Duke University,OTHER,malaria
NCT02153996,Unknown,TERMINATED,2014-05-15,Malaria,No interventions listed,Bethesda - United States,2016-03-15,2014-06-03,2019-12-17,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT02601716,Unknown,COMPLETED,2016-01,Malaria,"PfSPZ Vaccine, CHMI (7G8), CHMI (NF135.C10)","Baltimore - United States, Silver Spring - United States",2017-09,2015-11-10,2018-10-16,INTERVENTIONAL,PHASE2,Sanaria Inc.,INDUSTRY,malaria
NCT03554616,Unknown,COMPLETED,2019-02-01,"Malaria, Anaemia","Chlorfenapyr LLIN, pyriproxyfen LLIN, Piperonyl butoxide LLIN, Standard LLIN",Misungwi - Tanzania,2022-02-28,2018-06-13,2024-11-26,INTERVENTIONAL,NA,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT00948896,PROMOTE-Chemop,COMPLETED,2010-06,Malaria,"trimethoprim-sulfamethoxazole (TS; TMP/SMX), sulfadoxine-pyrimethamine (SP), dihydroartemisinin-piperaquine (DP)",Tororo - Uganda,2014-04,2009-07-29,2015-11-24,INTERVENTIONAL,PHASE3,"University of California, San Francisco",OTHER,malaria
NCT01658696,Unknown,COMPLETED,2012-08,Malaria,"ChAd63 ME-TRAP and MVA ME-TRAP, Rabies vaccine",Dakar - Senegal,2013-02,2012-08-07,2013-12-12,INTERVENTIONAL,PHASE2,University of Oxford,OTHER,malaria
NCT00445796,ATOL,COMPLETED,2005-06,Malaria,"Artesunate, Amodiaquine","Yaounde - Cameroon, Dakar - Senegal",Unknown Date,2007-03-09,2008-04-10,INTERVENTIONAL,PHASE4,Sanofi,INDUSTRY,malaria
NCT02207816,Unknown,COMPLETED,2014-09-18,Malaria,"Blood sampling, Malaria Vaccine 257049 (MALARIA-055 PRI), Meningococcal C Conjugate Vaccine (MALARIA-055 PRI), Cell-culture rabies vaccine (MALARIA-055 PRI), TritanrixHepB/Hib (MALARIA-055 PRI), Polio Sabin Oral Polio Vaccine (GSK) (MALARIA-055 PRI)","Ouagadougou - Burkina Faso, Kisumu - Kenya, Tanga - Tanzania",2017-01-31,2014-08-04,2019-11-25,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,malaria
NCT01065116,Unknown,COMPLETED,2010-03,Malaria,"AL Blister-packs with Instruction leaflets, AL unit dose age specific pre-packs",Tororo District - Uganda,2010-11,2010-02-09,2011-07-21,INTERVENTIONAL,PHASE3,"Malaria Consortium, Uganda",OTHER,malaria
NCT04862416,STOP-TRANS,COMPLETED,2021-05-17,"Malaria, Malaria,Falciparum",R0.6C transmission blocking vaccine,Nijmegen - Netherlands,2022-06-29,2021-04-28,2025-03-05,INTERVENTIONAL,PHASE1,Radboud University Medical Center,OTHER,malaria
NCT00421473,Unknown,COMPLETED,2007-03,"HIV Infections, Malaria",Atovaquone / Proguanil,"Tilburg - Netherlands, Arnhem - Netherlands, Nijmegen - Netherlands, Leiden - Netherlands, Rotterdam - Netherlands",2008-12,2007-01-12,2020-11-12,INTERVENTIONAL,PHASE4,Radboud University Medical Center,OTHER,malaria
NCT00403260,Unknown,COMPLETED,2007-01,Falciparum Malaria,"Pyronaridine - artesunate, Mefloquine plus artesunate","Bobo Dioulasso - Burkina Faso, Pailin - Cambodia, Abidjan - Côte D'Ivoire, Mangalore - India, Bagamoyo - Tanzania, Mae Ramat - Thailand, Mae Sot - Thailand, Hanoi - Vietnam, Ho Chi Minh City - Vietnam",2008-10,2006-11-23,2021-11-02,INTERVENTIONAL,PHASE3,Medicines for Malaria Venture,OTHER,malaria
NCT05478720,Unknown,RECRUITING,2022-08-16,"Malaria, Cerebral","6-diazo-5-oxo-L-norleucine (DON), Placebo, 6-diazo-5-oxo-L-norleucine (DON)","Blantyre - Malawi, Blantyre - Malawi",2025-12,2022-07-28,2023-11-13,INTERVENTIONAL,PHASE2,"Douglas Postels, MD, MS",UNKNOWN,malaria
NCT01152931,AMM,COMPLETED,2010-08,Malaria,"Amodiaquine + Artesunate, Amodiaquine + Artesunate, Lumefantrine + Artemether, Artesunate + vitamin A, Artesunate + vitamin E, Artesunate + Zinc, Artesunate + selenium, Amodiaquine + vitamin A, Amodiaquine + Vitamin E, Amodiaquine + Zinc, Amodiaquine + Selenium, Artesunate + vitamin A + vitamin E, Artesunate + Vitamin A + Zinc, Artesunate + Vitamin A + Selenium, Artesunate + Vitamin E + Selenium, Artesunate + Vitamin E + Zinc","Ekpoma - Nigeria, Ekpoma - Nigeria",2010-11,2010-06-29,2012-05-31,INTERVENTIONAL,PHASE3,"University of Lagos, Nigeria",OTHER,malaria
NCT00146731,Unknown,COMPLETED,2004-01,Malaria,"SP, SP + amodiaquine, AQ + artesunate, chlorproguanil-dapsone",Muheza - Tanzania,2007-09,2005-09-07,2017-01-12,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT04708496,OPTIMAL,UNKNOWN,2021-01-18,"HIV Coinfection, Malaria",Artemether-lumefantrine,"Kampala - Uganda, Tororo - Uganda",2024-01,2021-01-14,2023-01-06,INTERVENTIONAL,PHASE4,Makerere University,OTHER,malaria
NCT00164216,Unknown,COMPLETED,2005-03,Malaria Falciparum,mefloquine plus artesunate,Iquitos - Peru,2008-03,2005-09-14,2012-09-11,OBSERVATIONAL,Not Available,Centers for Disease Control and Prevention,FED,malaria
NCT01456858,Unknown,COMPLETED,2003-12,Malaria,"Insecticide Treated Polyethylene Sheeting, Untreated Plastic Sheeting",Freetown - Sierra Leone,2004-07,2011-10-21,2011-10-21,INTERVENTIONAL,PHASE3,The Mentor Initiative,OTHER,malaria
NCT03529396,Unknown,COMPLETED,2018-07-20,"Vivax Malaria, G6PD Deficiency","Chloroquine, Primaquine, Primaquine, Chloroquine, Primaquine","Manaus - Brazil, Porto Velho - Brazil",2022-12-20,2018-05-18,2025-02-20,INTERVENTIONAL,PHASE2,Fundação de Medicina Tropical Dr. Heitor Vieira Dourado,OTHER,malaria
NCT02482116,Unknown,UNKNOWN,2015-08,"Malaria, Pneumonia",malaria or pneumonia diagnosis,Benin City - Nigeria,2017-07,2015-06-26,2016-08-31,OBSERVATIONAL,Not Available,University of Nottingham,OTHER,malaria
NCT01651416,Unknown,COMPLETED,2012-07,"Malaria, Anaemia","Artemether-lumefantrine combination, Dihydroartemisinin Piperaquine combination, Amodiaquine plus sulphadoxine-pyrimethamine combination",Kumasi - Ghana,2012-12,2012-07-27,2015-09-18,INTERVENTIONAL,PHASE4,"Centre for Global Health Research, Ghana",OTHER,malaria
NCT04009096,Unknown,COMPLETED,2019-07-18,"Malaria, Vivax",ChAd63 PvDBP and MVA PvDBP,Oxford - United Kingdom,2022-07-07,2019-07-05,2024-04-12,INTERVENTIONAL,PHASE2,University of Oxford,OTHER,malaria
NCT03377296,VAC068,COMPLETED,2018-03-03,"Malaria, Vivax","Plasmodium vivax infection, Collection of 250mL blood from each volunteer (N=2)","Oxford - United Kingdom, Oxford - United Kingdom",2023-04-13,2017-12-19,2023-06-29,INTERVENTIONAL,NA,University of Oxford,OTHER,malaria
NCT00144716,Unknown,COMPLETED,2003-06,Malaria,Insect Repellent plus Insecticide Treated Net,No locations listed,Unknown Date,2005-09-05,2017-01-12,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT02115516,Unknown,COMPLETED,2014-04,"Malaria, Plasmodium Falciparum Malaria","PfSPZ Challenge, 0.9% Sodium Chloride (Placebo)",Tübingen - Germany,2015-12,2014-04-16,2017-05-15,INTERVENTIONAL,PHASE1,Sanaria Inc.,INDUSTRY,malaria
NCT01378286,Unknown,COMPLETED,2012-01,Malaria,"ARTESUNATE + AMODIAQUINE, Chloroquine",Sao Paulo - Brazil,2013-06,2011-06-22,2013-07-18,INTERVENTIONAL,PHASE3,Sanofi,INDUSTRY,malaria
NCT00425763,IPTi DRWG,COMPLETED,2007-05,Malaria,AQAS,Kisumu - Kenya,2007-08,2007-01-23,2012-04-05,INTERVENTIONAL,PHASE4,Centers for Disease Control and Prevention,FED,malaria
NCT03955263,MIP,UNKNOWN,2018-09-28,Pregnant Women,No interventions listed,Nagpur - India,2019-01-31,2019-05-20,2019-05-30,OBSERVATIONAL,Not Available,"Lata Medical Research Foundation, Nagpur",OTHER,malaria
NCT01605786,PEBS-POC1,UNKNOWN,2012-05,Malaria,"Lyophilised PEBS synthetic protein (PfPEBS), Lyophilised PEBS synthetic protein (PfPEBS), Rehydragel™ HPA",Lausanne - Switzerland,2013-05,2012-05-25,2012-05-25,INTERVENTIONAL,PHASE2,Vac4All,INDUSTRY,malaria
NCT02692963,BCG-EHMI,COMPLETED,2016-04,"Malaria, Plasmodium Falciparum",BCG vaccination,Nijmegen - Netherlands,2016-10,2016-02-26,2017-04-20,INTERVENTIONAL,PHASE2,Radboud University Medical Center,OTHER,malaria
NCT01103063,Unknown,TERMINATED,2010-10,Intermittent Preventive Treatment In Pregnancy (IPTp),"Azithromycin plus chloroquine, sulfadoxine-pyrimethamine","Cotonou - Benin, Cotonou - Benin, Siaya - Kenya, Zomba - Malawi, Muheza - Tanzania, Mwanza - Tanzania, Mwanza - Tanzania, Mwanza - Tanzania, Kampala - Uganda",2013-10,2010-04-13,2015-06-16,INTERVENTIONAL,PHASE3,Pfizer,INDUSTRY,malaria
NCT00111163,Unknown,COMPLETED,2004-03,"Malaria, Anemia","sulfadoxine-pyrimethamine with artesunate, amodiaquine with artesunate, chlorproguanil-dapsone",Asembo (Rarieda Division) - Kenya,2006-03,2005-05-18,2012-09-27,INTERVENTIONAL,NA,Centers for Disease Control and Prevention,FED,malaria
NCT00872963,MAL059,UNKNOWN,2009-02,Malaria,"RTS,S/AS01E",Kilifi - Kenya,2016-02,2009-04-01,2015-12-07,OBSERVATIONAL,Not Available,KEMRI-Wellcome Trust Collaborative Research Program,OTHER,malaria
NCT01867463,Unknown,COMPLETED,2013-03-27,Malaria,"Pfs25-EPA/Alhydrogel, Euvax B, Menactra",Bamako - Mali,2015-12-22,2013-06-04,2018-07-05,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT01054248,DMA,COMPLETED,2010-02-16,Malaria,"dihydroartemisinin-piperaquine, Artesunate-mefloquine, arthemeter-lumefantrin",Mae Sot - Thailand,2016-09,2010-01-22,2022-03-25,INTERVENTIONAL,PHASE3,University of Oxford,OTHER,malaria
NCT00168948,Unknown,UNKNOWN,2003-03,"Malaria, Anemia",Sulfadoxin (12.5) Pyrimethamine (250 mg),No locations listed,Unknown Date,2005-09-15,2005-11-02,INTERVENTIONAL,PHASE4,"Charite University, Berlin, Germany",OTHER,malaria
NCT01389557,Unknown,COMPLETED,2011-02,Malaria,Dihydroartemisinin-piperaquine with primaquine,Lampung - Indonesia,2011-11,2011-07-08,2012-03-23,INTERVENTIONAL,PHASE4,Indonesia University,OTHER,malaria
NCT06549257,Unknown,NOT_YET_RECRUITING,2024-10,Plasmodium Falciparum Malaria,"Pfs25-IMX313, Pfs48/45",No locations listed,2025-12,2024-08-12,2024-08-12,INTERVENTIONAL,PHASE2,University of Oxford,OTHER,malaria
NCT01465048,Unknown,COMPLETED,2011-10,"Malaria, Plasmodium Falciparum","Plasmodium falciparum sporozoites 2sites, Plasmodium falciparum sporozoites 1 site, Plasmodium falciparum sporozoites 1site",Oxford - United Kingdom,2012-02,2011-11-04,2013-06-24,INTERVENTIONAL,NA,University of Oxford,OTHER,malaria
NCT05856357,Unknown,ACTIVE_NOT_RECRUITING,2023-08-11,"Malaria, Anemia",Sulfadoxine pyrimethamine,Séguéla - Côte D'Ivoire,2025-06,2023-05-12,2025-01-09,OBSERVATIONAL,Not Available,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT04264130,SACT,COMPLETED,2018-07-31,Schistosomiasis Haematobia,"Artesunate-Pyronaridine, Artemether-Lumefantrine, Artefenomel-Ferroquine",Lambaréné - Gabon,2019-12-31,2020-02-11,2020-02-11,INTERVENTIONAL,PHASE2,Centre de Recherche Médicale de Lambaréné,OTHER,malaria
NCT04203186,ECG-CHMI,WITHDRAWN,2020-03,Plasmodium Falciparum,atovaquone-proguanil,No locations listed,2021-06,2019-12-18,2020-05-08,INTERVENTIONAL,NA,U.S. Army Medical Research and Development Command,FED,malaria
NCT01038063,Unknown,UNKNOWN,2010-10,Malaria,Artemether-lumefantrine combination,Blantyre - Malawi,2013-09,2009-12-23,2010-12-09,INTERVENTIONAL,PHASE4,Liverpool School of Tropical Medicine,OTHER,malaria
NCT02991963,Unknown,UNKNOWN,2016-12,Epidemiology,"Interview, Blood collection (Dried Blood Spot), Blood Collection (Venous Blood collection), Blood Smear",Ubon Ratchathani - Thailand,2018-12,2016-12-14,2017-01-20,OBSERVATIONAL,Not Available,University of Oxford,OTHER,malaria
NCT00527163,Unknown,COMPLETED,2007-09-04,"Malaria, Pulmonary Hypertension",No interventions listed,Bamako - Mali,Unknown Date,2007-09-10,2019-12-16,OBSERVATIONAL,Not Available,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,malaria
NCT05354258,MALHELMIN,UNKNOWN,2022-06-16,"Malaria, Soil Transmitted Helminths, Schistosomiasis, Integrated Control, Seasonal Malaria Chemoprevention, Mass Drug Administration With Anthelminthic Drugs","Albendazole, Praziquantel, Amodiaquine, Sulfadoxine pyrimethamine",Saraya - Senegal,2022-11-30,2022-04-29,2022-07-14,INTERVENTIONAL,NA,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT00146796,Unknown,COMPLETED,2005-01,"Malaria, Febrile Illness",Rapid diagnostic test for malaria,Moshi - Tanzania,Unknown Date,2005-09-07,2017-01-12,INTERVENTIONAL,PHASE4,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT01156896,MIA,COMPLETED,2010-07,Iron Deficiency,"Ferrous sulfate, Ferrous sulfate, Ferrous sulfate, Ferrous sulfate",Bangkok - Thailand,2014-07,2010-07-05,2015-02-12,INTERVENTIONAL,NA,Columbia University,OTHER,malaria
NCT03014258,Unknown,COMPLETED,2017-06-07,Plasmodium Falciparum Infection,NF54 P. falciparum malaria challenge,Baltimore - United States,2019-07-19,2017-01-09,2021-06-08,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT02563496,Unknown,COMPLETED,2017-02-06,"Malaria, Vivax","Tafenoquine, Chloroquine","Monteria - Colombia, Hanoi - Vietnam, Ho Chi Minh City - Vietnam, Ho Chi Minh - Vietnam",2019-12-15,2015-09-30,2020-11-02,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,malaria
NCT01088958,NICHE,COMPLETED,2007-01,"Anemia, Iron-deficiency",Micronutrient powders (Sprinkles),Kisumu - Kenya,2012-01,2010-03-18,2015-07-30,INTERVENTIONAL,PHASE4,Centers for Disease Control and Prevention,FED,malaria
NCT00132535,Unknown,COMPLETED,2003-08,"Malaria in Pregnancy, HIV Infections","sulfadoxine-pyrimethamine intermittent preventive treatment, chloroquine",Kampala - Uganda,Unknown Date,2005-08-22,2017-01-12,INTERVENTIONAL,NA,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT00545935,Unknown,COMPLETED,2007-07,Malaria,"Methylenblue-Amodiaquine (MB-AQ), Methylenblue-Artesunate (MB-AS), Artesunate-Amodiaquine (AS-AQ)",Nouna - Burkina Faso,Unknown Date,2007-10-17,2009-02-03,INTERVENTIONAL,PHASE2,Heidelberg University,OTHER,malaria
NCT03580824,Unknown,COMPLETED,2019-04-30,"Malaria,Falciparum",R21 in Matrix- M adjuvant vaccine,Kilifi - Kenya,2022-06-14,2018-07-09,2023-08-03,INTERVENTIONAL,PHASE2,University of Oxford,OTHER,malaria
NCT01043796,MTC-ITWL,COMPLETED,2010-05,Malaria,"Insecticide treated nets and wall liners, Insecticide treated nets alone",Kisumu - Kenya,2011-06,2010-01-07,2015-02-03,INTERVENTIONAL,PHASE3,Centers for Disease Control and Prevention,FED,malaria
NCT00329134,Unknown,COMPLETED,2006-07,Malaria,Administration of quinine sulphate taste-masked pellets,Butare - Rwanda,2007-05,2006-05-24,2009-04-17,INTERVENTIONAL,PHASE2,University Ghent,OTHER,malaria
NCT00811096,Unknown,COMPLETED,2008-11,"Malaria, Vivax","Tinidazole, chloroquine","Mae Sot, 63110 - Thailand",2009-01,2008-12-18,2012-12-03,INTERVENTIONAL,PHASE2,Walter Reed Army Institute of Research (WRAIR),FED,malaria
NCT01836458,Unknown,COMPLETED,2014-01,Malaria,KAE609,Ho Chi Minh - Vietnam,2015-03,2013-04-19,2016-10-31,INTERVENTIONAL,PHASE2,Novartis Pharmaceuticals,INDUSTRY,malaria
NCT00819858,Unknown,COMPLETED,2009-01,"Weight Loss, Weight Gain, Convalescence, Malaria",RUTF (Plumpynut®),Dubie - Congo,2009-03,2009-01-09,2013-10-16,INTERVENTIONAL,NA,"Medecins Sans Frontieres, Netherlands",OTHER,malaria
NCT01256658,Unknown,COMPLETED,2010-11,Malaria,COA566,"Burkina Faso - Burkina Faso, Ouagadougou - Burkina Faso, Ouagadougou - Burkina Faso",2012-07,2010-12-08,2014-02-10,INTERVENTIONAL,PHASE4,Novartis,INDUSTRY,malaria
NCT03503058,Unknown,COMPLETED,2022-05-07,Malaria,"PfSPZ Vaccine, PfSPZ Challenge under chloroquine (CQ) chemoprophylaxis, Normal Saline, Chloroquine chemoprophylaxis alone","Jakarta - Indonesia, Jakarta - Indonesia",2024-02-27,2018-04-19,2024-12-11,INTERVENTIONAL,PHASE2,Sanaria Inc.,INDUSTRY,malaria
NCT01024686,Unknown,TERMINATED,2010-03,Malaria,"p52-/p36- GAP Vaccine, p52-p36- GAP Vaccine, p52-/p36- GAP Vaccine",Silver Spring - United States,2011-06,2009-12-03,2019-10-28,INTERVENTIONAL,PHASE2,Seattle Children's Hospital,OTHER,malaria
NCT00320658,Unknown,COMPLETED,2006-03,Malaria,"MSP1 42-C1/Alhydrogel, CPG 7909",Washington - United States,2007-07,2006-05-03,2008-01-21,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT00203801,Unknown,COMPLETED,2002-01,Malaria,"Sulfadoxine-pyrimethamine, Artesunate plus sulfadoxine-pyrimethamine, Artemether-lumefantrine","Bela Vista - Mozambique, Namaacha - Mozambique, Ndumo - South Africa, Lulekani - South Africa, Naas - South Africa, Ndzevane - Swaziland, Vuvulane - Swaziland",2005-07,2005-09-20,2018-10-19,INTERVENTIONAL,NA,University of Cape Town,OTHER,malaria
NCT02329301,Unknown,COMPLETED,2014-09,"Malaria, Malaria, Falciparum","MDA with DHAp (Eurartesim), Focal MDA with DHAp (Eurartesim)",Choma - Zambia,2016-06,2014-12-31,2020-09-16,INTERVENTIONAL,NA,PATH,OTHER,malaria
NCT05757167,INTREPiD,RECRUITING,2023-11-06,"Malaria,Falciparum, Malaria in Pregnancy, Malaria in Childbirth, Pregnancy, Neonatal Health, Low Birthweight, Stillbirth, Gestational Age and Weight Conditions, Preterm Birth","Malaria High-Sensitivity Rapid Diagnostic Test (HS-RDT), Artemether-Lumefantrine 20 Mg-120 Mg Oral Tablet","Kinshasa - Congo, The Democratic Republic of the, Eldoret - Kenya",2026-10-09,2023-03-07,2025-01-24,INTERVENTIONAL,PHASE4,Duke University,OTHER,malaria
NCT00616304,ARGISM,SUSPENDED,2008-02,Severe Falciparum Malaria,"L-arginine hydrochloride, Normal saline",Timika - Indonesia,2009-03,2008-02-15,2024-03-13,INTERVENTIONAL,PHASE2,Menzies School of Health Research,OTHER,malaria
NCT00400101,Unknown,TERMINATED,2003-11,Falciparum Malaria,Virosome-formulated synthetic peptides (malaria vaccine),No locations listed,Unknown Date,2006-11-16,2006-11-16,INTERVENTIONAL,PHASE1,Swiss Tropical & Public Health Institute,OTHER,malaria
NCT02294201,SR-M-KEN,WITHDRAWN,2016-06,Malaria,"Spatial Repellent product with active ingredient, Active ingredient, Spatial Repellent product without active ingredient (SHIELD)",Kisumu - Kenya,2016-07,2014-11-19,2016-10-06,INTERVENTIONAL,NA,University of Notre Dame,OTHER,malaria
NCT01754701,Unknown,COMPLETED,2013-06,"Iron Deficiency, Malaria, Nutrition, Global Health","Immediate iron, Delayed iron",Kampala - Uganda,2015-05,2012-12-21,2015-11-30,INTERVENTIONAL,NA,University of Minnesota,OTHER,malaria
NCT00529867,Unknown,COMPLETED,2007-05,"Malaria, Falciparum","Artemether/lumefantrine tablets, Artemether/Lumefantrine suspension",Kisumu - Kenya,2007-12,2007-09-14,2008-01-18,INTERVENTIONAL,PHASE4,Dafra Pharma,INDUSTRY,malaria
NCT00427167,Unknown,COMPLETED,2007-01-23,Malaria,"AMA1-C1/Alhydrogel + CPG 7909 (Saline), AMA1-C1/Alhydrogel + CPG 7909 (Phosphate), AMA1-C1/Alhydrogel + CPG 7909","Washington, D.C. - United States, Bethesda - United States",2008-11-05,2007-01-26,2017-07-02,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT04329104,Unknown,COMPLETED,2021-02-15,"Plasmodium Falciparum Infection, Malaria","VRC-MALMAB0100-00-AB (CIS43LS), Normal saline","Kalifabougou - Mali, Torodo - Mali",2022-01-26,2020-04-01,2024-05-02,INTERVENTIONAL,PHASE2,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT01240603,Unknown,COMPLETED,2010-10-24,Malaria,No interventions listed,Phnom Penh - Cambodia,Unknown Date,2010-11-15,2018-04-05,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT02925403,Unknown,COMPLETED,2016-08-26,Malaria,"R21/Matrix-M1, Saline",Ouagadougou - Burkina Faso,2017-02-15,2016-10-05,2019-11-06,INTERVENTIONAL,PHASE2,University of Oxford,OTHER,malaria
NCT00740090,Unknown,COMPLETED,2008-08-11,"Malaria, Malaria Infection",AMA1-C1/Alhydrogel plus CPG 7909,Bamako - Mali,2009-06-09,2008-08-22,2017-07-02,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT03640403,InSMART-school,COMPLETED,2019-03-26,"Malaria,Falciparum, Anemia","Dihydroartemisinin-piperaquine, Artesunate-amodiaquine",Tanga - Tanzania,2020-12-31,2018-08-21,2024-11-20,INTERVENTIONAL,PHASE3,"National Institute for Medical Research, Tanzania",OTHER_GOV,malaria
NCT00131703,Unknown,COMPLETED,2003-03,"Malaria, Pregnancy","Amodiaquine, Sulphadoxine-pyrimethamine, Chloroquine",No locations listed,Unknown Date,2005-08-19,2025-03-04,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT06607003,Unknown,RECRUITING,2024-11-26,Malaria,"P. vivax challenge agent derived from PvHMB-CCE001, P. vivax challenge agent derived from PvHMB-CCE002",Bethesda - United States,2026-07-15,2024-09-23,2025-02-06,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT02315690,fMDA,COMPLETED,2015-09,Malaria,"dihydroartemisinin-piperaquine (DHAp), reactive case detection",Mbabane - Swaziland,2017-07,2014-12-12,2021-09-05,INTERVENTIONAL,PHASE3,"University of California, San Francisco",OTHER,malaria
NCT00223990,Unknown,COMPLETED,2005-04-08,"Malaria, Falciparum","FMP1/AS02A, RabAvert",Kisumu - Kenya,2006-04-26,2005-09-22,2021-02-12,INTERVENTIONAL,PHASE2,U.S. Army Medical Research and Development Command,FED,malaria
NCT02497612,FALCI,TERMINATED,2015-07-25,Plasmodium Falciparum Infection,"Ferroquine SSR97193, Artefenomel, Placebo","Cotonou - Benin, Comoé - Burkina Faso, Niangoloko - Burkina Faso, Ouagadougou - Burkina Faso, Lambaréné - Gabon, Libreville - Gabon, Kisumu - Kenya, Siaya - Kenya, Chokwé - Mozambique, Tororo - Uganda, Binh Phuoc - Vietnam, Gia Lai - Vietnam",2019-09-23,2015-07-14,2022-03-24,INTERVENTIONAL,PHASE2,Sanofi,INDUSTRY,malaria
NCT01459146,ACTIPT,UNKNOWN,2010-12,"Malaria, Schistosomiasis, Helminthiasis, Anemia, Change in Sustained Attention","Artemether-lumefantrine combination plus albendazole, Artemether-lumefantrine plus Praziquantel plus Albendazole, Albendazole plus Praziquantel",Navrongo - Ghana,2011-10,2011-10-25,2011-10-25,INTERVENTIONAL,PHASE4,"Navrongo Health Research Centre, Ghana",OTHER,malaria
NCT00408369,Unknown,COMPLETED,2006-11,Prophylactic Activity Against Malaria,DB289,Baltimore - United States,2007-11,2006-12-06,2008-01-29,INTERVENTIONAL,PHASE2,"Immtech Pharmaceuticals, Inc",INDUSTRY,malaria
NCT00408668,Unknown,COMPLETED,2005-08,"Malaria, Malaria, Falciparum","PEV3A, FP9 ME-TRAP, MVA ME-TRAP",Oxford - United Kingdom,Unknown Date,2006-12-07,2006-12-07,INTERVENTIONAL,PHASE2,University of Oxford,OTHER,malaria
NCT01967472,Unknown,COMPLETED,2013-09-16,Malaria,"amodiaquine-artesunate (AQAS) fixed-dose, Artemether-lumefantrine combination (AL) dispersable","Freetown - Sierra Leone, Freetown - Sierra Leone",2013-12,2013-10-23,2018-01-11,INTERVENTIONAL,NA,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT00978068,PROMOTE-PEDS,COMPLETED,2009-09,"Malaria, HIV Infections","Lopinavir/Ritonavir (LPV/r), Nevirapine (NVP), Efavirenz (EFV), 2 nucleoside reverse transcriptase inhibitor (NRTI)",Tororo - Uganda,2013-01,2009-09-16,2018-12-28,INTERVENTIONAL,PHASE3,"University of California, San Francisco",OTHER,malaria
NCT01076868,VHC,COMPLETED,2010-02,Vivax Malaria,Primaquine,Mae Sot - Thailand,2014-09-02,2010-02-26,2023-01-17,INTERVENTIONAL,NA,University of Oxford,OTHER,malaria
NCT03307369,SeverePV,COMPLETED,2017-10-27,"Malaria, Vivax",No interventions listed,Mae Sot - Thailand,2020-07-15,2017-10-11,2020-08-27,OBSERVATIONAL,Not Available,University of Oxford,OTHER,malaria
NCT00513669,PMAL03,COMPLETED,2008-01,Falciparum Malaria,"PEV 301& 302 in virosomes, Inflexal V (active comparator)",Bagamoyo - Tanzania,2009-03,2007-08-09,2013-03-15,INTERVENTIONAL,PHASE1,Swiss Tropical & Public Health Institute,OTHER,malaria
NCT00147368,Unknown,COMPLETED,2005-02,"Malaria, Falciparum",intravenous (IV) arginine,Timika - Indonesia,2006-04,2005-09-07,2008-06-02,INTERVENTIONAL,PHASE2,Menzies School of Health Research,OTHER,malaria
NCT01442168,Unknown,TERMINATED,2011-09,"Malaria, Falciparum","Sevuparin sodium + atovaquone/proquanil, atovaquone/proquanil","Mae Ramat - Thailand, Mae Sot - Thailand, Bangkok - Thailand",2013-09,2011-09-28,2014-08-19,INTERVENTIONAL,PHASE2,Modus Therapeutics AB,INDUSTRY,malaria
NCT00460369,Unknown,COMPLETED,2007-04,Uncomplicated Malaria,"sulfadoxine-pyrimethamine, artemether-lumefantrine, amodiaquine-artesunate coformulation",Allada - Benin,2007-11,2007-04-13,2008-04-14,INTERVENTIONAL,NA,Institut de Recherche pour le Developpement,OTHER_GOV,malaria
NCT02932072,Autoscope,COMPLETED,2016-11-10,Malaria,No interventions listed,No locations listed,2017-07-19,2016-10-13,2020-09-17,OBSERVATIONAL,Not Available,University of Oxford,OTHER,malaria
NCT02528279,REPLAMO,COMPLETED,2014-10,Malaria,Coartem,"Lambaréné - Gabon, Fougamou - Gabon",2016-10,2015-08-19,2017-01-25,INTERVENTIONAL,NA,Albert Schweitzer Hospital,OTHER,malaria
NCT01055002,Unknown,COMPLETED,2010-01,"Healthy, Non-smokers",Blood stage parasite (BSP) inoculum,Brisbane - Australia,2010-07,2010-01-25,2011-06-27,INTERVENTIONAL,PHASE2,Medicines for Malaria Venture,OTHER,malaria
NCT00938379,Unknown,UNKNOWN,2009-07,"Malaria, Dengue, Japanese Encephalitis","20% deet insect repellent, placebo control",Pakse - Lao People's Democratic Republic,2010-12,2009-07-13,2009-07-14,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT00393679,Unknown,COMPLETED,2007-07,"Fever, Malaria","amodiaquine-artesunate (ASAQ), dihydroartemisinin-piperaquine (DHAPQ), artemether-lumefantrine (AL), Lapdap (Chlorproguanil-Dapsone) + artesunate (AS)","Bobo-Dioulasso - Burkina Faso, Lambaréné - Gabon, Manhica - Mozambique, Calabar - Nigeria, Kigali - Rwanda, Kampala - Uganda, Mbarara - Uganda, Ndola - Zambia",2009-12,2006-10-29,2014-02-03,INTERVENTIONAL,PHASE3,"Institute of Tropical Medicine, Belgium",OTHER,malaria
NCT01703884,AQUAMOD,COMPLETED,2012-08,Malaria,ASAQ,Bobo-Dioulasso - Burkina Faso,2014-07,2012-10-11,2015-07-31,INTERVENTIONAL,PHASE4,Centre Muraz,OTHER,malaria
NCT04565184,Unknown,COMPLETED,2019-05-09,"Malaria,Falciparum","Artesunate-amodiaquine combination, Artemether, Lumefantrine Drug Combination",Yaoundé - Cameroon,2020-11-30,2020-09-25,2021-04-02,INTERVENTIONAL,PHASE4,University of Yaounde 1,OTHER,malaria
NCT05071079,MIST2,RECRUITING,2022-05-23,Plasmodium Vivax Infection,"An inoculum of malaria parasitised red blood cells with whole dose blood-stage inoculum, An inoculum of malaria parasitised red blood cells with 1:5 dilution blood-stage inoculum, An inoculum of malaria parasitised red blood cells with 1:10 dilution blood-stage inoculum, An inoculum of malaria parasitised red blood cells with 1:20 dilution blood-stage inoculum",Bangkok - Thailand,2025-11,2021-10-07,2024-06-26,INTERVENTIONAL,NA,University of Oxford,OTHER,malaria
NCT00312702,Unknown,COMPLETED,2006-04,"Malaria, Plasmodium Falciparum Malaria",Falciparum Malaria Protein 11 with AS02A adjuvant,Silver Spring - United States,2006-10,2006-04-10,2018-11-26,INTERVENTIONAL,PHASE2,U.S. Army Medical Research and Development Command,FED,malaria
NCT06450379,IVAR,COMPLETED,2021-03-15,Vaccine,No interventions listed,Blantyre - Malawi,2024-04-26,2024-06-10,2024-06-10,OBSERVATIONAL,Not Available,Malawi Liverpool Wellcome Programme,OTHER,malaria
NCT02614404,MIM,COMPLETED,2015-11,Plasmodium Falciparum Malaria,"Imatinib combination therapy, Dihydroartemisinin-piperaquine",Huong Hoa - Vietnam,2016-12-02,2015-11-25,2021-02-11,INTERVENTIONAL,PHASE1,HuLow,INDUSTRY,malaria
NCT02535767,PQSAFETY,COMPLETED,2015-08,Malaria,Primaquine,Bamako - Mali,2016-01,2015-08-31,2017-02-06,INTERVENTIONAL,PHASE2,"University of California, San Francisco",OTHER,malaria
NCT02600767,Unknown,COMPLETED,2015-12,Malaria,Artemether-lumefantrine combination,Cruzeiro do Sul - Brazil,2016-05,2015-11-09,2017-10-09,INTERVENTIONAL,NA,Centers for Disease Control and Prevention,FED,malaria
NCT03261401,Unknown,COMPLETED,2017-09-15,Healthy,"M5717, Placebo, M5717",Brisbane - Australia,2019-06-14,2017-08-25,2023-10-16,INTERVENTIONAL,PHASE1,"Merck KGaA, Darmstadt, Germany",INDUSTRY,malaria
NCT05085301,Unknown,COMPLETED,2021-12-01,"Malaria, Diagnoses Disease, RDT",Rapid diagnostic test,"Jakarta - Indonesia, Khartoum - Sudan",2022-05-30,2021-10-20,2023-10-13,OBSERVATIONAL,Not Available,"Foundation for Innovative New Diagnostics, Switzerland",OTHER,malaria
NCT01845701,Unknown,COMPLETED,2010-03,Malaria,"Artesunate-Amodiaquine, Dihydroartemisinine-Piperaquine, Artemether-lumefantrine combination","Garoua - Cameroon, Mutengene - Cameroon",2014-04,2013-05-03,2018-09-26,INTERVENTIONAL,PHASE3,University of Yaounde 1,OTHER,malaria
NCT01728701,Unknown,COMPLETED,2012-09,"Malaria, Plasmodium Falciparum","PfSPZ Challenge, Normal Saline (NS)",Nijmegen - Netherlands,2013-12,2012-11-20,2017-05-15,INTERVENTIONAL,PHASE1,Sanaria Inc.,INDUSTRY,malaria
NCT02251704,Unknown,COMPLETED,2014-10-22,"Malaria, Malaria Vaccines","Blood sampling, Assessment of body temperature","Nouna - Burkina Faso, Ouagadougou - Burkina Faso, Kintampo - Ghana, Navrongo - Ghana, Kisumu - Kenya, Kisumu - Kenya, Nairobi - Kenya, Chikwawa - Malawi, Mangochi - Malawi, Dakar - Senegal, Dakar - Senegal, Amani Tanga - Tanzania",2024-07-06,2014-09-29,2024-08-05,INTERVENTIONAL,PHASE4,GlaxoSmithKline,INDUSTRY,malaria
NCT01290601,Unknown,TERMINATED,2003-09-15,"Malaria, Plasmodium Vivax","Tafenoquine, Chloroquine + Primaquine, tafenoquine, Chloroquine + Primaquine",Bangkok - Thailand,2005-01-10,2011-02-07,2018-02-23,INTERVENTIONAL,PHASE2,U.S. Army Medical Research and Development Command,FED,malaria
NCT05644067,SUM-101,COMPLETED,2023-08-25,Malaria,"SumayaVac-1(SUM-101), Verorab",Bagamoyo - Tanzania,2024-04-02,2022-12-09,2024-04-15,INTERVENTIONAL,PHASE1,Swiss Tropical & Public Health Institute,OTHER,malaria
NCT00432367,Unknown,COMPLETED,2007-02,"Malaria, Anaemia, Pregnancy",Amodiaquine plus artesunate combination; sulphadoxine-pyrimethamine,Juaben - Ghana,2009-02,2007-02-07,2016-10-20,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT06386367,Unknown,COMPLETED,2022-07-01,"Buddhist Monks, Health Education, Malaria, Monastery-based, Myanmar, Preventive Practice",Monastery-based health education by Buddhist monks,Yangon - Myanmar,2023-03-31,2024-04-26,2024-04-29,INTERVENTIONAL,NA,Myanmar Health Network Organization,OTHER,malaria
NCT05306067,GenMoz,COMPLETED,2021-10-12,"Malaria,Falciparum, Malaria in Pregnancy, Malaria","LDH-based malaria rapid diagnostic test, Malaria rapid diagnostic test",Manhiça - Mozambique,2023-12-31,2022-03-31,2024-08-27,OBSERVATIONAL,Not Available,Centro de Investigacao em Saude de Manhica,OTHER,malaria
NCT00124267,Unknown,UNKNOWN,2003-09,Cerebral Malaria,Intrarectal quinine,Kampala - Uganda,Unknown Date,2005-07-27,2005-08-04,INTERVENTIONAL,PHASE3,Makerere University,OTHER,malaria
NCT00197067,Unknown,COMPLETED,2004-03-15,Malaria,"RTS,S/AS02D and RTS,S/AS02A",Maputo - Mozambique,2005-04-26,2005-09-20,2019-12-27,INTERVENTIONAL,PHASE1,GlaxoSmithKline,INDUSTRY,malaria
NCT01376167,Unknown,COMPLETED,2014-04-24,"Malaria, Vivax","Chloroquine 600mg, Chloroquine 300mg, Tafenoquine 50mg, Tafenoquine 100mg, Tafenoquine 300mg, Tafenoquine 600mg, Primaquine 15mg, Chloroquine 600mg (Part 2 ), Chloroquine 300mg (Part 2 ), Tafenoquine 300mg (Part 2), Primaquine 15mg (Part2 )","Bandarban - Bangladesh, Manaus - Brazil, Porto Velho - Brazil, Oddar Meancheay Province - Cambodia, Gondar - Ethiopia, Jimma - Ethiopia, Bikaner - India, Chennai - India, Lucknow - India, Secunderabad - India, Iquitos - Peru, Rio Tuba, Bataraza - Philippines, Bangkok - Thailand, Tak - Thailand",2016-11-18,2011-06-20,2018-04-23,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,malaria
NCT00936767,AMOS,WITHDRAWN,2010-10,Uncomplicated Falciparum Malaria,"Artemisone/Mefloquine (AmiM3), Artesunate",Pailin - Cambodia,2010-10,2009-07-10,2018-08-31,INTERVENTIONAL,PHASE3,University of Oxford,OTHER,malaria
NCT00384267,Unknown,COMPLETED,2006-10,Malaria,No interventions listed,Bamako - Mali,2009-04,2006-10-06,2011-11-11,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT00152204,Unknown,UNKNOWN,2005-03,"Malaria, Falciparum, Anemia","Sulfadoxine-pyrimethamine used for IPTi, IPTi",Dar es Salaam - Tanzania,2007-12,2005-09-09,2008-05-22,INTERVENTIONAL,PHASE3,Swiss Tropical & Public Health Institute,OTHER,malaria
NCT02645604,Unknown,COMPLETED,2016-01-01,Accute Falciparum Malaria,No interventions listed,Bamako - Mali,2018-12-14,2016-01-05,2019-12-17,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT01441167,Unknown,COMPLETED,2011-09-14,"Malaria, Prevention and Control, Acquired Immunity",PfSPZ,Bethesda - United States,2013-06-05,2011-09-27,2018-07-05,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT05974267,Unknown,COMPLETED,2023-11-28,Malaria Infection,"M5717 60 mg, Pyronaridine, Atovaquone-Proguanil, M5717 200 mg, M5717 660mg","Ouagadougou 06 - Burkina Faso, Banjul - Gambia, Kisumu - Kenya, Ndola - Zambia",2024-12-29,2023-08-03,2025-01-31,INTERVENTIONAL,PHASE2,"Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany",INDUSTRY,malaria
NCT02646410,SMC,UNKNOWN,2014-08,"Malaria, Anemia","FPD+NDOT, FPD+DOT, DDD+NDOT, DDD+DOT",Bamako - Mali,2018-12,2016-01-05,2018-05-02,INTERVENTIONAL,NA,University of Bamako,OTHER,malaria
NCT06257810,Unknown,COMPLETED,2023-06-01,"Dengue, Chikungunya, Malaria","VIDAS® Dengue Antigen NS1, VIDAS® Anti-Dengue IgM, VIDAS® Anti-Dengue IgG, VIDAS® Anti-Chikungunya IgM and VIDAS® Anti-Chikungunya IgG, Standard of care practices","Ouagadougou - Burkina Faso, Abidjan - Côte D'Ivoire, Abidjan - Côte D'Ivoire",2023-06-07,2024-02-14,2025-02-11,INTERVENTIONAL,NA,BioMérieux,INDUSTRY,malaria
NCT00209781,Unknown,UNKNOWN,2003-08,Pregnancy,"Sulfadoxine-Pyrimethamine (Fansidar), ITNs",Manhiça - Mozambique,Unknown Date,2005-09-21,2008-03-06,INTERVENTIONAL,NA,Hospital Clinic of Barcelona,OTHER,malaria
NCT02691910,Unknown,COMPLETED,2014-08,"Malaria, Vivax","Chloroquine, Primaquine","Rio de Janeiro - Brazil, São Paulo - Brazil",2015-08,2016-02-25,2016-02-25,INTERVENTIONAL,PHASE3,Oswaldo Cruz Foundation,OTHER,malaria
NCT04327310,Unknown,WITHDRAWN,2023-03,Malaria (Plasmodium Falciparum),"Meplazumab for Injection, Sterile normal saline (0.9%)",No locations listed,2023-12,2020-03-31,2023-09-21,INTERVENTIONAL,PHASE1,Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd,INDUSTRY,malaria
NCT03510481,Unknown,COMPLETED,2018-05-14,Malaria,"PfSPZ Vaccine, Normal Saline, artemether 20mg/lumefantrine 120mg (AL)",Bamako - Mali,2019-11-23,2018-04-27,2021-08-20,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT00164710,Unknown,COMPLETED,2005-04,"Malaria, Falciparum","sulfadoxine-pyrimethamine, amodiaquine plus sulfadoxine-pyrimethamine, amodiaquine plus artesunate, chlorproguanil-dapsone plus artesunate, lumefantrine-artemether","Lilongwe - Malawi, Liwonde - Malawi, Dwangwa - Malawi",2005-09,2005-09-14,2012-09-27,INTERVENTIONAL,PHASE4,Centers for Disease Control and Prevention,FED,malaria
NCT01659281,Unknown,COMPLETED,2007-09,Plasmodium Falciparum Malaria,"Artesunate, Artesunate, Mefloquine, Mefloquine","Borai, Khaosaming and Muang districts - Thailand",2008-05,2012-08-07,2012-08-07,INTERVENTIONAL,NA,"Armed Forces Research Institute of Medical Sciences, Thailand",OTHER_GOV,malaria
NCT01434381,Unknown,COMPLETED,2011-08,Malaria,Pfs25-EPA/Alhydrogel,Baltimore - United States,2013-08,2011-09-14,2014-02-11,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT01322581,Unknown,COMPLETED,2011-05-01,Malaria,No interventions listed,Bamako - Mali,2022-03-28,2011-03-24,2022-03-31,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT00142246,Unknown,COMPLETED,2005-01,"Malaria, Falciparum","Intermittent preventive treatment (SP and amodiaquine), Placebo",Bondo - Kenya,2006-04,2005-09-02,2017-01-26,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT00225368,Unknown,COMPLETED,Unknown Date,"Malaria, All-cause Mortality",Insecticide treated bednets,Nouna - Burkina Faso,Unknown Date,2005-09-23,2010-02-08,INTERVENTIONAL,NA,Heidelberg University,OTHER,malaria
NCT01323972,Unknown,COMPLETED,2011-05-16,Malaria,GSK Biologicals' candidate Plasmodium falciparum malaria vaccine (257049),"Enugu - Nigeria, Jos - Nigeria",2011-11-22,2011-03-28,2018-08-17,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,malaria
NCT00978172,Unknown,COMPLETED,2007-12,Malaria,artesunate and mefloquine,Yaounde - Cameroon,Unknown Date,2009-09-16,2009-09-16,INTERVENTIONAL,PHASE4,Mepha Ltd.,INDUSTRY,malaria
NCT06651372,Unknown,NOT_YET_RECRUITING,2024-12,Arbovirus Infections,The retrospective analyses planned for these samples consist of serological analysis and molecular analysis (RT-PCR ) according to the date of symptoms ons,Strasbourg - France,2024-12,2024-10-21,2024-10-21,OBSERVATIONAL,Not Available,"University Hospital, Strasbourg, France",OTHER,malaria
NCT03431168,PREMISE,COMPLETED,2018-03-07,"HIV, Pregnancy Malaria, Sexually Transmitted Infection","Azithromycin/TMPS, Placebo/TMPS",Birmingham - United States,2021-01-01,2018-02-13,2023-11-27,INTERVENTIONAL,PHASE2,University of Alabama at Birmingham,OTHER,malaria
NCT01857869,Unknown,COMPLETED,2013-05-20,Malaria,"GSK257049 Dosage 1, GSK257049 Dosage 2, Sporozoite-infected mosquitoes challenge",Silver Spring - United States,2014-03-24,2013-05-20,2019-06-26,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,malaria
NCT06294912,Unknown,COMPLETED,2024-04-18,Malaria,"Plasmodium falciparum, MK-7602, Artemether/lumefantrine, Primaquine, Artesunate, Atovaquone/proguanil",South Brisbane - Australia,2025-01-06,2024-03-06,2025-01-13,INTERVENTIONAL,PHASE1,Merck Sharp & Dohme LLC,INDUSTRY,malaria
NCT05874869,SMC-DP,COMPLETED,2020-07-01,"Malaria, Chemoprophylaxis, Underfive Children",Dihydroartemisinin-piperaquine,Dar es Salaam - Tanzania,2021-06-30,2023-05-25,2023-05-25,INTERVENTIONAL,NA,Richard Mwaiswelo,OTHER_GOV,malaria
NCT02168569,MEFI,COMPLETED,2011-06,Malaria,"Coartem™ (Artemether-lumefantrine combination), Coarsucam™ (Amodiaquine-artesunate combination)","Montepuez - Mozambique, Chokwe - Mozambique, Manhiça - Mozambique, Dondo - Mozambique, Tete - Mozambique",2012-01,2014-06-20,2014-06-20,INTERVENTIONAL,PHASE4,Centro de Investigacao em Saude de Manhica,OTHER,malaria
NCT02083068,Unknown,COMPLETED,2014-08,Malaria,"Vaccine PvCS N+C+R, Vaccine PvCS N+C, SSN Montanide ISA-51",Cali - Colombia,2015-09,2014-03-11,2018-03-23,INTERVENTIONAL,PHASE2,Malaria Vaccine and Drug Development Center,OTHER,malaria
NCT00709969,Unknown,COMPLETED,2002-07,Plasmodium Falciparum Malaria,Artemether-lumefantrine,"Kilifi - Kenya, Ibadan - Nigeria, Dar es Salaam - Tanzania",Unknown Date,2008-07-03,2008-07-03,INTERVENTIONAL,PHASE3,Novartis,INDUSTRY,malaria
NCT00451269,TDR-PALU,COMPLETED,2007-04,Malaria,Rapid diagnosis test for malaria,Paris - France,2010-01,2007-03-23,2011-02-21,OBSERVATIONAL,Not Available,Assistance Publique - Hôpitaux de Paris,OTHER,malaria
NCT03737669,MERIT,RECRUITING,2019-11-13,Transfusion-Transmitted Infectious Disease,"Mirasol-treated Fresh Whole Blood, Standard Fresh Whole Blood",Kampala - Uganda,2026-10-07,2018-11-09,2024-10-08,INTERVENTIONAL,PHASE3,Johns Hopkins University,OTHER,malaria
NCT03963869,CSCMi20,COMPLETED,2019-08-03,Malaria,Malaria Camps,Rourkela - India,2020-11-30,2019-05-28,2022-01-11,INTERVENTIONAL,NA,NYU Langone Health,OTHER,malaria
NCT00406146,Unknown,UNKNOWN,2004-10,Uncomplicated Malaria,amodiaquine+artesunate/artemether-lumefantrine,Accra - Ghana,Unknown Date,2006-12-04,2006-12-04,INTERVENTIONAL,PHASE3,University of Ghana Medical School,OTHER,malaria
NCT02654912,CORE Zambia,COMPLETED,2016-02,Malaria,Reactive Focal Drug Administration,Choma - Zambia,2020-06,2016-01-13,2021-02-04,INTERVENTIONAL,PHASE4,PATH,OTHER,malaria
NCT04505046,INSPiRED-WP3,UNKNOWN,2020-03-20,"Testing, Performance, Specificity, Sensitivity",No interventions listed,Lambaréné - Gabon,2022-12-31,2020-08-07,2020-08-07,OBSERVATIONAL,Not Available,Centre de Recherche Médicale de Lambaréné,OTHER,malaria
NCT05400746,Unknown,UNKNOWN,2022-11-02,"Malaria, Plasmodium Falciparum",Pfs48/45 in Matrix-M,Oxford - United Kingdom,2023-05-30,2022-06-02,2022-12-14,INTERVENTIONAL,PHASE1,University of Oxford,OTHER,malaria
NCT04147546,ASSERMalaria,COMPLETED,2020-08-31,"Plasmodium Falciparum Malaria, Malaria Diagnosis","Additional screening using ultra sensitive RDTs, Dihydroartemisinin-piperaquin, Reminders",Ouagadougou - Burkina Faso,2021-08-31,2019-11-01,2023-03-30,INTERVENTIONAL,PHASE3,"Institut de Recherche en Sciences de la Sante, Burkina Faso",OTHER_GOV,malaria
NCT00519467,Unknown,COMPLETED,2003-06,Malaria,Chlorproguanil-dapsone-artesunate (CDA),"Banjul - Gambia, Blantyre - Malawi",2005-02,2007-08-22,2016-12-06,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,malaria
NCT05117567,Unknown,UNKNOWN,2021-12-01,Plasmodium Infection,Personal protection package,No locations listed,2022-06,2021-11-11,2021-11-11,INTERVENTIONAL,NA,Macfarlane Burnet Institute for Medical Research and Public Health Ltd,OTHER,malaria
NCT00376155,Unknown,COMPLETED,2006-05,Malaria,sulfadoxine /pyrimethamine plus amodiaquine,Banjul - Gambia,Unknown Date,2006-09-14,2017-02-10,INTERVENTIONAL,PHASE4,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT03855995,EPI-MAL-003,RECRUITING,2019-03-21,"Malaria, Malaria Vaccines",Whole blood sample,"Kintampo - Ghana, Navrongo - Ghana, Kisumu - Kenya, Kisumu - Kenya, Kisumu - Kenya, Chikwawa - Malawi, Mangochi - Malawi",2025-05-26,2019-02-27,2025-02-18,OBSERVATIONAL,Not Available,GlaxoSmithKline,INDUSTRY,malaria
NCT01660672,LVT1,COMPLETED,2013-01,"Seizure, Epilepsy, Cerebral Malaria",LEVETIRACETAM,Blantyre - Malawi,2013-07,2012-08-09,2016-09-15,INTERVENTIONAL,PHASE2,University of Rochester,OTHER,malaria
NCT05348746,ERASE,UNKNOWN,2022-05-01,"Malaria, Malaria in Pregnancy",Advanced Analysis of Polymorphism,No locations listed,2023-04-01,2022-04-27,2022-04-27,OBSERVATIONAL,Not Available,Doctors with Africa - CUAMM,OTHER,malaria
NCT02562872,Unknown,COMPLETED,2016-03,Healthy,"DSM265, Placebo, Sporozoites, Infective mosquito bite",Seattle - United States,2017-05,2015-09-29,2022-01-14,INTERVENTIONAL,PHASE1,Medicines for Malaria Venture,OTHER,malaria
NCT00346346,Unknown,COMPLETED,2006-04-17,Malaria,No interventions listed,Bamako - Mali,Unknown Date,2006-06-29,2019-12-05,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT04978272,MIC-DroP,ACTIVE_NOT_RECRUITING,2022-02-08,Malaria,"Dihydroartemisinin-piperaquine (DP), DP Placebo",Tororo - Uganda,2026-08-31,2021-07-27,2024-03-08,INTERVENTIONAL,PHASE3,"Grant Dorsey, M.D, Ph.D.",OTHER,malaria
NCT00873938,Compliance,COMPLETED,2005-10,Malaria,No interventions listed,Brong Ahafo Region - Ghana,2006-07,2009-04-02,2010-04-30,OBSERVATIONAL,Not Available,"Kintampo Health Research Centre, Ghana",OTHER,malaria
NCT00214643,Unknown,COMPLETED,2005-06,Malaria,"Fosmidomycin, clindamycin",Lambaréné - Gabon,Unknown Date,2005-09-22,2009-02-04,INTERVENTIONAL,PHASE3,"Albert Schweitzer Hospital, Netherlands",UNKNOWN,malaria
NCT03453840,EXALT,COMPLETED,2018-02-21,Uncomplicated Plasmodium Falciparum Malaria,Artemether-lumefantrine,"Busia - Uganda, Tororo - Uganda",2021-08-31,2018-03-05,2025-01-03,INTERVENTIONAL,PHASE4,"University of California, San Francisco",OTHER,malaria
NCT00322738,Unknown,COMPLETED,2006-06-07,Plasmodium Falciparum Malaria,No interventions listed,Fajara - Gambia,2008-03-31,2006-05-08,2019-02-01,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT05095272,Unknown,COMPLETED,2022-02-15,Malaria,HMPBS02-Pv,Bethesda - United States,2022-06-24,2021-10-27,2023-07-11,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT02563704,Unknown,COMPLETED,2013-09,Malaria,"Artesunate, Quinine",No locations listed,2014-03,2015-09-30,2015-10-01,INTERVENTIONAL,PHASE3,University of Yaounde 1,OTHER,malaria
NCT03939104,DeTACT-ASIA,COMPLETED,2021-06-30,Plasmodium Falciparum Malaria (Uncomplicated),"Artemether-lumefantrine+amodiaquine, Artemether-lumefantrine+placebo, Artesunate-mefloquine+piperaquine, Artesunate-mefloquine+placebo","Cox's Bāzār - Bangladesh, Phnum Kravanh - Cambodia, Siem Pang - Cambodia",2023-01-06,2019-05-06,2024-03-20,INTERVENTIONAL,PHASE3,University of Oxford,OTHER,malaria
NCT02895568,Unknown,COMPLETED,2016-09-16,Plasmodium Falciparum,No interventions listed,Kome - Chad,2018-09-06,2016-09-09,2022-04-07,OBSERVATIONAL,Not Available,University of Oxford,OTHER,malaria
NCT01907672,GhanaCommRDT,COMPLETED,2011-08,Malaria,Rapid Diagnostic Test,Dodowa - Ghana,2012-12,2013-07-25,2013-07-25,INTERVENTIONAL,PHASE4,Ghana Health Services,OTHER_GOV,malaria
NCT01165372,Unknown,COMPLETED,2010-08,Malaria,Artesunate or dihydroartemisinin-piperaquine,Dong Xoai - Vietnam,2011-05,2010-07-19,2011-09-15,INTERVENTIONAL,PHASE2,"Oxford University Clinical Research Unit, Vietnam",OTHER,malaria
NCT06578572,SERVAL,RECRUITING,2024-05-30,Malaria,R21Matrix M,"Nanoro - Burkina Faso, Fajara - Gambia",2024-12-31,2024-08-29,2024-08-29,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT01783340,MMV,WITHDRAWN,2013-04,"Malaria, Falciparum","Azithromycin capsules, Placebo, Immunization with falciparum",Leiden - Netherlands,2013-12,2013-02-04,2014-11-13,INTERVENTIONAL,PHASE2,Radboud University Medical Center,OTHER,malaria
NCT01190540,IDCAP,COMPLETED,2008-11,"Capacity Building, Support for Midlevel Health Professionals, Diagnostic Training","Training and supervision, Training and Supervision, Integrated Management of Infectious Disease (IMID), Integrated Management of Infectious Disease (IMID)",Kampala - Uganda,2012-08,2010-08-27,2014-12-03,INTERVENTIONAL,NA,University of Washington,OTHER,malaria
NCT04327440,RTSS/PBO,UNKNOWN,2020-02-04,"Malaria, Malaria Vaccine, Insecticide-treated Bednets","RTS,S/AS01 malaria vaccine, PBO bed nets",Blantyre - Malawi,2023-03,2020-03-31,2020-03-31,OBSERVATIONAL,Not Available,Michigan State University,OTHER,malaria
NCT03590340,Unknown,COMPLETED,2018-07-30,Malaria,"PfSPZ Vaccine, Normal saline, PfSPZ Challenge (for CHMI)",Santiago De Baney - Equatorial Guinea,2019-03-12,2018-07-18,2020-01-07,INTERVENTIONAL,PHASE1,Sanaria Inc.,INDUSTRY,malaria
NCT04767191,Kenya-TES,COMPLETED,2021-03-15,Uncomplicated Malaria,"artemether lumefantrine, dihydroartemisinin piperaquine","Bungoma - Kenya, Siaya - Kenya",2022-12-18,2021-02-23,2023-11-01,INTERVENTIONAL,PHASE4,Jhpiego,OTHER,malaria
NCT03276962,Unknown,COMPLETED,2017-09-28,Malaria,"RTS,S/AS01E (Full dose), RTS,S/AS01E (1/5th dose), Rabies vaccine","Kumasi - Ghana, Kisumu - Kenya",2019-11-04,2017-09-08,2024-05-21,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,malaria
NCT03281291,Unknown,COMPLETED,2018-11-19,Malaria,No interventions listed,"Kumasi - Ghana, Kisumu - Kenya",2022-04-22,2017-09-13,2025-01-23,OBSERVATIONAL,Not Available,GlaxoSmithKline,INDUSTRY,malaria
NCT03384472,Unknown,COMPLETED,2016-06-01,"Parasitology, Entomology, Malaria",No interventions listed,No locations listed,2017-02-01,2017-12-27,2022-05-24,OBSERVATIONAL,Not Available,University of Oxford,OTHER,malaria
NCT04280692,CHMI-TransMod,SUSPENDED,2022-08-22,"Malaria,Falciparum","PfSPZ Challenge, Sulfadoxine-Pyrimethamine, Piperaquine, Artemether lumefantrine, Primaquine",Kilifi - Kenya,2025-12,2020-02-21,2024-05-23,INTERVENTIONAL,PHASE2,University of Oxford,OTHER,malaria
NCT02325180,Unknown,COMPLETED,2015-01,"Malaria, Falciparum","Dihydroartemisinin-Piperaquine, Artemether-lumefantrine","Kuala Langkat - Indonesia, Tanjung Tiram - Indonesia, Tello island - Indonesia",2015-06,2014-12-24,2015-09-02,INTERVENTIONAL,PHASE4,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT02334462,Unknown,COMPLETED,2015-01-07,Malaria,"Pfs230D1M-EPA/Alhydrogel, Pfs25M-EPA/Alhydrogel, TWINRIX, Menactra","Bethesda - United States, Bamako - Mali",2016-03-31,2015-01-08,2019-04-11,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT04368910,Unknown,TERMINATED,2007-09-06,Malaria,"Pyronaridine - artesunate, Chloroquine","Goyang-si - Korea, Republic of, Seoul - Korea, Republic of",2010-10-16,2020-04-30,2022-01-26,INTERVENTIONAL,PHASE3,Medicines for Malaria Venture,OTHER,malaria
NCT00853281,Unknown,COMPLETED,2004-03,Malaria,"Hammocks with LLIN, Standard vector control measures",Phan Rang - Vietnam,2006-12,2009-03-02,2010-09-14,INTERVENTIONAL,NA,"Institute of Tropical Medicine, Belgium",OTHER,malaria
NCT01308112,PIMAL,COMPLETED,2011-10,Malaria,iron,Nairobi - Kenya,2013-04,2011-03-03,2013-05-29,INTERVENTIONAL,PHASE4,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT01669512,Unknown,COMPLETED,2012-08,"Malaria, Matrix M","Control Regimen, Low Dose Matrix M Regimen, Standard Dose Matrix M Regimen",Oxford - United Kingdom,2014-12,2012-08-21,2015-01-07,INTERVENTIONAL,PHASE1,University of Oxford,OTHER,malaria
NCT00114010,Unknown,COMPLETED,2005-04-01,Malaria,AMA1/Alhydrogel,Bethesda - United States,2006-12-22,2005-06-13,2017-07-02,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT05441410,Unknown,NOT_YET_RECRUITING,2025-06-01,Malaria,"Pyronaridine Tetraphosphate, Artesunate Drug Combination, PfSPZ Challenge (NF54), MVA ME-TRAP, ChAd63 ME-TRAP, Sodium chloride (NaCl) 0.9%",No locations listed,2026-06-30,2022-07-01,2024-12-06,INTERVENTIONAL,PHASE2,University Hospital Tuebingen,OTHER,malaria
NCT04660110,Unknown,UNKNOWN,2021-01-28,Malaria,IPT with Dihydroartemisinin Piperaquine,Kampala - Uganda,2021-06-03,2020-12-09,2021-02-24,INTERVENTIONAL,PHASE3,Makerere University,OTHER,malaria
NCT05343312,MEFI_IV,ACTIVE_NOT_RECRUITING,2022-03-16,Malaria,"AL (Coartem), AS-AQ (Carsucam), DHP, PA","Montepuez - Mozambique, Massinga - Mozambique, Dondo - Mozambique, Moatize - Mozambique, Mopeia - Mozambique",2023-09-30,2022-04-25,2023-12-08,INTERVENTIONAL,PHASE4,Centro de Investigacao em Saude de Manhica,OTHER,malaria
NCT05764746,3ACT,RECRUITING,2023-05-01,Uncomplicated Plasmodium Falciparum Malaria,"Artemether-lumefantrine and Amodiaquine Drug Combination, Artemether-lumefantrine then Artesunate amodiaquine, Artemether-lumefantrine","Bagamoyo - Tanzania, Bagamoyo - Tanzania",2024-12-30,2023-03-13,2024-12-11,INTERVENTIONAL,PHASE3,Muhimbili University of Health and Allied Sciences,OTHER,malaria
NCT00663546,Unknown,COMPLETED,2008-03-24,Malaria,No interventions listed,"Phnom Penh - Cambodia, Preah Vihear Province - Cambodia, Ratanakiri Province - Cambodia",Unknown Date,2008-04-22,2018-08-20,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT01236612,EHMI9,COMPLETED,2011-04,Plasmodium Falciparum Malaria,"Chloroquine prophylaxis, Immunization, Plasmodium falciparum Bloodstage challenge, Plasmodium falciparum mosquito challenge, Malarone treatment",Nijmegen - Netherlands,2012-06,2010-11-07,2014-01-22,INTERVENTIONAL,NA,Radboud University Medical Center,OTHER,malaria
NCT01026246,Unknown,COMPLETED,2010-06,Plasmodium Falciparum Malaria,"Placebo, EBA-175 RII-NG Malaria Vaccine",Legon - Ghana,2012-03,2009-12-04,2013-03-29,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT02001012,CAN KNOW,COMPLETED,2014-01,Uncomplicated Knowlesi Malaria,"Artemether-lumefantrine combination, Chloroquine","Kota Marudu - Malaysia, Kudat - Malaysia, Pitas - Malaysia",2015-01,2013-12-04,2017-07-07,INTERVENTIONAL,PHASE3,Menzies School of Health Research,OTHER,malaria
NCT06601712,PDMC-SL,NOT_YET_RECRUITING,2025-02-01,"Severe Malaria, Severe Anaemia","Adherence support strategy A, Adherence support strategy B, Control","Abomey - Benin, Cotonou - Benin",2026-06-01,2024-09-19,2025-01-16,INTERVENTIONAL,PHASE4,Institut de Recherche Clinique du Benin,OTHER,malaria
NCT02119312,GS,COMPLETED,2010-06,Malaria,No interventions listed,Seattle - United States,2020-09-01,2014-04-21,2020-09-14,OBSERVATIONAL,Not Available,Fred Hutchinson Cancer Center,OTHER,malaria
NCT06805110,Unknown,NOT_YET_RECRUITING,2025-04,Malaria,Monthly RDT validation during DHIS2 data review meetings,No locations listed,2025-09,2025-02-03,2025-02-03,INTERVENTIONAL,NA,PATH,OTHER,malaria
NCT00298610,Unknown,COMPLETED,2006-03,Malaria,"Artesunate, Malarone",Kisumu - Kenya,2007-10,2006-03-02,2019-10-01,INTERVENTIONAL,PHASE2,U.S. Army Medical Research and Development Command,FED,malaria
NCT01982812,LVT2,COMPLETED,2014-01,"Seizure, Epilepsy, Cerebral Malaria","Oral Levetiracetam, Standard AED",Blantyre - Malawi,2015-06,2013-11-13,2016-07-29,INTERVENTIONAL,PHASE2,University of Rochester,OTHER,malaria
NCT05958810,TES,COMPLETED,2017-01-02,"Malaria,Falciparum, Malaria Recrudescence","Artemether-lumefantrine, Primaquine",No locations listed,2018-12-28,2023-07-25,2023-07-25,OBSERVATIONAL,Not Available,"Research Institute for Tropical Medicine, Philippines",OTHER_GOV,malaria
NCT00368810,Unknown,COMPLETED,2006-02-21,Malaria,No interventions listed,Bethesda - United States,Unknown Date,2006-08-25,2017-07-02,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT04566510,LLINEUP2,COMPLETED,2020-10-17,Malaria,"long lasting insecticidal nets with alpha-cypermethrin + pyriproxyfen (PPF LLIN, Royal Guard)), long lasting insecticidal nets with deltamethrin + piperonyl butoxide (PBO LLIN, PermaNet 3.0)), Social behaviour change communication",Kampala - Uganda,2023-03-31,2020-09-28,2024-11-14,INTERVENTIONAL,NA,"University of California, San Francisco",OTHER,malaria
NCT01360112,Unknown,COMPLETED,2011-05-20,Malaria,No interventions listed,Bamako - Mali,Unknown Date,2011-05-25,2019-11-07,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT01374581,QuinAct,COMPLETED,2012-05,Malaria,"Artemether/Lumefantrine, Artesunate/Amodiaquine, Quinine + Clindamycin","Kinshasa - Congo, Kiruhura - Uganda",2014-06,2011-06-16,2014-10-22,INTERVENTIONAL,PHASE3,Universiteit Antwerpen,OTHER,malaria
NCT05361486,Unknown,RECRUITING,2023-08-28,"Malaria, Vivax","Training on revised algorithm, Enhancing Pharmacovigilance, Supervision of malaria services in selected facilities., G6PD testing, Tafenoquine, Primaquine, Follow Up Visit at Day 3 [+2 days] after treatment start",Nauta - Peru,2024-10-31,2022-05-04,2023-12-05,OBSERVATIONAL,Not Available,Medicines for Malaria Venture,OTHER,malaria
NCT01976416,NOHARM,COMPLETED,2014-09,"Sickle Cell Anemia, Sickle Cell Disease, Malaria","Hydroxyurea, Placebo",Kampala - Uganda,2016-10,2013-11-05,2018-12-04,INTERVENTIONAL,PHASE3,Indiana University,OTHER,malaria
NCT02792816,Unknown,COMPLETED,2009-06,"Drug Resistance, Plasmodium Falciparum Malaria","First line antimalarial in Myanmar (artemether-lumefrantrine, dihydroartemisinin-piperaquine, and artesunate-mefloquine)",Yangon - Myanmar,2013-12,2016-06-08,2016-06-08,OBSERVATIONAL,Not Available,"Department of Medical Research, Lower Myanmar",OTHER,malaria
NCT00487916,Unknown,COMPLETED,2007-06-13,Malaria,AMA1-C1/ISA 720,Herston - Australia,2009-02-05,2007-06-19,2017-07-02,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT00258024,Unknown,COMPLETED,2005-11,"Anaemia, Malaria",IPT-sulphadoxinepyrimethamine,Kumasi - Ghana,2007-09,2005-11-24,2008-02-21,INTERVENTIONAL,NA,DBL -Institute for Health Research and Development,OTHER,malaria
NCT00356824,Unknown,COMPLETED,2005-11,"HIV Infections, Malaria","Amodiaquine, Artesunate",Kampala - Uganda,2007-04,2006-07-26,2021-11-01,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT01939886,TRANSACT2,COMPLETED,2013-04,Malaria,"Mefloquine - Artesunate, Artemether-lumefantrine combination",Mbita - Kenya,2013-11,2013-09-11,2013-11-28,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT05879224,SCOPE,RECRUITING,2023-08-07,"Vivax Malaria, G6PD Deficiency",Revised case management package,"Hanura - Indonesia, Labuhanbatu - Indonesia, Mimika - Indonesia, Mimika - Indonesia, Mimika - Indonesia, Mimika - Indonesia",2025-05-31,2023-05-30,2024-02-05,INTERVENTIONAL,NA,Menzies School of Health Research,OTHER,malaria
NCT02741024,Unknown,COMPLETED,2013-10,Malaria,"Amodiaquine-Artesunate (ASAQ), Artemether-Lumefantrine (AL)",No locations listed,2014-12,2016-04-18,2016-04-18,INTERVENTIONAL,PHASE4,"Medecins Sans Frontieres, Netherlands",OTHER,malaria
NCT03637517,Unknown,COMPLETED,2018-10-03,Healthy Volunteers,"DSM265-TPGS 34% SDD, 400 mg fasted, DSM265-TPGS 34% SDD, 400 mg fed, DSM265 25% SDD, 400 mg fasted",Grayslake - United States,2018-11-19,2018-08-20,2020-03-11,INTERVENTIONAL,PHASE1,Medicines for Malaria Venture,OTHER,malaria
NCT02880241,Unknown,TERMINATED,2017-10-20,Malaria,MMV390048,"Gondar - Ethiopia, Jimma - Ethiopia",2018-01-01,2016-08-26,2021-12-09,INTERVENTIONAL,PHASE2,Medicines for Malaria Venture,OTHER,malaria
NCT01669941,STOP MiP KENYA,COMPLETED,2012-08,"Pregnancy, Malaria","IPTp-SP, IPTp-DP, ISTp-DP","Rarieda - Kenya, Siaya - Kenya, Bondo - Kenya, Madiany - Kenya",2014-10,2012-08-21,2017-03-06,INTERVENTIONAL,PHASE4,Kenya Medical Research Institute,OTHER,malaria
NCT05581641,Unknown,COMPLETED,2022-12-15,Malaria,"BNT165b1, Placebo","Tempe - United States, Baltimore - United States, Las Vegas - United States, Knoxville - United States, San Antonio - United States",2024-02-23,2022-10-14,2024-10-01,INTERVENTIONAL,PHASE1,BioNTech SE,INDUSTRY,malaria
NCT00890019,Unknown,COMPLETED,2007-07,Malaria,"AdCh63 ME-TRAP, AdCh63 ME-TRAP; MVA ME-TRAP","Harrow - United Kingdom, Oxford - United Kingdom",2011-08,2009-04-29,2012-08-22,INTERVENTIONAL,PHASE1,University of Oxford,OTHER,malaria
NCT01713517,Unknown,UNKNOWN,2011-04,"Malaria, Falciparum","Indoor residual insecticide spraying (IRS), Long Lasting Insecticidal Nets (LLIN)","Gedarif - Sudan, Wad Medani - Sudan, Kassala - Sudan",2014-10,2012-10-24,2012-10-26,INTERVENTIONAL,PHASE4,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT02089841,ALE,COMPLETED,2012-05,Plasmodium Falciparum Malaria,Artemether-lumefantrine,Dar es Salaam - Tanzania,2013-08,2014-03-18,2014-03-18,INTERVENTIONAL,PHASE4,Richard Mwaiswelo,OTHER,malaria
NCT01524341,Unknown,COMPLETED,2012-01,Malaria,KAE609,"Bangkok - Thailand, Tak Province - Thailand, Tak - Thailand",2012-06,2012-02-01,2013-05-13,INTERVENTIONAL,PHASE2,Novartis Pharmaceuticals,INDUSTRY,malaria
NCT02858817,Unknown,COMPLETED,2016-11-28,Malaria,"atovaquone/proguanil 250mg/100mg (A/P), PfSPZ Challenge (NF54), NaCl 0,9%",No locations listed,2017-11-16,2016-08-08,2019-07-15,INTERVENTIONAL,PHASE1,University Hospital Tuebingen,OTHER,malaria
NCT03707041,Unknown,COMPLETED,2018-11-16,Malaria,"P218 (1000 mg) Oral Capsules, Placebo Oral Capsules, P218 (100 mg) Oral Capsules, PfSPZ Challenge",Antwerpen - Belgium,2019-05-27,2018-10-16,2021-04-09,INTERVENTIONAL,PHASE1,Medicines for Malaria Venture,OTHER,malaria
NCT04570241,Unknown,UNKNOWN,2017-01-20,Malaria,Malaria toolkit,Yaoundé - Cameroon,2020-12-31,2020-09-30,2020-09-30,INTERVENTIONAL,NA,Cameroon Coalition Against Malaria (CCAM),OTHER,malaria
NCT04739917,Unknown,UNKNOWN,2021-06-01,"Malaria, Vivax","Vaccine PvCS N+C+R 150 mcg, Placebo SSN Montanide ISA-51 1 mL",Cali - Colombia,2022-06-01,2021-02-05,2021-03-01,INTERVENTIONAL,PHASE2,Malaria Vaccine and Drug Development Center,OTHER,malaria
NCT00074841,Unknown,COMPLETED,2003-09,PLASMODIUM FALCIPARUM MALARIA,"Azithromycin/Chloroquine, Sulfadoxine-Pyrimethamine/Chloroquine","Dispur Guwahati - India, Bambolim - India, Nagpur - India, Parel Mumbai - India, Rourkela - India, Vellore - India, Indore - India",Unknown Date,2003-12-24,2011-05-10,INTERVENTIONAL,PHASE3,Pfizer,INDUSTRY,malaria
NCT00140517,Unknown,COMPLETED,2002-10,"Malaria in Pregnancy, Birth Weight, Anaemia","sulphadoxine-pyrimethamine, chloroquine",Ouagadougou - Burkina Faso,2007-06,2005-09-01,2017-01-12,INTERVENTIONAL,NA,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT00238017,Unknown,UNKNOWN,2005-10,Malaria,amodiaquine-artesunate versus amodiaquine,Tamale - Ghana,Unknown Date,2005-10-13,2006-02-02,INTERVENTIONAL,PHASE4,"Charite University, Berlin, Germany",OTHER,malaria
NCT05205941,Unknown,COMPLETED,2022-03-30,Malaria,MMV688533,Brisbane - Australia,2022-09-02,2022-01-25,2024-12-02,INTERVENTIONAL,PHASE1,Medicines for Malaria Venture,OTHER,malaria
NCT04516317,Palustar,COMPLETED,2020-08-10,Severe Malaria,"None (Observational study Group intravenous artesunate), None (Observational study Group intravenous quinine)",Le Chesnay - France,2022-03-15,2020-08-18,2022-03-24,OBSERVATIONAL,Not Available,Dr Fabrice BRUNEEL,OTHER,malaria
NCT05690841,FLAME,RECRUITING,2024-10-14,"Malaria, Vivax, Malaria",Focal Mass Drug Administration (fMDA),Iquitos - Peru,2027-05-01,2023-01-19,2025-02-12,INTERVENTIONAL,PHASE3,"University of California, San Francisco",OTHER,malaria
NCT00959517,Unknown,COMPLETED,2001-07,Uncomplicated Falciparum Malaria,"artesunate (AS), sulphadoxine-pyrimethamine (SP), Chloroquine (CQ), primaquine (PQ)",Peshawar - Pakistan,2005-06,2009-08-14,2009-08-14,INTERVENTIONAL,PHASE2,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT05776017,Unknown,RECRUITING,2023-03-27,"Malaria,Falciparum","MSP3-CRM-Vac4All/ Alhydrogel®, Anti-Rabies Vaccine",Bamako - Mali,2023-12-31,2023-03-20,2023-04-26,INTERVENTIONAL,PHASE2,Vac4All,INDUSTRY,malaria
NCT00544024,Unknown,COMPLETED,2004-03,Malaria,No interventions listed,Iquitos - Peru,Unknown Date,2007-10-16,2007-10-16,OBSERVATIONAL,Not Available,Centers for Disease Control and Prevention,FED,malaria
NCT01122134,Unknown,UNKNOWN,2010-05,Severe Malaria,intravenous artesunate,Kampala - Uganda,2010-08,2010-05-13,2010-05-13,OBSERVATIONAL,Not Available,Makerere University,OTHER,malaria
NCT00508417,Unknown,COMPLETED,2007-07-24,"Malaria Infection, Malaria Incidence, Anemia",No interventions listed,Bethesda - United States,Unknown Date,2007-07-30,2017-07-02,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT03944317,Unknown,UNKNOWN,2019-06-01,"Malaria in Pregnancy, Pregnancy","Sulfadoxine pyrimethamine, Azithromycin",Owo - Nigeria,2019-11-30,2019-05-09,2019-05-10,INTERVENTIONAL,NA,"Federal Medical Centre, Owo",INDUSTRY,malaria
NCT01743417,CM_CCRT,COMPLETED,2011-04,Malaria,Computerised cognitive rehabilitation training,Kampala - Uganda,2016-08-23,2012-12-06,2017-05-22,INTERVENTIONAL,NA,Makerere University,OTHER,malaria
NCT04767217,Unknown,COMPLETED,2021-06-14,Uncomplicated Malaria,"artemether-lumefantrine (ALN), dihydroartemisinin-piperaquine (DHA-PPQ)","Bugarama - Rwanda, Masaka - Rwanda, Rukara - Rwanda",2023-12-08,2021-02-23,2024-02-02,INTERVENTIONAL,PHASE4,Jhpiego,OTHER,malaria
NCT05317117,Unknown,UNKNOWN,2022-07-04,Malaria,NxTek™ Malaria P.f plus Rapid Diagnostic Test (RDT) and NxTek™ Malaria P.f/P.v RDT,Porto Velho - Brazil,2022-12-01,2022-04-07,2022-09-27,INTERVENTIONAL,NA,PATH,OTHER,malaria
NCT06816524,Unknown,NOT_YET_RECRUITING,2025-03-01,Iron Deficiencies,"Iron syrup, Multivitamin syrup, R21-Matrix/M Vaccine (malaria vaccine), Measles-Rubella vaccine",No locations listed,2027-09-01,2025-02-10,2025-02-10,INTERVENTIONAL,NA,Swiss Federal Institute of Technology,OTHER,malaria
NCT02561624,Unknown,COMPLETED,2015-07,Malaria,Behaviour change communication via text message,Moshi - Tanzania,2016-01,2015-09-28,2016-04-13,INTERVENTIONAL,NA,Queen's University,OTHER,malaria
NCT01366534,Unknown,COMPLETED,2011-08-10,Malaria,"Crucell's replication deficient adenovirus type 35 circumsporozoite malaria vaccine (Ad35.CS.01), GSK Biologicals' malaria vaccine 257049 (2 doses), GSK Biologicals' malaria vaccine 257049 (3 doses), Sporozoite challenge",Silver Spring - United States,2012-02-27,2011-06-06,2019-06-18,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,malaria
NCT03641534,PERFuSE,COMPLETED,2018-06-04,"Severe Sepsis, Malaria","Lung Ultrasound examination, Compression ultrasonography (CUS), Echocardiography, Inferior Vena Cava ultrasound, Passive leg raising test (PLR), Orthogonal polarization spectral imaging (OPS), Urine collection (Foley catheter), Venous blood samplings, Electrocardiogram, GlycoCheck",Chittagong - Bangladesh,2019-08-29,2018-08-22,2021-06-21,OBSERVATIONAL,Not Available,University of Oxford,OTHER,malaria
NCT04897919,Unknown,COMPLETED,2015-08-01,"Malaria, Effectiveness","Dihydroartemisinin-piperaquine 160 mg/20 mg Oral Tablet, Artemether-Lumefantrine 20 Mg-120 Mg Oral Tablet",Bissau - Guinea-Bissau,2017-10-01,2021-05-24,2022-04-12,INTERVENTIONAL,PHASE4,Bandim Health Project,OTHER,malaria
NCT00866619,Unknown,COMPLETED,2009-03-27,Malaria,"Malaria Vaccine 257049, Meningococcal C Conjugate Vaccine, Cell-culture rabies vaccine, TritanrixHepB/Hib, Polio Sabin Oral Polio Vaccine (GSK)","Ouagadougou - Burkina Faso, Lambaréné - Gabon, Kintampo - Ghana, Kumasi - Ghana, Kilifi - Kenya, Kisumu - Kenya, Lilongwe - Malawi, Maputo - Mozambique, Dar-es-Salaam - Tanzania, Tanga - Tanzania",2011-03-01,2009-03-20,2019-10-09,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,malaria
NCT02905019,Unknown,COMPLETED,2016-08,Malaria,"R21 with Matrix-M1, ChAd63 ME-TRAP, MVA ME-TRAP","London - United Kingdom, Oxford - United Kingdom, Southampton - United Kingdom",2017-12-21,2016-09-19,2018-06-13,INTERVENTIONAL,PHASE2,University of Oxford,OTHER,malaria
NCT02132299,Unknown,COMPLETED,2014-04,"Malaria, Plasmodium Falciparum Malaria","PfSPZ Vaccine, Normal Saline (Placebo), PfSPZ Challenge",Bagamoyo - Tanzania,2015-07,2014-05-07,2016-04-27,INTERVENTIONAL,PHASE1,Sanaria Inc.,INDUSTRY,malaria
NCT02708199,Unknown,COMPLETED,2015-01,"Increased Drug Resistance, Asymptomatic Infection, Malaria",No interventions listed,No locations listed,2015-12,2016-03-15,2016-03-15,OBSERVATIONAL,Not Available,"Department of Medical Research, Lower Myanmar",OTHER,malaria
NCT00739206,Unknown,TERMINATED,2008-08,Malaria,SAR97276A,"Porto Novo - Benin, Ouagadougou - Burkina Faso, Libreville - Gabon, Dodoma - Tanzania",2009-06,2008-08-21,2010-06-16,INTERVENTIONAL,PHASE2,Sanofi,INDUSTRY,malaria
NCT04271306,Unknown,TERMINATED,2021-05-25,"Malaria,Falciparum","Pfs25-IMX313 (10ug)/Matrix-M (50ug), Pfs25-IMX313 (50ug)/Matrix-M (50ug), Pfs25-IMX313 (50ug)/Matrix-M (50ug) & Pfs25-IMX313 (10ug)/Matrix-M (50ug)",Bagamoyo - Tanzania,2024-02-19,2020-02-17,2025-01-27,INTERVENTIONAL,PHASE1,University of Oxford,OTHER,malaria
NCT00716599,Unknown,COMPLETED,2008-01,"Malaria, Fever",training in use of rapid diagnostic tests (RDTs) for malaria,Kampala - Uganda,2008-06,2008-07-16,2008-07-16,INTERVENTIONAL,NA,"University of California, San Francisco",OTHER,malaria
NCT01023399,Unknown,COMPLETED,2009-11,Malaria,Artesunate + Amodiaquine,Agboville district - Côte D'Ivoire,2013-10,2009-12-02,2015-02-23,INTERVENTIONAL,PHASE4,Sanofi,INDUSTRY,malaria
NCT00711906,Unknown,TERMINATED,2009-02,Malaria in Pregnancy,"Cotrimoxazole, Sulfadoxine-pyrimethamine","Choma - Zambia, Shampande - Zambia",2010-02,2008-07-09,2016-01-18,INTERVENTIONAL,PHASE3,"Institute of Tropical Medicine, Belgium",OTHER,malaria
NCT00951106,Unknown,COMPLETED,1998-01,"Malaria, Vivax, Malaria, Falciparum",Pyrimethamine/sulfdoxine (Fansidar),Lima - Peru,1999-06,2009-08-04,2010-07-27,INTERVENTIONAL,NA,Walter Reed Army Institute of Research (WRAIR),FED,malaria
NCT02876549,GAP,COMPLETED,2016-09-01,Vivax Malaria,"Chloroquine, Primaquine 0.25 mg/kg/day, Primaquine 0.75 mg/kg weekly",Jalalabad - Afghanistan,2018-11,2016-08-23,2020-10-14,INTERVENTIONAL,PHASE4,University of Oxford,OTHER,malaria
NCT00126906,Unknown,COMPLETED,2002-10,"Malaria, Falciparum, HIV Infections","Monthly sulfadoxine/pyrimethamine, 2-dose sulfadoxine/pyrimethamine",Liwonde - Malawi,Unknown Date,2005-08-05,2005-08-23,INTERVENTIONAL,NA,Centers for Disease Control and Prevention,FED,malaria
NCT02699099,Unknown,COMPLETED,2017-05-10,"Malaria, Malaria Vaccines","Vitamin A, Candidate Plasmodium falciparum malaria vaccine, MR-Vac, Stamaril","Kintampo - Ghana, Kumasi - Ghana",2018-03-14,2016-03-04,2021-09-29,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,malaria
NCT04829695,Unknown,UNKNOWN,2021-04-05,Falciparum Malaria,"Artesunate-amodiaquine drug combination, Artemether-lumefantrine drug combination",No locations listed,2021-12-31,2021-04-02,2021-04-02,INTERVENTIONAL,PHASE4,University of Yaounde 1,OTHER,malaria
NCT00738946,IPTc/ITNs,COMPLETED,2008-08,Malaria,Intermittent preventive treatment with AQ+ SP,"Ouagadougou - Burkina Faso, Bamako - Mali",2008-12,2008-08-21,2010-06-04,INTERVENTIONAL,NA,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT00913146,Unknown,COMPLETED,2008-02,Malaria,No interventions listed,Allada - Benin,2008-06,2009-06-04,2009-06-04,OBSERVATIONAL,Not Available,Institut de Recherche pour le Developpement,OTHER_GOV,malaria
NCT00386750,Unknown,TERMINATED,2005-06,"Malaria, Falciparum",Artemether-lumefantrine,No locations listed,2005-11,2006-10-12,2012-04-27,INTERVENTIONAL,PHASE4,Novartis Pharmaceuticals,INDUSTRY,malaria
NCT03952650,Unknown,COMPLETED,2019-05-23,Malaria,"Chloroquine Phosphate, PfSPZ Challenge, Pyrimethamine, Coartem, ibuprofen",Bamako - Mali,2021-02-10,2019-05-16,2022-07-12,INTERVENTIONAL,PHASE2,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT01403350,Unknown,COMPLETED,2012-02,"Malaria, Fever, Acute Febrile Illness, Pneumonia",Malaria Rapid Diagnostic test,"Jalalabad - Afghanistan, Kabul - Afghanistan, Kunduz - Afghanistan",2012-08,2011-07-27,2022-07-15,INTERVENTIONAL,PHASE4,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT02149550,Unknown,COMPLETED,2014-08,Malaria,"NF135 n=5, NF135 n=2, NF135 n=1, NF166 n=5, NF166 n=2, NF166 n=1","Nijmegen - Netherlands, Rotterdam - Netherlands",2014-10,2014-05-29,2014-11-24,INTERVENTIONAL,NA,Radboud University Medical Center,OTHER,malaria
NCT01001650,Unknown,COMPLETED,2009-04,Plasmodium Falciparum,"Plasmodium falciparum Sporozoite (strain NF-54; Anopheles stephensi mosquitoes) Vaccine, Live, Inactivated (gamma irradiation)","Baltimore - United States, Bethesda - United States",2010-07,2009-10-26,2014-09-10,INTERVENTIONAL,PHASE1,Sanaria Inc.,INDUSTRY,malaria
NCT00341250,Unknown,COMPLETED,2006-01-19,Malaria,AMA1-C1/Alhydrogel Malaria Vaccine,"Bancoumana - Mali, Doneguebougou - Mali",Unknown Date,2006-06-21,2017-07-02,INTERVENTIONAL,PHASE2,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT05753150,ARCTIC,COMPLETED,2022-05-23,"Malaria, Vivax, G6PD Deficiency","Tafenoquine, Primaquine, Primaquine","Mae Sariang - Thailand, Mae Sariang - Thailand, Sop Moei - Thailand, Bannang Sata - Thailand, Bannang Sata - Thailand, Kabang - Thailand, Mueang - Thailand, Than To - Thailand, Than To - Thailand",2023-08-31,2023-03-03,2023-10-26,OBSERVATIONAL,Not Available,Dr. Prayuth Sudathip,OTHER_GOV,malaria
NCT00697164,EPOMAL,UNKNOWN,2007-10,Cerebral Malaria,"Placebo, Erythropoietin",Bamako - Mali,2008-12,2008-06-13,2008-06-13,INTERVENTIONAL,PHASE3,Claude Bernard University,OTHER,malaria
NCT03355664,TACT-CV,COMPLETED,2018-03-19,"Malaria, Falciparum","ACT, TACT","Siem Pang - Cambodia, Pailin - Cambodia, Van Ninh - Vietnam, Phuoc Long - Vietnam",2020-03-04,2017-11-28,2022-07-15,INTERVENTIONAL,PHASE3,University of Oxford,OTHER,malaria
NCT00935623,Pvivax,COMPLETED,2009-04-21,Plasmodium Vivax Malaria,Malaria Challenge,Silver Spring - United States,2011-06,2009-07-09,2018-08-16,INTERVENTIONAL,PHASE1,U.S. Army Medical Research and Development Command,FED,malaria
NCT00852423,PREGACT,COMPLETED,2010-06,Malaria in Pregnancy,"Dihydroartemisinin-piperaquine, Artesunate-mefloquine, Artesunate-amodiaquine, Artemether-lumefantrine","Nanoro - Burkina Faso, Nazoanga - Burkina Faso, Ejisu Sekyere East - Ghana, Juaben Government Hospital - Ghana, Effiduase - Ghana, Chikwawa District Hospital - Malawi, Nchelenge - Zambia",2013-10,2009-02-27,2016-03-14,INTERVENTIONAL,PHASE3,"Institute of Tropical Medicine, Belgium",OTHER,malaria
NCT04666350,Unknown,COMPLETED,2021-03-09,Malaria,"Direct Skin Feeding Assay (DSFA), Primaquine, Artemether/Lumefantrine",Kombewa - Kenya,2021-12-20,2020-12-14,2024-04-29,OBSERVATIONAL,Not Available,PATH,OTHER,malaria
NCT00658450,Unknown,COMPLETED,2008-02,"Malaria, Cerebral",Cognitive rehabilitation training,Kampala - Uganda,2010-10,2008-04-15,2012-12-06,INTERVENTIONAL,NA,Makerere University,OTHER,malaria
NCT02052323,Unknown,COMPLETED,2013-10,Malaria,Artesunate/mefloquine (AS/MQ),Amphoe Sangkhlaburi - Thailand,2015-10,2014-02-03,2016-01-25,INTERVENTIONAL,PHASE4,"Armed Forces Research Institute of Medical Sciences, Thailand",OTHER_GOV,malaria
NCT00687895,Unknown,COMPLETED,2003-07,Malaria,Clinical algorithm and microscopy diagnosis of malaria,Coast - Tanzania,2004-03,2008-06-02,2008-06-02,INTERVENTIONAL,PHASE4,Muhimbili University of Health and Allied Sciences,OTHER,malaria
NCT01998295,PCT,COMPLETED,2012-05,Instantaneous Clearance,Artemether/lumefantrine,Dar es Salaam - Tanzania,2012-06,2013-11-28,2014-03-18,INTERVENTIONAL,PHASE4,Muhimbili University of Health and Allied Sciences,OTHER,malaria
NCT02371395,Unknown,COMPLETED,2015-01,Malaria Diagnosis,Realtime amplification (RealAmp),Cruzeiro do Sul - Brazil,2015-06,2015-02-25,2018-10-23,OBSERVATIONAL,Not Available,Centers for Disease Control and Prevention,FED,malaria
NCT01133314,Unknown,COMPLETED,2010-05,Malaria,No interventions listed,Bissau - Guinea-Bissau,2012-12,2010-05-28,2021-05-26,OBSERVATIONAL,Not Available,Bandim Health Project,OTHER,malaria
NCT02640495,ARIMTIA,WITHDRAWN,2015-10,Malaria,Intravenous Artesunate as part of standard medical practice,No locations listed,2017-12,2015-12-29,2018-08-22,OBSERVATIONAL,Not Available,University of Oxford,OTHER,malaria
NCT01361269,Unknown,UNKNOWN,2011-06,Malaria,Fosmidomycin and clindamycin,Lambarene - Gabon,2011-09,2011-05-26,2011-05-26,INTERVENTIONAL,PHASE2,Zentopharm GmbH,INDUSTRY,malaria
NCT06040346,Unknown,ACTIVE_NOT_RECRUITING,2024-04-26,Malaria,Meplazumab for Injection,Kisumu - Kenya,2025-08,2023-09-15,2024-10-29,INTERVENTIONAL,PHASE2,Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd,INDUSTRY,malaria
NCT03178643,EPiTOMISE,COMPLETED,2018-01-23,"Malaria,Falciparum","Proguanil Oral Tablet, Sulfadoxine/Pyrimethanine-Amodiaquine (SP-AQ), Dihydroartemisinin-Piperaquine (DP)",Homa Bay Town - Kenya,2020-12-16,2017-06-07,2024-04-23,INTERVENTIONAL,PHASE4,Duke University,OTHER,malaria
NCT03511443,Unknown,UNKNOWN,2017-10-02,"Malaria Diagnosis, Malaria,Falciparum",hsRDT,Yangon - Myanmar,2018-06-28,2018-04-27,2018-04-27,INTERVENTIONAL,NA,"University Research Co, LLC",INDUSTRY,malaria
NCT01497236,MSF-nutcon03,COMPLETED,2011-03,"Child Malnutrition, Infant Morbidity",Dietary Supplement: Nutrition supplement with RUTF or MNP,Kaabong - Uganda,2012-10,2011-12-22,2015-06-30,INTERVENTIONAL,NA,"Medecins Sans Frontieres, Spain",OTHER,malaria
NCT01575613,REDHOT,COMPLETED,2012-04,Malaria,"Artemether-lumefantrine combination, Bacillus thuringiensis, Long lasting insecticide treated net (LLINs), Indoor Residual Spraying (IRS)",Rachuonyo District - Kenya,2012-11,2012-04-11,2012-11-27,INTERVENTIONAL,NA,Radboud University Medical Center,OTHER,malaria
NCT01082718,Unknown,WITHDRAWN,2010-03,"Malaria, Pregnancy",Mefloquine Artesunate,No locations listed,2010-10,2010-03-09,2012-04-13,INTERVENTIONAL,PHASE3,Centers for Disease Control and Prevention,FED,malaria
NCT02645513,Unknown,COMPLETED,2015-01,"Malaria, Pneumonia, Diarrhea","Malaria text message reminders to health workers, Malaria, pneumonia, and diarrhea text message reminders to health workers, Control",No locations listed,2016-02,2016-01-01,2017-12-12,INTERVENTIONAL,NA,Centers for Disease Control and Prevention,FED,malaria
NCT03576313,MASSIV,COMPLETED,2018-08-11,Malaria,"dihydroartemisinin-piperaquine (DP), ivermectin (IVM), standard malaria control interventions only",Basse Santa Su - Gambia,2019-12-31,2018-07-03,2022-03-14,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT02769013,TRANSMAL,COMPLETED,2016-04,Malaria Transmission,"Pre-treatment follow up, S. haematobium treatment, Post treatment follow up, Olfactometer experiment","Lambarene - Gabon, Kumasi - Ghana",2019-10,2016-05-11,2020-11-04,OBSERVATIONAL,Not Available,University Hospital Tuebingen,OTHER,malaria
NCT00351013,Unknown,COMPLETED,2006-06,Malaria,Malaria Tropica Nosode D200,Freetown - Sierra Leone,2007-06,2006-07-12,2009-02-04,INTERVENTIONAL,PHASE4,Malamed,OTHER,malaria
NCT03689036,Unknown,UNKNOWN,2018-04-02,Malaria,No interventions listed,São Paulo - Brazil,2023-10-31,2018-09-28,2022-05-12,OBSERVATIONAL,Not Available,Oswaldo Cruz Foundation,OTHER,malaria
NCT00277849,Unknown,COMPLETED,2006-01-11,"Hemoglobin Mutations, Erythrocyte Variants",No interventions listed,Bethesda - United States,Unknown Date,2006-01-16,2017-07-02,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT06173206,Unknown,COMPLETED,2024-06-10,Malaria,"SP (Macleods Pharmaceuticals Ltd), SPAQ (Guilin Pharmaceuticals), AS (Guilin Pharmaceuticals)",Magba - Cameroon,2024-12-25,2023-12-15,2025-03-12,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT02996513,SUPERKID,COMPLETED,2016-10,"Vitamin A Deficiency, Malaria, Inflammation",Retinol Isotope Dilution (RID),Ibadan - Nigeria,2016-12,2016-12-19,2017-08-25,INTERVENTIONAL,NA,Wageningen University,OTHER,malaria
NCT05468606,CoGA,UNKNOWN,2023-02-03,"Malaria,Falciparum","GA2, BCG, YF-17D (fractional ID dose), Imiquimod, Mock immunization",Leiden - Netherlands,2024-12,2022-07-21,2023-02-10,INTERVENTIONAL,PHASE1,Leiden University Medical Center,OTHER,malaria
NCT00075049,Unknown,COMPLETED,2003-12,Malaria,"RTS,S with AS02A/AS01B adjuvant",Silver Spring - United States,2006-01,2004-01-01,2014-08-21,INTERVENTIONAL,PHASE2,U.S. Army Medical Research and Development Command,FED,malaria
NCT04149106,Unknown,UNKNOWN,2019-07-01,"Malaria,Falciparum","Sulfadoxine pyrimethamine + Amodiaquin, Dihydroartemisinin piperaquin",Bamako - Mali,2022-12-31,2019-11-04,2023-03-07,INTERVENTIONAL,PHASE3,"University Clinical Research Center, Mali",OTHER,malaria
NCT02073149,SEICK,COMPLETED,2014-06,Anaemia,"Low-dose iron as NaFeEDTA, Conventional dose iron as ferrous salt, Placebo",Maseno - Kenya,2014-12,2014-02-27,2015-04-10,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT02903706,ORPAL,COMPLETED,2014-10,"Malaria, Epidemiology",Measure of Plasmodium prevalence (PCR),No locations listed,2015-06,2016-09-16,2016-09-16,OBSERVATIONAL,Not Available,Centre Hospitalier de Cayenne,OTHER,malaria
NCT01680406,Unknown,COMPLETED,2012-10,Plasmodium Vivax Infection,"Artemether-lumefantrine combination, Primaquine, Chloroquine","Debre Zeit - Ethiopia, Zeway - Ethiopia",2014-12,2012-09-07,2017-01-19,INTERVENTIONAL,PHASE4,Centers for Disease Control and Prevention,FED,malaria
NCT00444106,Unknown,COMPLETED,2007-05,"Malaria, Falciparum","Artesunate-mefloquine, Atovaquone-proguanil, Artemether-lumefantrine",Tumaco - Colombia,2008-11,2007-03-07,2011-04-05,INTERVENTIONAL,PHASE4,Novartis,INDUSTRY,malaria
NCT04969913,Unknown,COMPLETED,2022-03-07,Malaria,No interventions listed,"Bethesda - United States, Maferinyah - Guinea",2024-10-23,2021-07-21,2024-10-24,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT02504918,Unknown,COMPLETED,2015-07-21,Malaria,No interventions listed,Ouelessebougou - Mali,2016-12-31,2015-07-22,2018-06-14,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT00349713,Unknown,COMPLETED,2004-11,"Malaria, Plasmodium Falciparum Malaria","FMP2.1/AS02A, Rabies vaccine (RabAvert)",Bamako - Mali,2005-12,2006-07-10,2017-07-24,INTERVENTIONAL,PHASE1,U.S. Army Medical Research and Development Command,FED,malaria
NCT04778813,CHIMIO2,UNKNOWN,2021-06-01,"Malaria, Burkina Faso",Artemether-lumefantrine,Ouagadougou - Burkina Faso,2021-12-31,2021-03-03,2021-03-03,INTERVENTIONAL,PHASE4,Centre national de recherche et de formation sur le paludisme,OTHER_GOV,malaria
NCT02533336,DL,TERMINATED,2015-11-09,Malaria,abamectin and fenpyroximate,Tanga - Tanzania,2016-08-31,2015-08-26,2019-02-05,INTERVENTIONAL,PHASE3,"National Institute for Medical Research, Tanzania",OTHER_GOV,malaria
NCT00397449,Unknown,UNKNOWN,2006-10,Malaria,GMZ2 (GLURP + MSP3 Hybrid) (malaria vaccine),Tubingen - Germany,Unknown Date,2006-11-09,2007-08-10,INTERVENTIONAL,PHASE1,European Vaccine Initiative,OTHER,malaria
NCT00344006,Unknown,COMPLETED,2006-06,"Malaria, Falciparum","chlorproguanil-dapsone-artesunate, artemether-lumefantrine","Bobo-Dioulasso - Burkina Faso, Kintampo - Ghana, Eldoret - Kenya, Kilifi - Kenya, Barkin Ladi - Nigeria, Calabar - Nigeria, Enugu - Nigeria, Ibadan - Nigeria, Ifakara - Tanzania",2007-08,2006-06-26,2016-12-05,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,malaria
NCT03542149,Unknown,COMPLETED,2018-04-23,Malaria,"480 mg Piperaquine phosphate, 640 mg Piperaquine phosphate, 200 mg OZ 439, 400 mg OZ 439, 800 mg OZ 439, 960 mg PQP, 320 mg PQP",Herston - Australia,2019-04-19,2018-05-31,2024-05-10,INTERVENTIONAL,PHASE1,Medicines for Malaria Venture,OTHER,malaria
NCT00587249,Unknown,COMPLETED,2002-07,Plasmodium Falciparum Malaria,"Malaria ICC-1132, Alhydrogel",Baltimore - United States,2005-07,2008-01-07,2013-04-12,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT01258049,Unknown,COMPLETED,2010-12,Plasmodium Falciparum Malaria,"Artemether Sublingual Spray, Quinine","Ouagadougou - Burkina Faso, Navrongo - Ghana, Rwinkwavu - Rwanda",2012-08,2010-12-10,2014-02-28,INTERVENTIONAL,PHASE3,Proto Pharma Ltd,INDUSTRY,malaria
NCT03508349,Unknown,COMPLETED,2016-09-05,Malaria in Pregnancy,IST,"Huye - Rwanda, Huye - Rwanda, Huye - Rwanda, Huye - Rwanda, Huye - Rwanda, Huye - Rwanda, Huye - Rwanda, Huye - Rwanda, Kamonyi - Rwanda, Kamonyi - Rwanda, Kamonyi - Rwanda, Kamonyi - Rwanda, Kamonyi - Rwanda, Kamonyi - Rwanda",2018-10-31,2018-04-25,2019-12-06,INTERVENTIONAL,NA,Jhpiego,OTHER,malaria
NCT00561899,Unknown,COMPLETED,2007-08,Malaria,"SP, amodiaquine, piperaquine, dihdroartemisinin, intermittent preventive treatment, Du-Cotecxin",Banjul - Gambia,2008-02,2007-11-21,2017-01-26,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT00314899,Unknown,COMPLETED,2006-09-15,Plasmodium Falciparum Malaria,No interventions listed,Nairobi - Kenya,2009-11-15,2006-04-17,2019-02-01,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT02491606,Unknown,COMPLETED,1997-05,Malaria,"Tafenoquine, Placebo",No locations listed,1997-09,2015-07-08,2018-09-13,INTERVENTIONAL,PHASE2,U.S. Army Medical Research and Development Command,FED,malaria
NCT04704999,SEADOT,RECRUITING,2024-07-22,Plasmodium Vivax Malaria,"Tafenoquine, Chloroquine, Artemether 20 mg-Lumefantrine 120 mg","Siem Reap - Cambodia, Vientiane - Lao People's Democratic Republic, Bangkok - Thailand, Bangkok - Thailand, Binh Phuoc - Vietnam",2027-10-04,2021-01-12,2025-03-06,INTERVENTIONAL,PHASE4,University of Oxford,OTHER,malaria
NCT03167242,Unknown,COMPLETED,2017-08-02,Acute Uncomplicated Plasmodium Falciparum Malaria,"KAF156, Coartem, Lumefantrine Solid Dispersion Formulation","Nanoro - Burkina Faso, Lambarene - Gabon, Ranchi - India, Kombewa - Kenya, Siaya - Kenya, Sotuba - Mali, Chokwe - Mozambique, Tak - Thailand, Masaka - Uganda, Tororo - Uganda, Binh Phuoc Province - Vietnam",2021-06-14,2017-05-25,2022-02-10,INTERVENTIONAL,PHASE2,Novartis Pharmaceuticals,INDUSTRY,malaria
NCT05540470,CUREMA,RECRUITING,2022-09-12,"Malaria, Vivax","PART, Malakit, CROSS-SECTIONAL PRE- AND POST-INTERVENTION SURVEYS, QUALITATIVE STUDY","Oiapoque - Brazil, Paramaribo - Suriname",2024-12-12,2022-09-14,2024-12-11,INTERVENTIONAL,NA,Centre Hospitalier de Cayenne,OTHER,malaria
NCT04622241,UHMS,UNKNOWN,2021-01-29,"Malaria, Anemia","Eave Tubes, Eave Ribbons, Full House Screening, Partial House Screening",Kampala - Uganda,2023-05,2020-11-09,2022-08-04,INTERVENTIONAL,NA,"Infectious Diseases Research Collaboration, Uganda",OTHER,malaria
NCT00282919,Unknown,COMPLETED,2006-03,Falciparum Malaria,Azithromycin plus chloroquine,"San Andres de Tumaco - Colombia, Bambolim - India",2008-02,2006-01-27,2014-06-26,INTERVENTIONAL,PHASE2,Pfizer,INDUSTRY,malaria
NCT04158713,IMPROVE-2,COMPLETED,2019-11-11,Pregnancy; HIV; Malaria,Intermittent Preventive Therapy with Dihydroartemisinin-Piperaquine,Kisumu - Kenya,2022-04-15,2019-11-12,2023-08-22,INTERVENTIONAL,PHASE3,Liverpool School of Tropical Medicine,OTHER,malaria
NCT01103713,Unknown,TERMINATED,2011-03,Asymptomatic Parasitemia In Pregnancy,Azithromycin plus chloroquine,"Cotonou - Benin, Cotonou - Benin, Siaya - Kenya, Zomba - Malawi, Muheza - Tanzania, Mwanza - Tanzania, Kampala - Uganda",2013-06,2010-04-15,2015-01-26,INTERVENTIONAL,PHASE3,Pfizer,INDUSTRY,malaria
NCT01921413,Unknown,COMPLETED,2013-07,Malaria,Urine Malaria Test,Idi-Araba - Nigeria,2014-02,2013-08-13,2014-04-22,OBSERVATIONAL,Not Available,Fyodor Biotechnologies Inc,INDUSTRY,malaria
NCT03143218,RTSS-SMC,COMPLETED,2017-04-17,"Malaria,Falciparum, Children, Only","RABIPUR®, RTS,S/AS01, SMC with SP+AQ, SMC placebo","Ouagadougou - Burkina Faso, Bamako - Mali",2020-03-31,2017-05-08,2022-04-07,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT00347113,Unknown,COMPLETED,2006-07,"Anaemia, Malaria, Hepatosplenomegaly",Albendazole and praziquantel,Mwanza - Tanzania,2011-01,2006-07-04,2014-09-23,INTERVENTIONAL,NA,DBL -Institute for Health Research and Development,OTHER,malaria
NCT06076213,TES2022,COMPLETED,2023-05-01,Uncomplicated Plasmodium Falciparum Malaria,"Artesunate-amodiaquine, Artemether-lumefantrine","Kapolowe - Congo, The Democratic Republic of the, Kazumba - Congo, The Democratic Republic of the, Kimpese - Congo, The Democratic Republic of the, Vanga - Congo, The Democratic Republic of the, Kalima - Congo, The Democratic Republic of the, Kabondo - Congo, The Democratic Republic of the, Boende - Congo, The Democratic Republic of the",2024-09-24,2023-10-10,2024-11-05,INTERVENTIONAL,PHASE4,"Ministry of Public Health, Democratic Republic of the Congo",OTHER_GOV,malaria
NCT01816113,Unknown,COMPLETED,2013-04,"Malaria, Plasmodium Vivax","ChAd63 PvDBP 5 x 10^9, ChAd63 PvDBP 5 x 10^10, MVA PvDBP 1 x 10^8, MVA PvDBP 2 x 10^8",Oxford - United Kingdom,2014-07,2013-03-21,2017-05-08,INTERVENTIONAL,PHASE1,University of Oxford,OTHER,malaria
NCT01047436,Unknown,COMPLETED,2009-12,Falciparum Malaria,"Quinine, Artemether",No locations listed,2010-01,2010-01-12,2011-01-27,INTERVENTIONAL,PHASE2,Proto Pharma Ltd,INDUSTRY,malaria
NCT01084213,IPTp_IST,COMPLETED,2010-06,"Malaria, Pregnancy, Anaemia","Intermittent screening and treatment of malaria in pregnancy (IST), SP-IPTp","Ouagadougou - Burkina Faso, Basse - Gambia, Navrongo - Ghana, Bamako - Mali",2012-07,2010-03-10,2014-04-11,INTERVENTIONAL,PHASE4,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT01231113,DHAPPQ/MIP,COMPLETED,2011-07,Pregnancy Complicated by Malaria as Antepartum Condition,"artesunate-amodiaquine, Dihydroartemisinin-piperaquine",Kumasi - Ghana,2012-12,2010-11-01,2016-02-24,INTERVENTIONAL,PHASE3,Kwame Nkrumah University of Science and Technology,OTHER,malaria
NCT03773536,AcoV,COMPLETED,2017-05-09,Plasmodium Falciparum Malaria,Artesunate-amodiaquine given with single low dose primaquine,Zanzibar - Tanzania,2017-09-25,2018-12-12,2018-12-12,INTERVENTIONAL,PHASE4,Professor Anders Björkman,OTHER,malaria
NCT02090036,Unknown,COMPLETED,2014-07,Plasmodium Falciparum,"Primaquine (For artemether-lumefantrine+primaquine arm), Placebo (For artemether-lumefantrine arm)",Dar es Salaam - Tanzania,2014-10,2014-03-18,2014-12-08,INTERVENTIONAL,PHASE4,Muhimbili University of Health and Allied Sciences,OTHER,malaria
NCT00167713,Unknown,COMPLETED,2003-04,Fever,Ibuprofen,Lambaréné - Gabon,Unknown Date,2005-09-14,2005-09-21,INTERVENTIONAL,PHASE4,Albert Schweitzer Hospital,OTHER,malaria
NCT06524336,Unknown,ACTIVE_NOT_RECRUITING,2024-06-12,"Malaria,Falciparum",No interventions listed,Moroto - Uganda,2024-10-28,2024-07-29,2024-07-29,OBSERVATIONAL,Not Available,Malaria Consortium,OTHER,malaria
NCT05746819,MRIA,COMPLETED,2021-01-02,"Brain Injuries, Malaria, MRI Imaging, Neurocognitive Deficits, Chronic Kidney Diseases, Behavior Problem",Aggressive antipyretics therapy of fever vs usual care in the Malaria RCT study,"Blantyre - Malawi, Chipata - Zambia",2023-08-31,2023-02-28,2024-04-15,OBSERVATIONAL,Not Available,University of Rochester,OTHER,malaria
NCT02639299,Unknown,RECRUITING,2016-12-08,Malaria,No interventions listed,Bethesda - United States,2030-09-30,2015-12-24,2025-03-04,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT03719599,Unknown,COMPLETED,2019-10-01,Malaria,No interventions listed,"Margibi - Liberia, Monrovia - Liberia",2021-02-04,2018-10-25,2025-02-11,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT01739036,Unknown,COMPLETED,2013-01,Plasmodium Falciparum Malaria,"ChAd63 CS/ME-TRAP, MVA CS/ME-TRAP, ChAd63 CS/ME-TRAP/AMA1, MVA CS/ME-TRAP/AMA1, Controlled Human Malaria Infection Administered by Mosquito Bite","Southampton - United Kingdom, Oxford - United Kingdom, London - United Kingdom",2013-10,2012-11-30,2013-11-11,INTERVENTIONAL,PHASE2,University of Oxford,OTHER,malaria
NCT02532049,Unknown,COMPLETED,2015-10-12,Malaria,"ChAd63 Pfs25-IMX313, MVA Pfs25-IMX313","Oxford - United Kingdom, Southampton - United Kingdom",2017-05-25,2015-08-25,2017-07-17,INTERVENTIONAL,PHASE1,University of Oxford,OTHER,malaria
NCT03399318,Unknown,COMPLETED,2019-01-07,"Malaria, Seizures, Coma, Parasitemia, Hyperpyrexia, Fever","Acetaminophen, Ibuprofen, placebo for acetaminophen, placebo for ibuprofen","Blantyre - Malawi, Chipata - Zambia, Lusaka - Zambia",2022-12-02,2018-01-16,2024-03-05,INTERVENTIONAL,PHASE2,University of Rochester,OTHER,malaria
NCT04105855,Unknown,COMPLETED,2020-07-13,Malaria,No interventions listed,Maferinyah - Guinea,2023-10-30,2019-09-26,2023-11-14,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT04601714,BLOOMy,COMPLETED,2020-09-07,Malaria,No interventions listed,Ouagadougou - Burkina Faso,2021-09-28,2020-10-26,2023-02-24,OBSERVATIONAL,Not Available,Groupe de Recherche Action en Sante,OTHER,malaria
NCT01095055,Unknown,COMPLETED,2010-03,Malaria,"AdCh63 AMA1, AdCh63 AMa1 and MVA AMA1","London - United Kingdom, Oxford - United Kingdom",2010-10,2010-03-29,2011-03-28,INTERVENTIONAL,PHASE1,University of Oxford,OTHER,malaria
NCT02793414,Unknown,WITHDRAWN,2016-09,Malaria,No interventions listed,No locations listed,2017-04,2016-06-08,2020-10-06,OBSERVATIONAL,Not Available,Menzies School of Health Research,OTHER,malaria
NCT00623155,Unknown,COMPLETED,2002-07,Malaria,Seasonal IPT in children - Sulfadoxine-pyrimethamine,Bamako - Mali,2003-07,2008-02-25,2008-02-25,INTERVENTIONAL,NA,University of Bamako,OTHER,malaria
NCT00563914,Unknown,COMPLETED,2007-10,Malaria,"ferroquine (SSR97193), amodiaquine","Lambaréné - Gabon, Nairobi - Kenya",2008-11,2007-11-26,2009-12-21,INTERVENTIONAL,PHASE2,Sanofi,INDUSTRY,malaria
NCT00850655,Unknown,COMPLETED,2008-03,Malaria,No interventions listed,Saint Paul - United States,2015-03,2009-02-25,2016-10-26,OBSERVATIONAL,Not Available,University of Minnesota,OTHER,malaria
NCT01003314,Unknown,COMPLETED,2009-11,Malaria,"AdCh63-MSP1 (lower dose) vaccine and MVA-MSP1 vaccine, AdCh63-MSP1 vaccine (higher dose) and MVA-MSP1 vaccine followed by challenge",Oxford - United Kingdom,2010-09,2009-10-28,2011-03-28,INTERVENTIONAL,PHASE2,University of Oxford,OTHER,malaria
NCT01753323,Unknown,COMPLETED,2013-03,Malaria,KAF156,"Bangkok - Thailand, Srisaket - Thailand, Tak - Thailand, Tak - Thailand, Hanoi - Vietnam",2014-08,2012-12-20,2018-06-07,INTERVENTIONAL,PHASE2,Novartis Pharmaceuticals,INDUSTRY,malaria
NCT02851108,BlueACTn,COMPLETED,2016-10,"Malaria, Falciparum","Methylene Blue, Primaquine",Nouna - Burkina Faso,2016-12,2016-08-01,2020-03-25,INTERVENTIONAL,PHASE2,Heidelberg University,OTHER,malaria
NCT06413108,Unknown,ACTIVE_NOT_RECRUITING,2024-07-12,"Malaria,Falciparum","TB31F, Normal saline",Bamako - Mali,2026-01,2024-05-14,2025-03-11,INTERVENTIONAL,PHASE2,Radboud University Medical Center,OTHER,malaria
NCT02974608,Unknown,COMPLETED,2017-02-15,Malaria,No interventions listed,Bamako - Mali,2021-10-20,2016-11-28,2023-03-23,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT04083508,MIST1,RECRUITING,2020-10-05,Plasmodium Vivax Infection,Mosquito bites,Bangkok - Thailand,2025-09-30,2019-09-10,2024-05-17,INTERVENTIONAL,NA,University of Oxford,OTHER,malaria
NCT01445938,Unknown,TERMINATED,2011-10,Malaria,"SAR97276A, arthemeter + lumefantrine (ACTs)","Cotonou - Benin, Ouagadougou - Burkina Faso, Libreville - Gabon, Kisumu - Kenya",2012-01,2011-10-04,2012-12-13,INTERVENTIONAL,PHASE2,Sanofi,INDUSTRY,malaria
NCT02669823,PALUBAC,COMPLETED,2016-04-01,Tropical Infectious Diseases,"None, treatment as actual best practice",Nanaro - Burkina Faso,2017-06-30,2016-02-01,2017-07-21,OBSERVATIONAL,Not Available,Sysmex Europe GmbH,INDUSTRY,malaria
NCT02859350,Unknown,COMPLETED,2016-11,Malaria,"PfSPZ Vaccine, PfSPZ Challenge (for CHMI), Normal Saline, PfSPZ Challenge (for PfSPZ-CVac)",Malabo - Equatorial Guinea,2017-12,2016-08-09,2018-10-15,INTERVENTIONAL,PHASE1,Sanaria Inc.,INDUSTRY,malaria
NCT00362050,Unknown,COMPLETED,2006-06,Plasmodium Falciparum Malaria,Treatment with 3 dose groups of RBx11160 over 7 days,"Rourkela - India, Kivunge - Tanzania, Dar es Salaam - Tanzania, Bangkok - Thailand",Unknown Date,2006-08-09,2007-08-29,INTERVENTIONAL,PHASE2,Medicines for Malaria Venture,OTHER,malaria
NCT02294214,SR-M-Tz,WITHDRAWN,2016-02,Malaria,"Spatial Repellent product with active ingredient, Active ingredient, Spatial Repellent product without active ingredient (SHIELD)",Bagamoyo - Tanzania,2016-04,2014-11-19,2016-10-06,INTERVENTIONAL,NA,University of Notre Dame,OTHER,malaria
NCT03431714,GF-TES-2017,COMPLETED,2017-07-14,Uncomplicated Falciparum Malaria,Artesunate amodiaquine,Tanga - Tanzania,2017-12-08,2018-02-13,2018-02-13,INTERVENTIONAL,PHASE4,"National Institute for Medical Research, Tanzania",OTHER_GOV,malaria
NCT01083095,ChallengeII,COMPLETED,2005-01,"Malaria, Vivax",Sporozoite Challenge Model for Plasmodium vivax in Humans,Cali - Colombia,2005-03,2010-03-09,2010-03-09,INTERVENTIONAL,PHASE1,Malaria Vaccine and Drug Development Center,OTHER,malaria
NCT03199755,Unknown,WITHDRAWN,2018-08-20,Malaria,"ACT, DLA1, DLA2","Goma - Congo, The Democratic Republic of the",2018-12-31,2017-06-27,2021-10-14,INTERVENTIONAL,PHASE2,Worcester Polytechnic Institute,OTHER,malaria
NCT00137514,Unknown,COMPLETED,2001-03,"Malaria, Falciparum","chloroquine, amodiaquine",Apartado 861 - Guinea-Bissau,2004-05,2005-08-30,2008-04-08,INTERVENTIONAL,PHASE4,Bandim Health Project,OTHER,malaria
NCT00439595,EARS,COMPLETED,2007-02,Anaemia,"Hemocue 210 meter, Copack HBCS",Tanga - Tanzania,2008-04,2007-02-23,2010-05-27,INTERVENTIONAL,NA,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT02996695,Unknown,COMPLETED,2017-04-06,Plasmodium Falciparum Infection,"Artesunate, Chloroquine, PfSPZ (NF54) Challenge, Placebo",Sikasso - Mali,2018-06-22,2016-12-19,2019-12-02,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT05951595,FD-TACT,NOT_YET_RECRUITING,2024-01-01,Uncomplicated Plasmodium Falciparum Malaria,"Artemether-Lumefantrine-Amodiaquine (ALAQ), Artemether-Lumefantrine (AL), Artesunate-Amodiaquine (ASAQ)",No locations listed,2024-11-30,2023-07-19,2023-07-24,INTERVENTIONAL,PHASE3,University of Oxford,OTHER,malaria
NCT00863408,Unknown,COMPLETED,2009-03-03,Malaria,No interventions listed,Bethesda - United States,Unknown Date,2009-03-18,2017-07-02,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT02453308,TRACII,COMPLETED,2015-08,"Malaria, Falciparum","ACT, TACT","Ramu - Bangladesh, Pailin - Cambodia, Preah Vihear - Cambodia, Pursat - Cambodia, Ratankiri - Cambodia, Kinshasa - Congo, The Democratic Republic of the, Agartala - India, Midnapore - India, Rourkela - India, Sekong - Lao People's Democratic Republic, Ann - Myanmar, Pyay - Myanmar, Pyin oo Lwin - Myanmar, Thabeikkyin - Myanmar, Phusing - Thailand, Tha Song Yang - Thailand, Chumphon - Thailand, Si Sa Ket - Thailand, Yala - Thailand, Binh Phuoc - Vietnam",2018-03,2015-05-25,2018-05-09,INTERVENTIONAL,PHASE3,University of Oxford,OTHER,malaria
NCT03768908,ACOII,COMPLETED,2005-01-05,Plasmodium Falciparum Malaria,"Artemether-lumefantrine, Artesunate + Amodiaquine",No locations listed,2005-07-11,2018-12-07,2018-12-07,INTERVENTIONAL,PHASE4,Professor Anders Björkman,OTHER,malaria
NCT02094508,Unknown,COMPLETED,2014-03-07,Malaria,No interventions listed,Kalisizo - Uganda,2015-12-28,2014-03-21,2018-04-05,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT01019408,ECQNWFP,COMPLETED,1993-11,"Malaria, Falciparum",Chloroquine,"Adezai - Pakistan, Baghicha - Pakistan, Kagan - Pakistan",1995-01,2009-11-25,2009-11-25,INTERVENTIONAL,PHASE4,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT01704508,Unknown,COMPLETED,2012-11,Malaria,"Artemether-lumefantrine, Dihydroartemisinin-piperaquine",Bissau - Guinea-Bissau,2015-10,2012-10-11,2021-05-26,INTERVENTIONAL,PHASE4,Bandim Health Project,OTHER,malaria
NCT02592408,MalTreSu,COMPLETED,2015-11,Malaria,"ASP, SDPQ, 14DPQ, 14DPQ on Day 42","New Halfa - Sudan, Khartoum - Sudan",2016-05,2015-10-30,2017-02-01,INTERVENTIONAL,PHASE4,Menzies School of Health Research,OTHER,malaria
NCT00331708,Unknown,TERMINATED,2006-04,Malaria,Artesunate plus sulfadoxine-pyrimethamine,Ndlavela - Mozambique,2007-07,2006-05-31,2016-10-26,INTERVENTIONAL,NA,Professor Karen I Barnes,OTHER,malaria
NCT03813108,CPS135,TERMINATED,2019-04-01,"Malaria,Falciparum, Controlled Human Malaria Infection, Immunization; Infection","CPS-immunization, malaria challenge infection, P. falciparum NF135.C10, malaria challenge infection, P. falciparum NF54, CPS-immunization (A/L), Atovaquone / Proguanil Oral Tablet [Malarone]",Nijmegen - Netherlands,2021-02-01,2019-01-23,2023-05-26,INTERVENTIONAL,NA,Radboud University Medical Center,OTHER,malaria
NCT00299208,Unknown,COMPLETED,Unknown Date,Plasmodium Falciparum Malaria,"Artesunate, Azithromycin, Quinine",Bangkok - Thailand,2005-07,2006-03-06,2010-08-27,INTERVENTIONAL,PHASE2,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT00121823,Unknown,COMPLETED,2004-06,Malaria,"FP9 ME-TRAP, MVA ME-TRAP",Banjul - Gambia,Unknown Date,2005-07-21,2017-01-12,INTERVENTIONAL,PHASE2,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT02123290,Unknown,COMPLETED,2016-01,"Plasmodium Falciparum Malaria, Plasmodium Vivax Malaria","DSM265 400mg, DSM265 xmg, DSM265 ymg",Iquitos - Peru,2016-01,2014-04-25,2016-06-22,INTERVENTIONAL,PHASE2,Medicines for Malaria Venture,OTHER,malaria
NCT02118090,CRePViCam,COMPLETED,2014-05,Vivax Malaria,"Chloroquine sulfate, DHA-PP",Ban Lung - Cambodia,2014-12,2014-04-21,2015-03-24,INTERVENTIONAL,PHASE4,"Institut Pasteur, Cambodia",OTHER,malaria
NCT00549003,ZRDT,COMPLETED,2005-02,Malaria,Rapid Diagnostic Test for P. falciparum malaria,Zanzibar - Tanzania,Unknown Date,2007-10-25,2007-10-25,INTERVENTIONAL,PHASE4,Karolinska University Hospital,OTHER,malaria
NCT01540903,Unknown,COMPLETED,2012-02,Malaria,"PfSPZ Challenge, Saline",Bagamoyo - Tanzania,2012-09,2012-02-29,2014-09-10,INTERVENTIONAL,PHASE1,Sanaria Inc.,INDUSTRY,malaria
NCT04445103,Unknown,TERMINATED,2020-06-21,"Plasmodium Falciparum, Plasmodium Vivax, Heart Diseases, Cardiovascular Diseases",Assessment of cardiac function,Cruzeiro do Sul - Brazil,2021-01-25,2020-06-24,2022-07-19,OBSERVATIONAL,Not Available,"University Hospital, Gentofte, Copenhagen",OTHER,malaria
NCT00342043,Unknown,COMPLETED,2005-08-02,"Malaria, Severe Malaria",No interventions listed,Bamako - Mali,Unknown Date,2006-06-21,2017-07-02,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT06080243,Unknown,NOT_YET_RECRUITING,2025-03-01,Healthy Women of Child Bearing Potential,"R21/Matrix-M1, Saline and R21/Matrix-M1, Sterile isotonic (0.9%) normal saline",No locations listed,2027-09-01,2023-10-12,2025-02-03,INTERVENTIONAL,PHASE2,University of Oxford,OTHER,malaria
NCT01231503,Unknown,COMPLETED,2011-01-13,Malaria,"GSK Biological's Investigational Malaria Vaccine 257049, Engerix-B, Tritanrix HepB Hib, BCG, OPV, Rouvax","Bangwe, Blantyre - Malawi",2014-04-30,2010-11-01,2018-08-15,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,malaria
NCT00341003,Unknown,COMPLETED,2005-07-22,"Severe Malaria, Malaria, Antimalarial Drug Resistance",No interventions listed,Pursat - Cambodia,Unknown Date,2006-06-21,2017-07-02,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT03278808,Unknown,WITHDRAWN,2018-09-17,Malaria,"Chloroquine-Azithromycin (CQ/AZ), Chloroquine (CQ), atovaquone-proguanil (Malarone®)","Bethesda - United States, Silver Spring - United States",2019-12-30,2017-09-12,2020-02-27,INTERVENTIONAL,PHASE2,U.S. Army Medical Research and Development Command,FED,malaria
NCT00495508,Unknown,COMPLETED,2006-10,Malaria,"Quinine, artemether / lumefantrine",Mbarara - Uganda,2009-06,2007-07-03,2022-06-03,INTERVENTIONAL,PHASE4,Epicentre,OTHER,malaria
NCT01464138,Unknown,COMPLETED,2010-09,Malaria,Fosmidomycin and Clindamycin co-administration,Maputo - Mozambique,2011-09,2011-11-03,2011-11-03,INTERVENTIONAL,PHASE2,Jomaa Pharma GmbH,INDUSTRY,malaria
NCT00361114,Unknown,TERMINATED,2006-07,Malaria,"sulphadoxine/pyrimethamine, Chlorproguanil/dapsone, Sulfadoxine/pyrimethamine",Korogwe - Tanzania,2007-08,2006-08-07,2017-01-26,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT03162614,Unknown,COMPLETED,2017-05-24,Malaria,"RTS,S/AS01E, RTS,S/AS01B, Sporozoite-infected mosquitoes challenge.",Silver Spring - United States,2018-07-09,2017-05-22,2020-10-27,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,malaria
NCT00203814,Unknown,COMPLETED,2004-01,Malaria,"Sulfadoxine-pyrimethamine, Artesunate plus sulfadoxine-pyrimethamine","Boane - Mozambique, Magude - Mozambique",Unknown Date,2005-09-20,2006-11-16,INTERVENTIONAL,NA,University of Cape Town,OTHER,malaria
NCT00164255,Unknown,COMPLETED,2003-01,Malaria,"sulfadoxine/pyrimethamine, sulfadoxine/pyrimethamine plus artesunate","Ifakara - Tanzania, Ifakara - Tanzania",2009-06,2005-09-14,2012-09-11,INTERVENTIONAL,PHASE4,Centers for Disease Control and Prevention,FED,malaria
NCT00347555,Unknown,COMPLETED,2006-05,Plasmodium Falciparum Malaria,"Aluminum Phosphate, Placebo, EBA-175 RII-NG Malaria Vaccine",Houston - United States,2008-04,2006-07-04,2013-04-12,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT01555255,Unknown,UNKNOWN,2010-11,"Malaria, Placental Malaria, Malaria in Pregnancy",No interventions listed,"Bobo-Dioulasso - Burkina Faso, Tororo - Uganda",2012-03,2012-03-15,2015-04-23,OBSERVATIONAL,Not Available,"Foundation for Innovative New Diagnostics, Switzerland",OTHER,malaria
NCT04618523,TET2020,COMPLETED,2020-10-26,Malaria,"Artesunate-amodiaquine, Artemether-lumefantrine","Kapolowe - Congo, The Democratic Republic of the, Kazumba - Congo, The Democratic Republic of the, Kimpese - Congo, The Democratic Republic of the, Rutshuru - Congo, The Democratic Republic of the, Kisangani - Congo, The Democratic Republic of the, Boende - Congo, The Democratic Republic of the",2022-02-08,2020-11-06,2022-02-09,INTERVENTIONAL,PHASE4,"Ministry of Public Health, Democratic Republic of the Congo",OTHER_GOV,malaria
NCT02216123,Unknown,COMPLETED,2015-04-30,"Malaria, Vivax","Tafenoquine, Tafenoquine Placebo, Chloroquine, Primaquine, Primaquine Placebo","Manaus - Brazil, Cali - Colombia, Monteria - Colombia, Gondar - Ethiopia, Jimma - Ethiopia, Iquitos - Peru, Bangkok - Thailand, Mae Sot - Thailand, Tak - Thailand, Ho Chi Minh - Vietnam",2016-11-04,2014-08-13,2018-05-16,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,malaria
NCT01567423,Unknown,COMPLETED,2008-04,"Malaria, Falciparum","ASAQ Winthrop® Sanofi Aventis, Coartem®, Novartis","Pweto - Congo, The Democratic Republic of the",2009-04,2012-03-30,2012-03-30,INTERVENTIONAL,NA,Epicentre,OTHER,malaria
NCT00540410,Unknown,COMPLETED,2007-09,Malaria,"Coarsucam® (artésunate (AS) + amodiaquine (AQ) as fixed dose combination), Coartem® (arthemether+ lumefantrine)",Dakar - Senegal,2009-02,2007-10-08,2010-06-23,INTERVENTIONAL,PHASE4,Sanofi,INDUSTRY,malaria
NCT02509481,RIMDAMAL,COMPLETED,2015-06,"Malaria, Lymphatic Filariasis","Ivermectin, Albendazole","Fort Collins - United States, Bobo Dioulasso - Burkina Faso",2015-11,2015-07-28,2019-01-04,INTERVENTIONAL,PHASE3,Colorado State University,OTHER,malaria
NCT06278181,Unknown,RECRUITING,2023-09-21,"Malaria, Diabetes Mellitus, Metabolic Syndrome, Endemic",No interventions listed,Limbe - Cameroon,2024-12-30,2024-02-26,2024-03-01,OBSERVATIONAL,Not Available,Karolinska Institutet,OTHER,malaria
NCT00190281,Unknown,UNKNOWN,2005-08,"Malaria, Pyelonephritis, Bacterial Infections",No interventions listed,Paris - France,Unknown Date,2005-09-19,2005-12-13,OBSERVATIONAL,Not Available,Assistance Publique - Hôpitaux de Paris,OTHER,malaria
NCT02453581,Unknown,COMPLETED,2012-09,Malaria,OZ439,Herston - Australia,2013-03,2015-05-25,2015-08-17,INTERVENTIONAL,PHASE1,Medicines for Malaria Venture,OTHER,malaria
NCT00295581,Unknown,COMPLETED,2005-03-07,"Plasmodium Falciparum, Plasmodium Vivax Malaria",PpPfs25/ISA51 & ScPvs25/ISA51,"Baltimore - United States, Bethesda - United States",Unknown Date,2006-02-23,2017-07-02,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT05400655,Unknown,COMPLETED,2022-09-14,"Plasmodium Falciparum Infection, Malaria","L9LS, Normal Saline",Kisumu - Kenya,2024-06-02,2022-06-01,2024-09-19,INTERVENTIONAL,PHASE2,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT03810014,TESTsmART,COMPLETED,2019-03-28,"Malaria, Febrile Illness","Conditional ACT subsidy, Arm 1 levels, Conditional ACT subsidy, Arm 2 levels, Conditional ACT subsidy, Arm 3 levels, Conditional ACT subsidy, Arm 4 levels",Eldoret - Kenya,2019-10-31,2019-01-18,2020-11-12,INTERVENTIONAL,NA,Duke University,OTHER,malaria
NCT01392014,DHP+PQ,COMPLETED,2008-12,Malaria,"dihydroartemisinin-piperaquine, dihydroartemisinin-piperaquine + primaquine",Lampung - Indonesia,2010-03,2011-07-12,2011-07-12,INTERVENTIONAL,PHASE4,Indonesia University,OTHER,malaria
NCT00322816,Unknown,COMPLETED,2006-06-07,Plasmodium Falciparum Malaria,No interventions listed,Fajara - Gambia,2008-03-31,2006-05-08,2019-02-01,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT00889616,Unknown,COMPLETED,2009-04-23,Malaria,BSAM2/Alhydrogel + CPG 7909,"Baltimore - United States, Bamako - Mali",Unknown Date,2009-04-29,2019-12-17,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT00331136,Unknown,COMPLETED,2006-06,Uncomplicated Plasmodium Falciparum Malaria,Pyronaridine-Artesunate,Lambaréné - Gabon,2006-12,2006-05-29,2022-05-05,INTERVENTIONAL,PHASE2,Medicines for Malaria Venture,OTHER,malaria
NCT05286359,Unknown,COMPLETED,2022-05-24,Malaria,NxTekTM Malaria Pf Plus Rapid Diagnostic Test Device,Addis Ababa - Ethiopia,2022-11-17,2022-03-18,2023-04-24,INTERVENTIONAL,NA,Abbott Rapid Dx,INDUSTRY,malaria
NCT03610399,Unknown,COMPLETED,2018-04-09,"P Vivax, Malaria, Vivax",Primaquine,Cruzeiro do Sul - Brazil,2019-03-12,2018-08-01,2021-08-09,INTERVENTIONAL,NA,Centers for Disease Control and Prevention,FED,malaria
NCT01707199,Unknown,COMPLETED,2012-10,Uncomplicated P. Falciparum Malaria,Artesunate + Sulphadoxine-pyrimethamine,Kunar - Afghanistan,2014-01,2012-10-16,2020-10-14,INTERVENTIONAL,NA,University of Oxford,OTHER,malaria
NCT04844099,CHEMCHA,COMPLETED,2021-04-09,"Sickle Cell Anemia in Children, Malaria",Dihydroartemisinin Piperaquine,"Blantyre - Malawi, Jinja - Uganda, Kitgum - Uganda",2023-06-30,2021-04-14,2023-09-13,INTERVENTIONAL,PHASE3,Liverpool School of Tropical Medicine,OTHER,malaria
NCT00977899,Unknown,WITHDRAWN,2009-08-20,"Malaria, Malaria Vaccines, Plasmodium Falciparum Malaria",Malaria Transmission-Blocking Pfs25-Pfs25 Conjugate Vaccine,No locations listed,2013-03-05,2009-09-16,2018-07-05,INTERVENTIONAL,PHASE1,Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),NIH,malaria
NCT01746199,MACOMBA,COMPLETED,2013-12,"Malaria in Pregnancy, HIV Infection","cotrimoxazole daily prophylaxis, sulphadoxine-pyrimethamine","Bangui - Central African Republic, Bangui - Central African Republic, Bangui - Central African Republic, Bangui - Central African Republic",2015-10,2012-12-10,2020-11-30,INTERVENTIONAL,PHASE3,Institut Pasteur,INDUSTRY,malaria
NCT02992119,RTSS,COMPLETED,2017-06-04,Malaria Vaccine,"RTS,S/AS01B Fractional dose, Double RTS,S/AS01E Fractional dose, RTS,S/AS01E Standard dose, RTS,S/AS01E + DHA-PIP+PQ Standard dose, RTS,S/AS01E Fractional dose, RTS,S/AS01E + DHA-PIP+PQ Fractional dose, RTS,S/AS01E + DHA-PIP+PQ Fractional two-dose",Bangkok - Thailand,2018-02-20,2016-12-14,2022-03-31,INTERVENTIONAL,PHASE2,University of Oxford,OTHER,malaria
NCT02143934,Unknown,COMPLETED,2009-08,"Plasmodium Vivax Infection, Plasmodium Vivax Clinical Episode, Plasmodium Falciparum Infection, Plasmodium Falciparum Clinical Episode","Primaquine, Placebo, Chloroquine, Artemether Lumefantrine",Maprik - Papua New Guinea,2010-05,2014-05-21,2014-05-21,INTERVENTIONAL,PHASE4,Papua New Guinea Institute of Medical Research,OTHER_GOV,malaria
NCT05426434,SAPOT,ACTIVE_NOT_RECRUITING,2022-08-31,"Malaria, Malaria in Pregnancy, Pregnancy Related","Dihydroartemisinin-Piperaquine (DP), Sulfadoxine pyrimethamine (SP)",Madang - Papua New Guinea,2025-02,2022-06-22,2024-08-29,INTERVENTIONAL,PHASE3,Menzies School of Health Research,OTHER,malaria
NCT00540202,QALE,UNKNOWN,2007-09,Uncomplicated Malaria,"artemether-lumefantrine, Oral quinine",Kampala - Uganda,Unknown Date,2007-10-05,2007-10-05,INTERVENTIONAL,PHASE4,Makerere University,OTHER,malaria
NCT03172221,HSRDT MiP,COMPLETED,2017-07-25,"Plasmodium Falciparum, Pregnancy Malaria, Diagnoses Disease",HS-RDT,"Quibdó - Colombia, Tumaco - Colombia",2018-01-31,2017-06-01,2023-11-30,OBSERVATIONAL,Not Available,"Foundation for Innovative New Diagnostics, Switzerland",OTHER,malaria
NCT05096702,Trust,ACTIVE_NOT_RECRUITING,2021-09-09,"Malaria, Vivax, G6PD Deficiency","Tafenoquine, Primaquine, Primaquine","Manaus - Brazil, Manaus - Brazil, Manaus - Brazil, Manaus - Brazil, Manaus - Brazil, Manaus - Brazil, Manaus - Brazil, Manaus - Brazil, Manaus - Brazil, Manaus - Brazil, Manaus - Brazil, Manaus - Brazil, Manaus - Brazil, Manaus - Brazil, Porto Velho - Brazil, Porto Velho - Brazil, Porto Velho - Brazil, Porto Velho - Brazil, Porto Velho - Brazil, Porto Velho - Brazil, Porto Velho - Brazil, Porto Velho - Brazil, Porto Velho - Brazil, Porto Velho - Brazil, Porto Velho - Brazil, Porto Velho - Brazil, Porto Velho - Brazil, Porto Velho - Brazil, Porto Velho - Brazil, Porto Velho - Brazil, Porto Velho - Brazil, Porto Velho - Brazil, Porto Velho - Brazil, Porto Velho - Brazil, Porto Velho - Brazil, Porto Velho - Brazil, Manaus - Brazil, Manaus - Brazil, Manaus - Brazil, Manaus - Brazil, Rondônia - Brazil",2022-08-30,2021-10-27,2023-06-13,OBSERVATIONAL,Not Available,Fundação de Medicina Tropical Dr. Heitor Vieira Dourado,OTHER,malaria
NCT05650502,ISAMIMA,COMPLETED,2021-06-01,"Plasmodium Malariae Infection, SMC, Immune System Disease",saisonal malaria chimoprevention,Parakou - Benin,2021-08-30,2022-12-14,2022-12-28,OBSERVATIONAL,Not Available,Université de Parakou,OTHER,malaria
NCT01052584,Unknown,COMPLETED,2009-10,Malaria,"Chloroquine- P. vivax, Artemether-Lumefantrine: P. vivax, Artemether-lumefantrine: P. falciparum","Debrezeit - Ethiopia, Zeway - Ethiopia",2010-01,2010-01-20,2010-11-18,INTERVENTIONAL,NA,Centers for Disease Control and Prevention,FED,malaria
NCT01190202,Unknown,COMPLETED,2011-03-14,"Malaria, Malaria Vaccines","Blood sampling, Assessment of body temperature","Ouagadougou 01 - Burkina Faso, Lambaréné - Gabon, Kintampo - Ghana, Kumasi - Ghana, Kisumu - Kenya, Lilongwe - Malawi, Dar-es-Salaam - Tanzania, Korogwe, Tanga - Tanzania",2013-12-20,2010-08-27,2020-08-18,INTERVENTIONAL,NA,GlaxoSmithKline,INDUSTRY,malaria
NCT02084602,Artesunate,COMPLETED,2014-06-18,"Malaria, Falciparum","Artesunate, Mefloquine",Iquitos - Peru,2015-11-06,2014-03-12,2021-04-29,INTERVENTIONAL,PHASE4,Instituto Nacional de Salud. Peru,OTHER_GOV,malaria
NCT00719602,Unknown,COMPLETED,2009-08,"HIV Infections, Malaria","Lamivudine, Lopinavir/Ritonavir, Nevirapine, Zidovudine","Lilongwe - Malawi, Kampala - Uganda, Lusaka - Zambia",2013-08,2008-07-21,2016-09-19,INTERVENTIONAL,PHASE1,International Maternal Pediatric Adolescent AIDS Clinical Trials Group,NETWORK,malaria
NCT04318002,Unknown,COMPLETED,2021-01-21,"Malaria,Falciparum",RH5.1/Matrix-M,Bagamoyo - Tanzania,2023-08-27,2020-03-23,2024-11-22,INTERVENTIONAL,PHASE1,University of Oxford,OTHER,malaria
NCT03203421,Unknown,COMPLETED,2017-07-03,Malaria,"ChAdOx1 LS2, MVA LS2",Oxford - United Kingdom,2017-12-20,2017-06-29,2018-06-13,INTERVENTIONAL,PHASE2,University of Oxford,OTHER,malaria
NCT01887821,Unknown,COMPLETED,2013-02,Plasmodium Vivax Malaria,"Chloroquine, Dihydroartemisinin/Piperaquine",Bu Gia Map - Vietnam,2015-06,2013-06-27,2016-09-30,INTERVENTIONAL,PHASE4,"Oxford University Clinical Research Unit, Vietnam",OTHER,malaria
NCT03594084,ACMUS,UNKNOWN,2018-08-01,Malaria,No interventions listed,Strasbourg - France,2019-08,2018-07-20,2018-09-17,OBSERVATIONAL,Not Available,"University Hospital, Strasbourg, France",OTHER,malaria
NCT04072302,Unknown,COMPLETED,2014-09-15,Malaria,"KAF156, Placebo",Seattle - United States,2017-11-29,2019-08-28,2019-08-28,INTERVENTIONAL,PHASE1,Novartis Pharmaceuticals,INDUSTRY,malaria
NCT01713621,Unknown,COMPLETED,2013-03,Malaria,OZ439,"Mae Ramat - Thailand, Mae Sot - Thailand, Bangkok - Thailand",2015-04,2012-10-25,2017-04-14,INTERVENTIONAL,PHASE2,Medicines for Malaria Venture,OTHER,malaria
NCT04966702,BOHEMIA,ACTIVE_NOT_RECRUITING,2022-03-17,Malaria,"Albendazole Pill, Ivermectin Pill, Ivermectin Injectable Product","Kwale - Kenya, Mopeia - Mozambique",2024-04-16,2021-07-19,2024-10-21,INTERVENTIONAL,PHASE3,Barcelona Institute for Global Health,OTHER,malaria
NCT00811421,MiPPAD,COMPLETED,2009-09,"Pregnancy, Malaria, HIV Infections","Sulphadoxine-pyrimethamine, Mefloquine (full dose), Mefloquine (split dose), placebo, mefloquine","Allada - Benin, Lambaréné - Gabon, Kisumu - Kenya, Manhiça - Mozambique, Dodoma - Tanzania",2012-12,2008-12-19,2014-03-20,INTERVENTIONAL,NA,Hospital Clinic of Barcelona,OTHER,malaria
NCT04079621,Unknown,COMPLETED,2021-10-27,"Malaria, Malaria, Vivax, Malaria,Falciparum",primaquine,"Malakheti - Nepal, Tikapur - Nepal",2024-03-31,2019-09-06,2024-08-29,INTERVENTIONAL,PHASE4,Menzies School of Health Research,OTHER,malaria
NCT01941264,COSMIC,COMPLETED,2013-10,"Malaria, Antepartum, Maternal Malaria During Pregnancy - Baby Not Yet Delivered, Small for Gestational Age (Disorder)",community based screening and treatment,"Cotonou - Benin, Nanoro - Burkina Faso, Fajara - Gambia",2016-05,2013-09-13,2016-10-04,INTERVENTIONAL,NA,Royal Tropical Institute,OTHER,malaria
NCT01954264,Unknown,COMPLETED,2013-10-19,Malaria,"Capillary blood sample, Data collection","Nouna - Burkina Faso, Ouagadougou - Burkina Faso, Dakar - Senegal",2013-11-22,2013-10-01,2020-01-21,INTERVENTIONAL,NA,GlaxoSmithKline,INDUSTRY,malaria
NCT05323721,Unknown,ACTIVE_NOT_RECRUITING,2022-06-01,Malaria,"Sulfadoxine pyrimethamine and amodiaquine, dihydroartemisinin-piperaquine",Amudat - Uganda,2022-11-01,2022-04-12,2023-11-01,INTERVENTIONAL,PHASE4,Malaria Consortium,OTHER,malaria
NCT00307021,Unknown,COMPLETED,2006-04-07,Malaria,GSK Biologicals' candidate Plasmodium falciparum malaria vaccine 257049,Lambaréné - Gabon,2006-09-15,2006-03-27,2017-04-25,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,malaria
NCT05052502,COMBAT,UNKNOWN,2020-11-01,"Plasmodium Falciparum Malaria, Plasmodium Vivax Malaria","Case Management and Follow-up, Reactive focal mass drug administration (rfMDA)",Bangkok - Thailand,2022-03-31,2021-09-22,2022-04-04,INTERVENTIONAL,NA,"University of California, San Francisco",OTHER,malaria
NCT03989102,Unknown,COMPLETED,2019-07-03,Malaria,"PfSPZ Vaccine, Normal Saline",Ouelessebougou - Mali,2022-04-05,2019-06-18,2024-03-19,INTERVENTIONAL,PHASE2,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT02488902,Unknown,COMPLETED,1998-08,Malaria,"Placebo, Tafenoquine 25mg, Tafenoquine 50mg, Tafenoquine 100 mg, Tafenoquine 200 mg, Mefloquine 250 mg",No locations listed,1998-09,2015-07-02,2018-09-13,INTERVENTIONAL,PHASE2,U.S. Army Medical Research and Development Command,FED,malaria
NCT00379821,Unknown,COMPLETED,2007-02,Plasmodium Falciparum Infection,"Atovaquone-proguanil, Artesunate, Azithromycin, Chloroquine",Blantyre - Malawi,2009-08,2006-09-25,2014-08-11,INTERVENTIONAL,PHASE3,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT01843764,Unknown,COMPLETED,2009-06,Plasmodium Falciparum Malaria,HRP2 and LDH based rapid diagnostic tests for P.falciparum,"Dar es Salaam - Tanzania, Dar es Salaam - Tanzania",2011-04,2013-05-01,2013-05-03,OBSERVATIONAL,Not Available,Anders Björkman,OTHER,malaria
NCT00442403,Unknown,SUSPENDED,2002-04,Malaria,"chloroquine, dehydroepiandrosterone sulphate",Yaounde - Cameroon,Unknown Date,2007-03-01,2007-03-01,INTERVENTIONAL,PHASE3,Université Victor Segalen Bordeaux 2,OTHER,malaria
NCT02788864,PREMAL,COMPLETED,2016-05-20,Malaria,"Arterakine (DHA/piperaquine), Placebo",Binh Phuoc - Vietnam,2016-11-30,2016-06-02,2017-03-07,INTERVENTIONAL,PHASE4,"Oxford University Clinical Research Unit, Vietnam",OTHER,malaria
NCT03947190,Unknown,TERMINATED,2022-08-31,"Malaria,Falciparum","R21/Matrix-M, ChAd63/MVA ME-TRAP, intradermal injection (ID) or direct venous injection (DVI) of PfSPZ Challenge",Kilifi - Kenya,2023-02-26,2019-05-13,2025-02-20,INTERVENTIONAL,PHASE2,University of Oxford,OTHER,malaria
NCT05604521,Unknown,TERMINATED,2022-12-06,"Malaria, Malaria,Falciparum","PfSPZ Vaccine, PfSPZ Challenge (7G8), Normal Saline",Baltimore - United States,2023-09-05,2022-11-03,2024-11-25,INTERVENTIONAL,PHASE1,Sanaria Inc.,INDUSTRY,malaria
NCT01144702,Unknown,COMPLETED,2010-11,Falciparum Malaria,artesunate & mefloquine combination,"Rio de Janeiro - Brazil, São Paulo - Brazil",2013-04,2010-06-15,2015-05-19,INTERVENTIONAL,PHASE3,Oswaldo Cruz Foundation,OTHER,malaria
NCT00917202,Unknown,COMPLETED,Unknown Date,Malaria,Methylenblue,Nouna - Burkina Faso,Unknown Date,2009-06-10,2009-06-10,INTERVENTIONAL,PHASE2,Heidelberg University,OTHER,malaria
NCT03163121,Unknown,COMPLETED,2017-05-12,Malaria,"PfSPZ-GA1 Vaccine, PfSPZ Vaccine, Normal Saline, Mosquito-bite CHMI","Leiden - Netherlands, Nijmegen - Netherlands",2018-10-25,2017-05-22,2019-03-05,INTERVENTIONAL,PHASE1,Sanaria Inc.,INDUSTRY,malaria
NCT06804902,Unknown,NOT_YET_RECRUITING,2025-04,Malaria,Monthly RDT Validation Meeting,Cities In Selected Districts - Côte D'Ivoire,2025-09,2025-02-03,2025-02-03,INTERVENTIONAL,NA,PATH,OTHER,malaria
NCT00840502,UPS,COMPLETED,2009-02-10,"Pregnant Women, Malaria",No interventions listed,Mae Sot - Thailand,2018-02,2009-02-10,2020-09-02,OBSERVATIONAL,Not Available,University of Oxford,OTHER,malaria
NCT01872702,TME,COMPLETED,2013-04,Plasmodium Falciparum Malaria,malaria elimination using DP and low-dose primaquine,"Pailin - Cambodia, Savannakhet - Lao People's Democratic Republic, Rangoon - Myanmar, Mae Sot - Thailand, Ho Chi Minh city - Vietnam",2017-07,2013-06-07,2020-08-28,INTERVENTIONAL,NA,University of Oxford,OTHER,malaria
NCT06424002,Unknown,NOT_YET_RECRUITING,2024-06-01,"Malaria,Falciparum","Mosquirixs, artemether-lumefantrine",No locations listed,2024-12-20,2024-05-21,2024-05-21,INTERVENTIONAL,PHASE4,Kamuzu University of Health Sciences,OTHER,malaria
NCT02110784,Unknown,TERMINATED,2014-06-18,"Malaria, Vivax",Eurartesim tablets,"Bordeaux Cedex - France, Berlin - Germany, Munich - Germany, Tel Hashomer - Israel, Brescia - Italy, Milano - Italy, Reggio Emilia - Italy, Roma - Italy, Leiden - Netherlands, Barcelona - Spain, Barcelona - Spain, Basel - Switzerland, Bern - Switzerland",2016-11-23,2014-04-10,2018-09-17,INTERVENTIONAL,PHASE2,Alfasigma S.p.A.,INDUSTRY,malaria
NCT01838902,PRINOGAM,COMPLETED,2013-08,Malaria,"DHA-PPQ, PQ (0.75), PQ (0.4), PQ (0.2)",Fajara - Gambia,2015-02,2013-04-24,2018-03-22,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT00422084,Unknown,COMPLETED,2007-01,Malaria,"Pyronaridine artesunate, Coartem® (artemether lumefantrine)","Kinshasa - Congo, The Democratic Republic of the, Fajara - Gambia, Kumasi - Ghana, Maumere - Indonesia, Jayapura - Indonesia, Siaya - Kenya, Bamako - Mali, Maputo - Mozambique, Puerto Princesa - Philippines, Dakar - Senegal",2008-04,2007-01-15,2021-11-02,INTERVENTIONAL,PHASE3,Medicines for Malaria Venture,OTHER,malaria
NCT02836002,CHMI-trans1,COMPLETED,2016-06,Malaria,"Sulfadoxine-pyrimethamine (low dose), Piperaquine (low dose), Sulfadoxine-pyrimethamine (high dose), Piperaquine (high dose), malaria challenge infection, P. falciparum 3D7, Atovaquone-proguanil",Nijmegen - Netherlands,2017-06-29,2016-07-18,2018-03-23,INTERVENTIONAL,PHASE2,Radboud University Medical Center,OTHER,malaria
NCT04766879,AEGIS Kenya,COMPLETED,2021-03-02,Malaria,"Transfluthrin, Placebo","Busia - Kenya, Busia - Kenya",2023-10-23,2021-02-23,2024-04-15,INTERVENTIONAL,NA,University of Notre Dame,OTHER,malaria
NCT02773979,Unknown,COMPLETED,2016-09-12,Plasmodium Falciparum Infection,"Chloroquine, PfSPZ (NF54) Challenge, Placebo",Seattle - United States,2018-01-22,2016-05-16,2019-12-27,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT00372684,PALUREA,COMPLETED,2006-09,Malaria,"with severe malaria hospitalized in ICU, with uncomplicated malaria",Le Chesnay - France,2010-03,2006-09-07,2010-06-22,OBSERVATIONAL,Not Available,Assistance Publique - Hôpitaux de Paris,OTHER,malaria
NCT04296279,Unknown,UNKNOWN,2020-03-20,Vaccine Reaction,"FMP014, ALFQ",Silver Spring - United States,2021-12,2020-03-05,2021-04-19,INTERVENTIONAL,PHASE1,U.S. Army Medical Research and Development Command,FED,malaria
NCT00970879,PACOME,COMPLETED,2009-12,"Malaria in Pregnancy, HIV Infections","cotrimoxazole, mefloquine","Cotonou - Benin, Cotonou - Benin, Cotonou - Benin, Cotonou - Benin, Porto-Novo - Benin",2012-07,2009-09-03,2013-01-23,INTERVENTIONAL,PHASE3,Institut de Recherche pour le Developpement,OTHER_GOV,malaria
NCT03208179,IMPROVE,COMPLETED,2018-03-29,"Pregnancy, Malaria in Pregnancy, Malaria","dihydroartemisinin-piperaquine, sulphadoxine-pyrimethamine, dihydroartemisinin-piperaquine plus azithromycin","Ahero - Kenya, Homa Bay - Kenya, Kisumu - Kenya, Chikwawa - Malawi, Mangochi - Malawi, Handeni - Tanzania, Korogwe - Tanzania",2020-03-15,2017-07-05,2022-06-27,INTERVENTIONAL,PHASE3,Liverpool School of Tropical Medicine,OTHER,malaria
NCT01373879,Unknown,COMPLETED,2010-06,Malaria,"AdCh63 ME-TRAP, MVA ME-TRAP, AdCh63 ME-TRAP, MVA ME-TRAP, AdCh63 ME-TRAP, MVA ME-TRAP, AdCh63 ME-TRAP, MVA ME-TRAP, HDCRV, AdCh63 ME-TRAP, MVA ME-TRAP, AdCh63 ME-TRAP, MVA ME-TRAP, HDCRV",Banjul - Gambia,2011-12,2011-06-15,2013-03-14,INTERVENTIONAL,PHASE1,University of Oxford,OTHER,malaria
NCT02098590,BMGF2b,COMPLETED,2014-10,Malaria,"CPS-immunization, malaria challenge infection, P. falciparum NF135.C10, malaria challenge infection, P. falciparum NF166.C8, malaria challenge infection, P. falciparum NF54, atovaquone/proguanil",Nijmegen - Netherlands,2015-11,2014-03-28,2016-02-23,INTERVENTIONAL,NA,Radboud University Medical Center,OTHER,malaria
NCT00317590,Unknown,COMPLETED,2006-04,Malaria,Rapid Diagnostic Test for Malaria (Paracheck®),Bobo Dioulasso - Burkina Faso,Unknown Date,2006-04-25,2007-10-31,INTERVENTIONAL,PHASE4,Centro per le Malattie Tropicali,OTHER,malaria
NCT05444790,Unknown,COMPLETED,2022-06-30,"Malaria, RDT, Diagnoses Disease",Rapid Diagnostic Test,"Jakarta - Indonesia, Lima - Peru, Khartoum - Sudan",2023-04-30,2022-07-06,2023-10-13,OBSERVATIONAL,Not Available,"Foundation for Innovative New Diagnostics, Switzerland",OTHER,malaria
NCT00669084,Unknown,COMPLETED,2008-04-21,Malaria,No interventions listed,Bamako - Mali,Unknown Date,2008-04-29,2019-12-17,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT02900079,JOKA-I,WITHDRAWN,2023-07-01,"Fever, Malaria",rapid diagnostic test for malaria antigen,Antwerp - Belgium,2024-03,2016-09-14,2023-09-28,OBSERVATIONAL,Not Available,"Institute of Tropical Medicine, Belgium",OTHER,malaria
NCT04165590,Unknown,RECRUITING,2019-10-24,Advanced Malignant Solid Tumor,Plasmodium immunotherapy,Kunming - China,2024-04-30,2019-11-18,2024-02-20,INTERVENTIONAL,PHASE2,"CAS Lamvac Biotech Co., Ltd.",INDUSTRY,malaria
NCT04148690,GANC-TZ,TERMINATED,2019-11-15,"Malaria, Malaria in Pregnancy","Group antenatal care (GANC), Standard antenatal care",Chato - Tanzania,2021-07-10,2019-11-01,2021-07-29,INTERVENTIONAL,NA,Centers for Disease Control and Prevention,FED,malaria
NCT02898779,Unknown,COMPLETED,2017-05-01,Malaria,"Primaquine, R-Primaquine, S-Primaquine, SR Primaquine",Oxford - United States,2018-03-01,2016-09-13,2018-05-15,INTERVENTIONAL,PHASE1,"University of Mississippi, Oxford",OTHER,malaria
NCT04661579,Unknown,COMPLETED,2020-11-06,Plasmodium Falciparum,"Malaria Vaccine RTS,S/AS01E, Abhayrab rabies vaccine, Dihydroartemisinin-piperaquine (DHA/Pip), Artemether / Lumefantrine, Primaquine",Kisumu - Kenya,2022-06-22,2020-12-10,2024-07-19,INTERVENTIONAL,PHASE2,PATH,OTHER,malaria
NCT03352843,ESSLDPQP4502D6,COMPLETED,2019-06-11,Malaria,Primaquine,Arusha - Tanzania,2020-02-28,2017-11-24,2023-02-24,INTERVENTIONAL,PHASE4,"Tropical Pesticides Research Institute, Tanzania",OTHER_GOV,malaria
NCT01328990,Unknown,COMPLETED,2011-04,Malaria,sulfadoxine-pyrimethamine plus amodiaquine,Dakar - Senegal,2011-07,2011-04-05,2011-09-19,INTERVENTIONAL,PHASE2,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT00167843,Unknown,COMPLETED,2002-12,Malaria,sulfadoxine-pyrimethamine,Lambaréné - Gabon,Unknown Date,2005-09-14,2013-01-24,INTERVENTIONAL,PHASE4,Albert Schweitzer Hospital,OTHER,malaria
NCT01154803,Unknown,COMPLETED,2012-02,"Malnutrition, Malaria, Lower Respiratory Tract Infection, Diarrhoea","Ready to Use Therapeutic Food (RUTF), Micronutrient Powder (MNP)",Goronyo - Nigeria,2013-02,2010-07-01,2013-10-16,INTERVENTIONAL,NA,"Medecins Sans Frontieres, Netherlands",OTHER,malaria
NCT04009343,Unknown,ACTIVE_NOT_RECRUITING,2019-06-19,Uncomplicated Falciparum Malaria,"Artemether-lumefantrine, Dihydroartemisinin-piperaquine",Ndola - Zambia,2020-08-24,2019-07-05,2024-07-18,INTERVENTIONAL,PHASE3,Johns Hopkins Bloomberg School of Public Health,OTHER,malaria
NCT01178021,VRA,COMPLETED,2009-08,Vivax Malaria,"Chloroquine, Chloroquine/Primaquine","Maimana - Afghanistan, Jalalabad - Afghanistan, Kunduz - Afghanistan",2014-02,2010-08-09,2019-01-15,INTERVENTIONAL,PHASE4,University of Oxford,OTHER,malaria
NCT00327964,Unknown,COMPLETED,2005-10,"Febrile Illness, Malaria",No interventions listed,Kampala - Uganda,2006-05,2006-05-19,2020-02-28,OBSERVATIONAL,Not Available,"University of California, San Francisco",OTHER,malaria
NCT03496454,CHMI-Gambia1,COMPLETED,2018-03-29,Malaria,PfSPZ Challenge,Fajara - Gambia,2018-05-03,2018-04-12,2019-01-16,INTERVENTIONAL,NA,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT02787070,TRIPI,COMPLETED,2016-09-14,Uncomplicated Malaria,"PQ supervised, PQ unsupervised",Timika - Indonesia,2018-11,2016-06-01,2019-04-16,INTERVENTIONAL,PHASE4,Menzies School of Health Research,OTHER,malaria
NCT04478370,SG6,RECRUITING,2021-01-21,"Malaria, Dengue",Mosquito bites,Mae Sot - Thailand,2024-12-31,2020-07-20,2024-04-03,INTERVENTIONAL,NA,University of Oxford,OTHER,malaria
NCT02987270,MSaT,COMPLETED,2013-04,"Malaria,Falciparum",Dihydroartemisinin-piperaquine,No locations listed,2015-08,2016-12-08,2016-12-09,INTERVENTIONAL,PHASE3,Simon Kariuki,OTHER,malaria
NCT03695770,MALAKIT,COMPLETED,2018-04-16,"Malaria, Public Health",kit for self-diagnosis and self-treatment,"Rio De Janeiro - Brazil, Paramaribo - Suriname",2020-03-30,2018-10-04,2021-05-20,INTERVENTIONAL,NA,Centre Hospitalier de Cayenne,OTHER,malaria
NCT00442442,Unknown,UNKNOWN,2007-04,Malaria,"mosquito coils, LLIN",Simao - China,Unknown Date,2007-03-02,2007-10-31,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT05946642,BF-IPTsc,RECRUITING,2023-07-15,Malaria,"Sulphadoxine-Pyrimethamine/Amodiaquine, Dihydroartemisinin/Piperaquine (DP) plus Ivermectin (IVM)",Ouagadougou - Burkina Faso,2024-05-31,2023-07-14,2023-11-22,INTERVENTIONAL,PHASE3,Malaria Consortium,OTHER,malaria
NCT00440999,Unknown,COMPLETED,2007-03,Malaria,"Pyronaridine artesunate, Chloroquine","Pailin - Cambodia, Mangalore - India, Maumere - Indonesia, Mae Ramat - Thailand, Mae Sot - Thailand",2008-04,2007-02-27,2021-11-02,INTERVENTIONAL,PHASE3,Medicines for Malaria Venture,OTHER,malaria
NCT02867059,SJ733IBSMCS,COMPLETED,2016-09-13,Plasmodium Falciparum Malaria,(+)-SJ000557733,"Brisbane - Australia, Herston - Australia",2016-12-22,2016-08-15,2020-05-05,INTERVENTIONAL,PHASE1,Medicines for Malaria Venture,OTHER,malaria
NCT01755559,Unknown,COMPLETED,2013-06,Malaria,"Artesunate-amodiaquine, Dihydroartemisinin-piperaquine, Artemether-lumefantrine",Maradi - Niger,2014-11,2012-12-24,2015-11-30,INTERVENTIONAL,PHASE4,Epicentre,OTHER,malaria
NCT02938975,URCT,UNKNOWN,2017-11,Malaria,"Ultra 30 Insect Repellent Lotion (30% Lipo DEET), Permethrin Factory-Treated Army Combat Uniforms, Placebo lotion, Army combat uniform",Bagamoyo - Tanzania,2019-01,2016-10-19,2017-06-06,INTERVENTIONAL,PHASE3,Ifakara Health Institute,OTHER,malaria
NCT01148459,Unknown,COMPLETED,2010-07-30,Malaria,"GSK Biological's Investigational Malaria Vaccine 257049, Human Diploid Cell Vaccine (HDCV) or Purified Vero Cell Rabies Vaccine (PVRV, Verorab) (Aventis Pasteur);, Purified Chick Embryo Cell Culture (PCEC) Rabies Vaccine (Rabipur or equivalent) (Novartis).","Kisian - Kenya, Kisumu - Kenya",2013-05-24,2010-06-22,2019-01-16,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,malaria
NCT00527800,TCC,COMPLETED,2007-08,"Malaria, HIV Infections","Dihydroartemisinin-piperaquine, Artemether-lumefantrine, Trimethoprim-sulfamethoxazole",Tororo - Uganda,2013-03,2007-09-11,2013-10-11,INTERVENTIONAL,PHASE3,"University of California, San Francisco",OTHER,malaria
NCT00287300,Unknown,COMPLETED,2003-09,Malaria,"Sulfadoxine-Pyrimethamine, Azithromycin, Artesunate",Blantyre - Malawi,Unknown Date,2006-02-06,2006-02-06,INTERVENTIONAL,NA,University of North Carolina,OTHER,malaria
NCT02610400,Unknown,COMPLETED,2016-02,Malaria,"RACD, RAVC, rfMDA",Windhoek - Namibia,2017-12,2015-11-20,2020-07-17,INTERVENTIONAL,PHASE3,"University of California, San Francisco",OTHER,malaria
NCT00513500,ZIMMAPS,COMPLETED,2007-06,"Pneumonia, Malaria","Coartem and amoxicillin, Coartem",Chikankata - Zambia,2009-02,2007-08-08,2010-07-20,INTERVENTIONAL,NA,Boston University,OTHER,malaria
NCT04839900,ProACT,COMPLETED,2021-04-15,"Malaria, Falciparum, Malaria",Proactive iCCM,Chadiza - Zambia,2023-06-30,2021-04-09,2024-07-25,INTERVENTIONAL,NA,PATH,OTHER,malaria
NCT02663700,Unknown,COMPLETED,2016-04-07,Plasmodium Falciparum Infection,"Artesunate, PfSPZ Vaccine, Placebo",Ouagadougou - Burkina Faso,2018-12-17,2016-01-26,2019-07-29,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT01018459,Unknown,COMPLETED,2010-04,Malaria,"Ad35.CS.01 Circumsporozoite Malaria Vaccine, Placebo",West Africa - Burkina Faso,2011-12,2009-11-23,2014-06-06,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT00164359,Unknown,COMPLETED,2005-04,"Malaria, Falciparum","Amodiaquine plus artesunate, chlorproguanil-dapsone plus artesunate","Lilongwe - Malawi, Liwonde - Malawi, Dwangwa - Malawi",2005-09,2005-09-14,2012-09-27,INTERVENTIONAL,PHASE4,Centers for Disease Control and Prevention,FED,malaria
NCT00336375,Unknown,COMPLETED,2006-06,Malaria,artemether-lumefantrine,Fukayosi - Tanzania,Unknown Date,2006-06-13,2007-11-01,INTERVENTIONAL,PHASE4,Karolinska University Hospital,OTHER,malaria
NCT05750459,Unknown,ACTIVE_NOT_RECRUITING,2023-11-29,Plasmodium Falciparum Infection,Artesunate,Kampala - Uganda,2025-04-15,2023-03-01,2025-03-07,INTERVENTIONAL,PHASE4,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT01350752,REACT,COMPLETED,2011-05,Malaria,"RDTs & Provider Training on Malaria Diagnosis and Treatment, Extended provider training (Cameroon only), School based malaria education (Nigeria only)","Yaounde - Cameroon, Bamenda - Cameroon, Enugu - Nigeria",2012-09,2011-05-10,2016-09-09,INTERVENTIONAL,NA,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT04791800,Unknown,COMPLETED,2019-04-08,Fever Malaria,Malaria/CRP combination test,New Delhi - India,2020-03-16,2021-03-10,2021-03-10,OBSERVATIONAL,Not Available,"Foundation for Innovative New Diagnostics, Switzerland",OTHER,malaria
NCT00484900,Unknown,COMPLETED,2006-05,Plasmodium Falciparum Malaria,"Co-Arinate FDC, Coartem","Yaounde - Cameroon, Bamako - Mali, Kigali - Rwanda, New Halfa - Sudan",Unknown Date,2007-06-11,2008-03-26,INTERVENTIONAL,PHASE3,Dafra Pharma,INDUSTRY,malaria
NCT01697852,Unknown,UNKNOWN,2011-01,Malaria,"Indoor residual spraying with bendiocarb, LLIN by universal coverage campaign",Muleba - Tanzania,2012-11,2012-10-02,2012-10-03,INTERVENTIONAL,PHASE4,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT01662700,Unknown,UNKNOWN,2012-10,Acute Uncomplicated Malaria With P.Vivax Infection,"Artesunate, Chloroquine","Ranong - Thailand, Srisaket - Thailand, Srisaket - Thailand, Surin - Thailand",2014-12,2012-08-10,2013-01-25,INTERVENTIONAL,PHASE4,Mahidol University,OTHER,malaria
NCT00231452,Unknown,COMPLETED,2005-09,Malaria,Sulfadoxine-pyrimethamine (SP) + Artesunate (AS),Manhiça - Mozambique,2009-03,2005-10-04,2011-10-28,INTERVENTIONAL,NA,Hospital Clinic of Barcelona,OTHER,malaria
NCT06225700,Unknown,COMPLETED,2023-03-01,"Malaria, Diagnoses Disease, RDT",No interventions listed,Kigali - Rwanda,2023-08-01,2024-01-26,2024-01-26,OBSERVATIONAL,Not Available,"Foundation for Innovative New Diagnostics, Switzerland",OTHER,malaria
NCT02878200,RHOST,COMPLETED,2016-11-04,Malaria,dihydroartemisinin-piperaquine,North Bank Region - Gambia,2018-12-18,2016-08-25,2020-09-07,INTERVENTIONAL,NA,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT00707200,CPM,COMPLETED,2007-10,Plasmodium Falciparum Malaria,No interventions listed,Kampala - Uganda,2009-11,2008-06-30,2010-01-26,OBSERVATIONAL,Not Available,"University Health Network, Toronto",OTHER,malaria
NCT02043652,Unknown,COMPLETED,2014-02,Malaria,"Chloroquine, Primaquine",Cruzeiro do Sul - Brazil,2014-12,2014-01-23,2018-02-07,INTERVENTIONAL,NA,Centers for Disease Control and Prevention,FED,malaria
NCT01992900,Unknown,COMPLETED,2013-11,"Malaria,Falciparum","Eurartesim dispersible oral tablet, eurartesim film coated tablet","Bobo Dioulasso - Burkina Faso, Ouagadougou - Burkina Faso, Kinshasa - Congo, The Democratic Republic of the, Fajara - Gambia, Manica - Mozambique, Bagamoyo - Tanzania, Tanga - Tanzania",2015-07,2013-11-25,2016-11-08,INTERVENTIONAL,PHASE2,sigma-tau i.f.r. S.p.A.,INDUSTRY,malaria
NCT02174900,Unknown,COMPLETED,2014-10,Malaria,"Artemether-Lumefantrine (AL) + 0.25 mg/kg primaquine, Artemether-Lumefantrine (AL) combination, Artemether-Lumefantrine (AL) + 0.4 mg/kg primaquine",Ouagadougou - Burkina Faso,2015-12,2014-06-26,2016-02-01,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT05889052,Unknown,ACTIVE_NOT_RECRUITING,2023-07-19,"Anemia, Malaria",Sulfadoxine pyrimethamine,Soa and Mbankomo - Cameroon,2025-09,2023-06-05,2025-01-09,OBSERVATIONAL,Not Available,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT01454752,Unknown,COMPLETED,2011-11,"Malaria, Anaemia","Intermittent parasite clearance, Placebo",Dakar - Senegal,2012-02,2011-10-19,2012-04-19,INTERVENTIONAL,NA,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT01086917,Unknown,COMPLETED,2010-08,Malaria,PfSPZ Challenge,Nijmegen - Netherlands,2011-02,2010-03-15,2015-04-21,INTERVENTIONAL,PHASE1,Sanaria Inc.,INDUSTRY,malaria
NCT01031524,DG002,COMPLETED,2004-03,Plasmodium Falciparum Malaria,"PfCS102, Montanide ISA 720",Lausanne - Switzerland,2004-07,2009-12-14,2009-12-14,INTERVENTIONAL,PHASE2,Swiss Tropical & Public Health Institute,OTHER,malaria
NCT00197041,Unknown,COMPLETED,2003-07,Malaria,"RTS,S/AS02A",Maputo - Mozambique,2005-04,2005-09-20,2016-09-21,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,malaria
NCT03896724,Unknown,COMPLETED,2019-05-07,"Malaria,Falciparum","R21 adjuvanted with 25mcg Matrix-M, Rabies Vaccine, R21 adjuvanted with 50mcg Matrix-M",Nanoro - Burkina Faso,2023-07-07,2019-04-01,2023-09-07,INTERVENTIONAL,PHASE2,University of Oxford,OTHER,malaria
NCT00509158,LSA-3-rec,COMPLETED,2007-10,Healthy,"arm I: PfLSA-3-rec with aluminium hydroxide as adjuvant, arm 2: PfLSA-3-rec with Montanide Isa 720 as adjuvant",Nijmegen - Netherlands,2008-10,2007-07-31,2010-02-23,INTERVENTIONAL,PHASE2,Radboud University Medical Center,OTHER,malaria
NCT01736319,Unknown,COMPLETED,2012-06-26,Plasmodium Falciparum Malaria,No interventions listed,Phnom Penh - Cambodia,Unknown Date,2012-11-29,2018-06-01,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT00203736,Unknown,COMPLETED,2003-01,Malaria,"Sulfadoxine-pyrimethamine, Artesunate plus sulfadoxine-pyrimethamine","Catuane - Mozambique, Namaacha - Mozambique",Unknown Date,2005-09-20,2006-11-16,INTERVENTIONAL,NA,University of Cape Town,OTHER,malaria
NCT03824236,Unknown,COMPLETED,2019-02-05,Malaria,"RTS,S/AS01E (SB257049)",Silver Spring - United States,2019-04-30,2019-01-31,2020-08-14,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,malaria
NCT00414336,Unknown,COMPLETED,2006-12-15,Malaria,AMA1-C1/Alhydrogel + CPG 7909 Vaccine,Doneguebougou - Mali,2006-12-15,2006-12-21,2017-07-02,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT05891236,Unknown,COMPLETED,2023-08-14,Malaria,"MAM01 1.5 mg/kg, Placebo, MAM01 5 mg/kg, MAM01 10 mg/kg, MAM01 40 mg/kg, MAM01 450 mg, Placebo, MAM01 5 mg/kg, Control, MAM01 600 mg, MAM01 900 mg",Baltimore - United States,2024-12-13,2023-06-06,2025-02-19,INTERVENTIONAL,PHASE1,Bill & Melinda Gates Medical Research Institute,OTHER,malaria
NCT01988636,Unknown,COMPLETED,2013-10-29,Malaria,"PfSPZ Vaccine, Placebo",Bamako - Mali,2015-08-20,2013-11-20,2019-12-03,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT04422015,AsintMal,COMPLETED,2020-03-01,Falciparum Malaria,No intervention,Manhiça - Mozambique,2021-03-31,2020-06-09,2023-09-01,OBSERVATIONAL,Not Available,Alfredo Mayor,OTHER,malaria
NCT04037332,Caramal DRM,COMPLETED,2018-07-27,Severe Malaria,Blood sample (combined with malaria RDT) followed by gentoyping analysis,"Kenge - Congo, The Democratic Republic of the, Ipamu - Congo, The Democratic Republic of the, Kingandu - Congo, The Democratic Republic of the, Yola - Nigeria, Lira - Uganda, Lira - Uganda, Lira - Uganda",2020-07-31,2019-07-30,2021-01-29,OBSERVATIONAL,Not Available,Swiss Tropical & Public Health Institute,OTHER,malaria
NCT06529237,GenMoz2,RECRUITING,2024-04-01,"Malaria, Falciparum Malaria, Malaria in Pregnancy","LDH-based malaria rapid diagnostic test, Malaria rapid diagnostic test",Manhiça - Mozambique,2027-03-31,2024-07-31,2024-08-26,OBSERVATIONAL,Not Available,Centro de Investigacao em Saude de Manhica,OTHER,malaria
NCT06769815,HIPPI,NOT_YET_RECRUITING,2025-02-15,"Malaria, Bacterial Co-infection","Blood sample, Urine sample, oropharyngeal sample, Optionnal : stool sample, Optionnal : cerebrospinal fluid, placental biopsy",No locations listed,2027-02-15,2025-01-10,2025-01-24,INTERVENTIONAL,NA,Institut Pasteur,INDUSTRY,malaria
NCT04650815,Unknown,COMPLETED,2021-06-10,Malaria,No interventions listed,"Sabou - Burkina Faso, Sabou - Burkina Faso",2024-06-25,2020-12-03,2024-09-19,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT03452475,TACTKenya,COMPLETED,2018-03-07,Plasmodium Falciparum,"Arterolane-piperaquine, Arterolane-piperaquine+mefloquine, Artemether-lumefantrine",Kilifi - Kenya,2019-06-03,2018-03-02,2021-09-29,INTERVENTIONAL,PHASE3,University of Oxford,OTHER,malaria
NCT00628459,Unknown,COMPLETED,2006-08,"Anemia, Undernutrition",micronutrient supplementation,Kongoussi - Burkina Faso,2007-02,2008-03-05,2008-03-05,INTERVENTIONAL,NA,Centre National de la Recherche Scientifique et Technologique,OTHER_GOV,malaria
NCT06122142,AEGIS Uganda,WITHDRAWN,2024-05,Malaria,"Transfluthrin - delivery by paid study personnel, Transfluthrin - delivery by voucher system, Transfluthrin - delivery by village health teams","Kampala - Uganda, Kampala - Uganda",2025-05,2023-11-08,2025-03-07,INTERVENTIONAL,NA,University of Notre Dame,OTHER,malaria
NCT01388842,Unknown,COMPLETED,2011-09,"Malaria, Cerebral","inhaled nitric oxide, Placebo",Mbarara - Uganda,2014-02,2011-07-07,2016-03-02,INTERVENTIONAL,PHASE2,Epicentre,OTHER,malaria
NCT02556242,TIRS,COMPLETED,2015-10,Malaria,"Targeted indoor residual spraying, Generalised Indoor residual spraying","Tzaneen - South Africa, Nelspruit - South Africa",2017-06,2015-09-22,2020-07-23,INTERVENTIONAL,PHASE4,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT00229775,Unknown,COMPLETED,2003-07,Malaria,artemether/lumafantrine vs chloroquine/sulfadoxine-pyrimethamine,"Tabuk - Philippines, Davao City - Philippines, Puerto Princesa - Philippines",2008-07,2005-09-30,2012-09-11,INTERVENTIONAL,NA,Centers for Disease Control and Prevention,FED,malaria
NCT02671175,PMC,COMPLETED,2016-05-20,"Malaria, Severe Anemia","dihydroartemisinin-piperaquine, dihydroartemisinin-piperaquine placebo","Homa Bay - Kenya, Migori - Kenya, Siaya - Kenya, Kisumu - Kenya, Hoima - Uganda, Jinja - Uganda, Kamuli - Uganda, Masaka - Uganda, Mubende - Uganda",2018-10-24,2016-02-02,2020-06-04,INTERVENTIONAL,PHASE3,Liverpool School of Tropical Medicine,OTHER,malaria
NCT05685875,Unknown,UNKNOWN,2022-06-07,"Diabetes Mellitus, Type 2, Obesity, Metabolic Syndrome, Severe Malaria, Malaria,Falciparum",diabetes,"Dschang - Cameroon, Bafoussam - Cameroon",2023-05,2023-01-17,2023-01-17,OBSERVATIONAL,Not Available,Karolinska Institutet,OTHER,malaria
NCT00772642,Unknown,COMPLETED,2008-10-08,Malaria,No interventions listed,Bamako - Mali,Unknown Date,2008-10-15,2017-07-02,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT01017770,ACTE,COMPLETED,2008-09,Uncomplicated P. Falciparum Malaria in Children,"Artesunate-amodiaquine, Artemether-lumefantrine","Nanoro - Burkina Faso, Nanoro - Burkina Faso, Bobo-Dioulasso - Burkina Faso, Bobo-Dioulasso - Burkina Faso",2010-01,2009-11-23,2015-07-31,INTERVENTIONAL,PHASE4,Centre Muraz,OTHER,malaria
NCT03201770,Unknown,COMPLETED,2017-06-22,"Malaria,Falciparum",pyronaridine artesunate,"Yaoundé - Cameroon, Kinshasa - Congo, The Democratic Republic of the, Brazzaville - Congo, Bouaké - Côte D'Ivoire, Lambaréné - Gabon",2019-04-10,2017-06-28,2019-06-26,INTERVENTIONAL,PHASE4,Shin Poong Pharmaceutical Co. Ltd.,INDUSTRY,malaria
NCT02600975,Unknown,COMPLETED,2015-12-08,Malaria,R21 with ASO1B,"Oxford - United Kingdom, Southampton - United Kingdom",2017-01-19,2015-11-09,2017-06-20,INTERVENTIONAL,PHASE1,University of Oxford,OTHER,malaria
NCT06300970,Unknown,COMPLETED,2022-08-09,"Plasmodium Falciparum, Malaria, Uncomplicated Malaria","Amodiaquine-artesunate (ASAQ), Artemether+Lumefantrine (AL)","Sinje - Liberia, Saclepea - Liberia",2023-08-16,2024-03-08,2024-05-07,INTERVENTIONAL,PHASE4,Centers for Disease Control and Prevention,FED,malaria
NCT00652275,Unknown,UNKNOWN,2008-05,Malaria,"MSP3 Long Synthetic Peptide 30 micrograms of MSP3 LSP, Verorab vaccine",Bamako - Mali,2010-11,2008-04-03,2008-05-07,INTERVENTIONAL,PHASE2,African Malaria Network Trust,NETWORK,malaria
NCT05979207,Unknown,COMPLETED,2023-08-01,"Infections, Vector Borne Diseases, Systemic Inflammatory Response Syndrome, Inflammation, Pathologic Processes, Malaria, Malaria,Falciparum, Parasitemia, Parasitic Diseases, Protozoan Infections, Antimalarials, Anti-Infective Agents","MMV367, P. falciparum IBSM infection","Brisbane - Australia, Brisbane - Australia",2023-10-30,2023-08-07,2024-01-16,INTERVENTIONAL,PHASE1,Medicines for Malaria Venture,OTHER,malaria
NCT01292707,TACT,COMPLETED,2011-02,Malaria,"Control, HW, HWC",Moshi - Tanzania,2012-02,2011-02-09,2014-11-19,INTERVENTIONAL,NA,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT02215707,Unknown,COMPLETED,2014-06,Malaria,PfSPZ Vaccine,Silver Spring - United States,2015-04,2014-08-13,2018-06-29,INTERVENTIONAL,PHASE1,Sanaria Inc.,INDUSTRY,malaria
NCT00878007,Unknown,COMPLETED,2010-01,"Anaemia, Malaria","Intermittent screening and treatment for malaria, Teacher training on literacy instruction, IST plus literacy instruction programme",Nairobi - Kenya,2012-04,2009-04-08,2014-02-17,INTERVENTIONAL,NA,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT01883609,Unknown,COMPLETED,2013-09,Plasmodium Falciparum Malaria,"RTS,S/AS01B, ChAd63 ME-TRAP, MVA ME-TRAP","Southampton - United Kingdom, Oxford - United Kingdom, London - United Kingdom, London - United Kingdom",2014-08,2013-06-21,2014-10-01,INTERVENTIONAL,PHASE2,University of Oxford,OTHER,malaria
NCT01949909,P27A,COMPLETED,2014-03,Malaria,"CH-Alum50, CH-GLA2.5/50, TZ Ver, TZ Alum 50, TZ GLA 2.5/10, TZ GLA5/50, TZ GLA2.5/50","Lausanne - Switzerland, Bagamoyo - Tanzania",2015-07,2013-09-25,2018-07-18,INTERVENTIONAL,PHASE1,Centre Hospitalier Universitaire Vaudois,OTHER,malaria
NCT00138307,Unknown,COMPLETED,Unknown Date,Malaria,No interventions listed,"Legon - Ghana, Navrongo - Ghana",Unknown Date,2005-08-30,2010-08-27,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT00142207,Unknown,COMPLETED,2004-01,"Malaria, Falciparum","Intermittent preventive treatment:sulphadoxine-pyrimethamine, Insecticide-treated mosquito bed net",Kabale - Uganda,2007-01,2005-09-02,2017-01-12,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT06735209,Unknown,NOT_YET_RECRUITING,2025-03-14,Malaria,"PfSPZ Vaccine, PfSPZ (7G8) Challenge, Sodium Chloride, 0.9%",Seattle - United States,2027-02-01,2024-12-16,2025-03-07,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT01265407,Unknown,COMPLETED,2010-12-22,Malaria,No interventions listed,Rakai - Uganda,2012-09-12,2010-12-23,2023-10-03,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT00301015,Unknown,COMPLETED,2006-03,Uncomplicated Plasmodium Falciparum Malaria,Rapid diagnostic test for malaria,Kibaha - Tanzania,Unknown Date,2006-03-10,2007-11-01,INTERVENTIONAL,PHASE4,Karolinska University Hospital,OTHER,malaria
NCT06392152,Unknown,ACTIVE_NOT_RECRUITING,2019-07-01,"Malaria, Mass Drug Administration, Myanmar, Plasmodium Vivax, Primaquine",Focal Mass Drug Administration with Primaquine,Yangon - Myanmar,2024-03-31,2024-04-30,2024-04-30,INTERVENTIONAL,NA,Pyae Linn Aung,OTHER,malaria
NCT04206332,Unknown,COMPLETED,2020-01-07,Malaria,"VRC-MALMAB0100-00-AB, Plasmodium falciparum (P. falciparum) sporozoite challenge","Baltimore - United States, Bethesda - United States",2022-02-28,2019-12-20,2023-04-18,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT00289185,Unknown,COMPLETED,2006-09-27,"Malaria, Malaria Vaccines","RTS,S/AS02D, Engerix-B®, TETRActHib™",Dar-es-Salaam - Tanzania,2008-02-11,2006-02-09,2020-10-29,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,malaria
NCT04310085,Unknown,COMPLETED,2020-02-19,"Malaria,Falciparum, Parasitemia, Protozoan Infections, Parasitic Disease","Artemether-Lumefantrine 20 Mg-120 Mg Oral Tablet, PfSPZ-DVI Challenge",Antwerpen - Belgium,2020-12-17,2020-03-17,2021-09-05,INTERVENTIONAL,PHASE1,Medicines for Malaria Venture,OTHER,malaria
NCT00541385,Unknown,COMPLETED,2007-10,Malaria,"pyronaridine artesunate, arthemeter lumefantrine","Ouagadougou - Burkina Faso, Kinshasa - Congo, The Democratic Republic of the, Abidjan - Côte D'Ivoire, Lambaréné - Gabon, Siaya - Kenya, Bamako - Mali, Maputo - Mozambique, Puerto Princesa - Philippines",2008-09,2007-10-10,2021-11-22,INTERVENTIONAL,PHASE3,Medicines for Malaria Venture,OTHER,malaria
NCT04558515,AutoMic,COMPLETED,2020-02-01,Malaria,Novel malaria diagnostics & tools,Khartoum - Sudan,2021-07-01,2020-09-22,2023-11-18,OBSERVATIONAL,Not Available,"Foundation for Innovative New Diagnostics, Switzerland",OTHER,malaria
NCT06555809,Unknown,RECRUITING,2024-10-06,Malaria,Artesunate Injection,Paris - France,2029-08-31,2024-08-15,2024-12-10,OBSERVATIONAL,Not Available,"Amivas (US), LLC",INDUSTRY,malaria
NCT00373607,Unknown,COMPLETED,2003-07,Malaria,"Dihydroartemisin-piperaquine, Mefloquine + Artesunate",No locations listed,2005-07,2006-09-08,2010-09-14,INTERVENTIONAL,PHASE3,"Institute of Tropical Medicine, Belgium",OTHER,malaria
NCT03208907,CuraVivax,COMPLETED,2018-07-05,"Malaria, Vivax, Therapeutics","CQ coadministered with PQ, DHA-PQP coadministered with PQ, CQ and PQ starting on Day 42, DHA-PQP and PQ starting on Day 42",Manaus - Brazil,2021-07-02,2017-07-06,2023-06-12,INTERVENTIONAL,PHASE3,Fundação de Medicina Tropical Dr. Heitor Vieira Dourado,OTHER,malaria
NCT02800109,Unknown,COMPLETED,2016-05,"Malaria, Pregnancy",No interventions listed,Mae Sot - Thailand,2018-02,2016-06-15,2024-02-28,OBSERVATIONAL,Not Available,University of Oxford,OTHER,malaria
NCT00984256,MALWEEK,COMPLETED,2009-09,Malaria,"Atovaquone Proguanil, Procedure - malaria challenge",Silver Spring - United States,2010-04,2009-09-25,2013-11-25,INTERVENTIONAL,PHASE2,U.S. Army Medical Research and Development Command,FED,malaria
NCT01160809,Unknown,COMPLETED,2008-09,"Malaria, Mosquito Repellent, Long Lasting Insecticidal Nets",Mosquito repellent,Awassa - Ethiopia,2008-12,2010-07-12,2010-07-12,INTERVENTIONAL,PHASE4,"Malaria Consortium, Ethiopia",OTHER,malaria
NCT00233337,Unknown,COMPLETED,2001-05,Acute Uncomplicated P. Falciparum Malaria,Co-artemether,No locations listed,2005-08,2005-10-05,2012-04-27,INTERVENTIONAL,PHASE4,Novartis Pharmaceuticals,INDUSTRY,malaria
NCT00680732,Unknown,COMPLETED,2003-06,"Malaria, Malaria in Pregnancy","Multiple micronutrients supplements (MMS), Iron and folic acid (IFA), Chloroquine (CQ), Sulphadoxyne-pyrimethamine (SP)",Bobo-Dioulasso - Burkina Faso,2006-10,2008-05-20,2010-09-14,INTERVENTIONAL,PHASE4,"Institute of Tropical Medicine, Belgium",OTHER,malaria
NCT01805232,IVAS,UNKNOWN,2013-03,Malaria,"artesunate, Quinine",Kassala - Sudan,2013-05,2013-03-06,2013-03-06,INTERVENTIONAL,PHASE4,University of Khartoum,OTHER,malaria
NCT00358332,Unknown,COMPLETED,2006-11,Plasmodium Falciparum Malaria,"FMP2.1/AS02A, Rabies vaccine (RabAvert)",Bamako - Mali,2007-12,2006-07-31,2011-10-24,INTERVENTIONAL,PHASE1,U.S. Army Medical Research and Development Command,FED,malaria
NCT01829737,Unknown,COMPLETED,2013-03-20,"Malaria, Falciparum",No interventions listed,Bethesda - United States,2015-01-20,2013-04-11,2018-08-02,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT06652737,Unknown,NOT_YET_RECRUITING,2025-03,"Malaria Falciparum, Malaria Infection","PfSPZ-LARC2 Vaccine, Normal Saline (Placebo)",Ouagadougou - Burkina Faso,2025-10,2024-10-22,2025-02-13,INTERVENTIONAL,PHASE1,Sanaria Inc.,INDUSTRY,malaria
NCT00522132,Unknown,COMPLETED,2007-09,Malaria,Artesunate,"Lambaréné - Gabon, Libreville - Gabon, Blantyre - Malawi",2008-06,2007-08-29,2011-09-16,INTERVENTIONAL,PHASE2,Medicines for Malaria Venture,OTHER,malaria
NCT00372632,Unknown,COMPLETED,2005-12,Non HIV Infected Pregnant Women,"Sulfadoxine-Pyrimethamine, placebo",Kigali - Rwanda,2008-04,2006-09-07,2010-09-14,INTERVENTIONAL,PHASE4,"Institute of Tropical Medicine, Belgium",OTHER,malaria
NCT00453856,Unknown,TERMINATED,2007-03,Malaria,Sulfadoxine Pyrimethamine,Lambaréné - Gabon,Unknown Date,2007-03-29,2007-08-10,INTERVENTIONAL,PHASE4,"Albert Schweitzer Hospital, Netherlands",UNKNOWN,malaria
NCT01350856,TRAC,COMPLETED,2011-05,Falciparum Malaria,"Artesunate 2, Artesunate 4","Cox's Bazaar - Bangladesh, Pailin - Cambodia, Preah Vihear - Cambodia, Pursat - Cambodia, Rattanakiri - Cambodia, Kinshasa - Congo, The Democratic Republic of the, West Bengal - India, Kilifi - Kenya, Phouvong - Lao People's Democratic Republic, Myitkyina - Myanmar, Luthaw - Myanmar, Mandalay - Myanmar, Thabeikkyin - Myanmar, Shwe Kyin - Myanmar, Ilorin - Nigeria, Mae Sot - Thailand, Ranong - Thailand, Srisaket - Thailand, Binh Phuoc - Vietnam",2014-04,2011-05-10,2015-06-01,INTERVENTIONAL,PHASE4,University of Oxford,OTHER,malaria
NCT02940756,TETRDC2016,COMPLETED,2017-03-15,Malaria,"artesunate-amodiaquine, artemether-lumefantrine, Dihydroartemisinine-piperaquine","Bolenge - Congo, The Democratic Republic of the, Kapolowe - Congo, The Democratic Republic of the, Kazumba - Congo, The Democratic Republic of the, Kimpese - Congo, The Democratic Republic of the, Rutshuru - Congo, The Democratic Republic of the, Kabondo - Congo, The Democratic Republic of the",2018-01-02,2016-10-21,2018-01-03,INTERVENTIONAL,PHASE4,"Ministry of Public Health, Democratic Republic of the Congo",OTHER_GOV,malaria
NCT05041556,MVPE-CC,RECRUITING,2021-10-18,Malaria,"Case-control study of clinical outcomes, Case-control study of mortality outcome","Kintampo - Ghana, Nairobi - Kenya, Nairobi - Kenya, Blantyre - Malawi",2025-04-30,2021-09-13,2025-02-28,OBSERVATIONAL,Not Available,"Kintampo Health Research Centre, Ghana",OTHER,malaria
NCT05711485,PLATFORM,RECRUITING,2024-02-24,"Severe Malaria, Thrombocytopenia",Whole blood transfusion,"Baltimore - United States, Ndola - Zambia",2026-04-30,2023-02-03,2024-10-31,INTERVENTIONAL,NA,Johns Hopkins Bloomberg School of Public Health,OTHER,malaria
NCT00119132,Unknown,COMPLETED,2005-06,Malaria,"artesunate-amodiaquine, sulphadoxine-pyrimethamine",Hohoe - Ghana,2006-12,2005-07-13,2017-01-12,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT03224052,ANTHEM,COMPLETED,2016-05-01,"Malaria, Bacteremia, Sepsis",No interventions listed,Yangon - Myanmar,2017-10-31,2017-07-21,2024-03-15,OBSERVATIONAL,Not Available,Menzies School of Health Research,OTHER,malaria
NCT02392832,LLML,COMPLETED,2015-04,Malaria,"Fourstar® granule, 90 day and 180 day briquettes Bti/Bs",Kisumu - Kenya,2019-09,2015-03-19,2021-03-29,INTERVENTIONAL,NA,"University of California, Irvine",OTHER,malaria
NCT01624337,MPC,TERMINATED,2012-05,Malaria,"DHA-piperaquine, placebo",Anlong Veng - Cambodia,2014-08,2012-06-20,2016-07-12,INTERVENTIONAL,NA,"Armed Forces Research Institute of Medical Sciences, Thailand",OTHER_GOV,malaria
NCT02431637,EFITA,COMPLETED,2015-04,Malaria,"Administration of the malaria inoculum, Piperaquine Phosphate 480 mg",Herston - Australia,2016-09,2015-05-01,2020-05-26,INTERVENTIONAL,PHASE1,Medicines for Malaria Venture,OTHER,malaria
NCT00473837,CQ-PMA,COMPLETED,2007-07,Malaria Anaemia,"Chloroquine, Placebo",No locations listed,2009-02,2007-05-16,2014-10-13,INTERVENTIONAL,NA,"Medical Research Council Unit, The Gambia",OTHER,malaria
NCT04228315,Unknown,UNKNOWN,2019-11-19,"Malaria, Vivax Malaria, Relapse, CYP2D6 Polymorphism",Primaquine,Khun Han - Thailand,2021-06-30,2020-01-14,2020-01-14,INTERVENTIONAL,NA,"Armed Forces Research Institute of Medical Sciences, Thailand",OTHER_GOV,malaria
NCT00392015,Unknown,COMPLETED,2006-10-12,Plasmodium Falciparum,"NMRC-M3V-Ad-PfCA, NMRC-MV-Ad-PfC, NMRC-M3V-Ad-PfCA",Bethesda - United States,2016-06-02,2006-10-25,2021-05-21,INTERVENTIONAL,PHASE2,U.S. Army Medical Research and Development Command,FED,malaria
NCT02288637,Unknown,COMPLETED,2014-09,"Malaria, Anaemia","Olyset Plus LLIN, Conventional Olyset LLIN, IRS",Muleba - Tanzania,2017-12,2014-11-11,2022-04-22,INTERVENTIONAL,NA,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT00459615,Unknown,COMPLETED,2007-04,"Falciparum Malaria, Uncomplicated Malaria",Artesunate for Injection,"Kisumu - Kenya, Sangkhlaburi - Thailand",2007-12,2007-04-12,2008-09-25,INTERVENTIONAL,PHASE2,U.S. Army Office of the Surgeon General,FED,malaria
NCT03128515,NOHARM-MTD,COMPLETED,2017-07-26,"Sickle Cell Anemia, Sickle Cell Disease, Malaria",Hydroxyurea,Kampala - Uganda,2019-04-07,2017-04-25,2020-02-20,INTERVENTIONAL,PHASE3,Indiana University,OTHER,malaria
NCT01784315,BCAPES,UNKNOWN,2013-03,Parasitemia,"Artemisinin combination therapies (ACT)will be used for Chloroquine resistant P.vivax, Chloroquine and Primaquine","Gelephu - Bhutan, Gelephu - Bhutan, Sarpang - Bhutan",2014-12,2013-02-05,2013-11-25,OBSERVATIONAL,Not Available,"Ministry of Health, Bhutan",OTHER_GOV,malaria
NCT02009215,START-IPT,COMPLETED,2014-02,Malaria,Dihydroartemisinin-piperaquine (DP),Kampala - Uganda,2015-04,2013-12-11,2015-09-24,INTERVENTIONAL,PHASE4,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT00158587,Unknown,COMPLETED,2004-04,"Malaria, Vivax Malaria",primaquine,No locations listed,Unknown Date,2005-09-12,2017-01-12,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT00436007,Unknown,COMPLETED,2007-04-30,Malaria,"GSK 257049, Tritanrix™ HepB/Hib, Rouvax™, Stamaril™, Polio Sabin™","Lambaréné - Gabon, Kintampo - Ghana, Dar-es-Salaam - Tanzania",2008-09-15,2007-02-16,2018-08-16,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,malaria
NCT00452907,Unknown,COMPLETED,2005-07,Malaria,"Artesunate, Artesunate + Sulfadoxine-Pyrimethamine, arthemether + lumefantrine",Bougoula - Mali,2007-06,2007-03-28,2010-02-17,INTERVENTIONAL,PHASE4,Sanofi,INDUSTRY,malaria
NCT00935688,Unknown,COMPLETED,2009-05,"Malaria, Fever",Rapid diagnostic test,"Jalalabad - Afghanistan, Kunduz - Afghanistan",2010-10,2009-07-09,2014-02-07,INTERVENTIONAL,PHASE4,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT00336388,Unknown,COMPLETED,2006-07,Malaria,Paracheck Device,Kisumu - Kenya,2006-09,2006-06-13,2010-03-09,INTERVENTIONAL,NA,Centers for Disease Control and Prevention,FED,malaria
NCT02471378,Unknown,RECRUITING,2015-07-28,Malaria,No interventions listed,Bamako - Mali,2025-06-30,2015-06-15,2024-11-12,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT02492178,REACH,COMPLETED,2015-07,Malaria,"Intrarectal artesunate, Intravenous artesunate, Intravenous quinine","Kinshasa - Congo, The Democratic Republic of the",2015-10,2015-07-08,2015-12-03,INTERVENTIONAL,PHASE2,University of Oxford,OTHER,malaria
NCT01205178,Unknown,COMPLETED,2009-07-02,Malaria,"Chloroquine, Primaquine, Tafenoquine","Bangkok - Thailand, Tak - Thailand",2013-04-01,2010-09-20,2017-06-07,INTERVENTIONAL,PHASE1,GlaxoSmithKline,INDUSTRY,malaria
NCT02450578,Unknown,COMPLETED,2015-10,"Plasmodium Falciparum, Malaria","DSM265 400mg, Placebo to DSM265 400 mg, Plasmodium falciparum sporozoite challenge, Malarone",Tübingen - Germany,2016-04,2015-05-21,2021-01-13,INTERVENTIONAL,PHASE1,Medicines for Malaria Venture,OTHER,malaria
NCT00682578,Unknown,COMPLETED,2007-07,"Uncomplicated Falciparum Malaria, Vivax Malaria","Dihydroartemisinin + Piperaquine (Artekin), artesunate-sulphadoxin/pyrimethamine, chloroquine","Faryab - Afghanistan, Jalalabad - Afghanistan, Maimana - Afghanistan, Takhar - Afghanistan",2010-02,2008-05-22,2018-05-09,INTERVENTIONAL,PHASE3,University of Oxford,OTHER,malaria
NCT01619878,Unknown,COMPLETED,2012-10,Acute Uncomplicated Falciparum Malaria,Artemether-lumefantrine (COA566),"Cotonou - Benin, Cotonou - Benin, Burkina Faso - Burkina Faso, Ouagadougou - Burkina Faso, Kinshasa - Congo, Calabar - Nigeria, Lome - Togo",2014-07,2012-06-14,2015-06-17,INTERVENTIONAL,PHASE3,Novartis Pharmaceuticals,INDUSTRY,malaria
NCT00121771,Unknown,COMPLETED,2004-01,Malaria,"FP9 CS, MVA CS",Banjul - Gambia,Unknown Date,2005-07-21,2017-01-12,INTERVENTIONAL,PHASE1,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT06860178,IMVACS,NOT_YET_RECRUITING,2025-04,Malaria Vaccine,Annual campaign of the 3-dose primary series vaccine R21/Matrix-M aligned with SMC distribution in children aged 3-59 months,"Ouagadougou - Burkina Faso, Bamako - Mali",2026-05,2025-03-05,2025-03-05,INTERVENTIONAL,PHASE4,Epicentre,OTHER,malaria
NCT01001871,Unknown,COMPLETED,2009-11,Anemia,"Sprinkles®, vitamin/mineral fortificant without iron",Kintampo - Ghana,2010-10,2009-10-27,2021-04-19,INTERVENTIONAL,NA,The Hospital for Sick Children,OTHER,malaria
NCT00461578,Unknown,COMPLETED,2005-04,Malaria,Chlorproguanil-dapsone + artesunate,Kigali - Rwanda,Unknown Date,2007-04-18,2007-04-18,INTERVENTIONAL,NA,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT00852371,Unknown,COMPLETED,2008-02,"Malaria, Intermittent Preventive Treatment","sulfadoxine-pyrimethamine, amodiaquine + sulfadoxine-pyrimethamine, dihydroartemisinin-piperaquine, Placebo",No locations listed,2008-06,2009-02-27,2024-03-21,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT05385471,Unknown,RECRUITING,2023-01-13,"Malaria, Falciparum",Matrix M with R78C and/or RH5.1,Oxford - United Kingdom,2024-07-31,2022-05-23,2023-12-18,INTERVENTIONAL,PHASE1,University of Oxford,OTHER,malaria
NCT04966871,Unknown,COMPLETED,2021-09-27,Malaria,"PfSPZ Vaccine, PfSPZ Challenge (7G8) for CHMI, Normal Saline",Seattle - United States,2022-06-21,2021-07-19,2022-07-18,INTERVENTIONAL,PHASE1,Sanaria Inc.,INDUSTRY,malaria
NCT04222088,TES,COMPLETED,2013-05-01,"Malaria, Falciparum Malaria, Vivax Malaria, Malaria Recrudescence","Arthemeter-lumefantrine, Chloroquine, Primaquine",No locations listed,2014-12-30,2020-01-09,2023-07-21,OBSERVATIONAL,Not Available,"Research Institute for Tropical Medicine, Philippines",OTHER_GOV,malaria
NCT02294188,SR-M-IDR,COMPLETED,2015-05,Malaria,"Spatial Repellent product with active ingredient (SHIELD), Active ingredient, Spatial Repellent product without active ingredient (SHIELD)",Jakarta - Indonesia,2018-04-15,2014-11-19,2018-05-03,INTERVENTIONAL,NA,University of Notre Dame,OTHER,malaria
NCT01625871,Unknown,COMPLETED,2011-09,Vivax Malaria,tablets artemether/lumefantrine,Kassala - Sudan,2012-09,2012-06-22,2013-01-17,INTERVENTIONAL,PHASE3,University of Khartoum,OTHER,malaria
NCT01115478,MAL2,COMPLETED,2010-07,"Malaria, Low Birth Weight, Anemia, Perinatal Mortality","Vitamin A, Zinc, Placebo",Dar es Salaam - Tanzania,2014-06,2010-05-04,2015-04-24,INTERVENTIONAL,NA,Harvard School of Public Health (HSPH),OTHER,malaria
NCT02223871,Unknown,COMPLETED,2014-06,Healthy Subjects,"ACT-451840:, Plasmodium falciparum-infected human erythrocytes:, Artemether 20 mg and lumefantrine 120mg combination tablet:, Primaquine:",Herston - Australia,2014-07,2014-08-22,2019-08-22,INTERVENTIONAL,PHASE1,Idorsia Pharmaceuticals Ltd.,INDUSTRY,malaria
NCT01190371,CATMAP,UNKNOWN,2011-04,Malaria,Artesunate,"Kadzinuni - Kenya, Kilifi - Kenya, Kilifi - Kenya",2011-11,2010-08-27,2018-02-23,INTERVENTIONAL,PHASE4,KEMRI-Wellcome Trust Collaborative Research Program,OTHER,malaria
NCT00565071,Unknown,UNKNOWN,2006-10,"Fever, Malaria",Field microscopy and Paracheck Pf®,Bushenyi and Iganga - Uganda,2012-03,2007-11-29,2012-03-28,INTERVENTIONAL,NA,Makerere University,OTHER,malaria
NCT02174978,Unknown,COMPLETED,2014-08,Malaria,"FMP012 with AS01B adjuvant system, P falciparum Controlled Human Malaria Infection (CHMI)",Silver Spring - United States,2015-06,2014-06-26,2017-10-13,INTERVENTIONAL,PHASE1,U.S. Army Medical Research and Development Command,FED,malaria
NCT02151578,HMM/P,COMPLETED,2009-01,"Malaria, Pneumonia",home/community case management,Ouagadougou - Burkina Faso,2012-06,2014-05-30,2014-05-30,INTERVENTIONAL,PHASE4,World Health Organization,OTHER,malaria
NCT01168271,Unknown,RECRUITING,2010-08-30,Malaria,No interventions listed,"Bamako - Mali, Ouelessebougou - Mali",Unknown Date,2010-07-23,2025-02-14,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT06162078,EPI-PAM,RECRUITING,2023-08-25,Maternal Malaria During Pregnancy - Baby Not Yet Delivered,No interventions listed,Banfora - Burkina Faso,2024-08,2023-12-08,2024-04-19,OBSERVATIONAL,Not Available,Groupe de Recherche Action en Sante,OTHER,malaria
NCT03512678,EasyScanGo,COMPLETED,2018-06-25,Malaria,No interventions listed,Mae Sot - Thailand,2019-10-31,2018-05-01,2020-09-03,OBSERVATIONAL,Not Available,University of Oxford,OTHER,malaria
NCT00169078,Unknown,COMPLETED,2002-07,Malaria,Chloroquine,Ouagadougou - Burkina Faso,Unknown Date,2005-09-15,2017-01-12,INTERVENTIONAL,NA,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT05140278,1STEP-AS,COMPLETED,2022-07-18,Severe Malaria,"Argesun 60mg (1 step parenteral artesunate), Artesun 60mg (2-step parenteral artesunate)","Kinshasa - Congo, The Democratic Republic of the",2022-07-29,2021-12-01,2024-03-15,INTERVENTIONAL,PHASE2,University of Oxford,OTHER,malaria
NCT00269178,Unknown,COMPLETED,2003-08,Malaria,Peer Health Education Programme,Banjul - Gambia,Unknown Date,2005-12-23,2024-11-26,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT00322907,Unknown,TERMINATED,2000-04,Clinical Malaria,Cotrifazid vs mefloquine or quinine+SP,Madang and Maprik - Papua New Guinea,Unknown Date,2006-05-08,2006-05-08,INTERVENTIONAL,PHASE2,"Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland",OTHER,malaria
NCT02181088,Unknown,COMPLETED,2014-08,"Malaria, Plasmodium Falciparum","ChAd63 RH5 low dose, ChAd63 RH5 full dose, MVA RH5 low dose, MVA RH5 full dose","Oxford - United Kingdom, Southampton - United Kingdom",2015-10,2014-07-03,2015-12-03,INTERVENTIONAL,PHASE1,University of Oxford,OTHER,malaria
NCT05980156,Unknown,COMPLETED,2023-02-13,"Malaria,Falciparum, Anemia in Children","Dihydroartemisinin-Piperaquine, Chloroquine, Sulfadoxine pyrimethamine",Blantyre - Malawi,2023-07-28,2023-08-07,2023-08-07,INTERVENTIONAL,PHASE4,"University of Maryland, Baltimore",OTHER,malaria
NCT03671109,MAMAH,COMPLETED,2019-09-18,"Malaria, HIV/AIDS, Pregnancy Related","Dihydroartemisinin-piperaquine (DHA-PPQ), Placebo Oral Tablet","Lambaréné - Gabon, Manhiça - Mozambique",2022-07-19,2018-09-14,2024-10-01,INTERVENTIONAL,PHASE3,Barcelona Institute for Global Health,OTHER,malaria
NCT04428385,Unknown,COMPLETED,2021-03-15,"Malaria, Febrile Illness","Testing incentive, Conditional artemisinin combination therapy subsidy",Lagos - Nigeria,2023-02-28,2020-06-11,2024-05-06,INTERVENTIONAL,NA,Duke University,OTHER,malaria
NCT00380393,Unknown,COMPLETED,2007-01-03,Malaria,"GSK malaria vaccine 257049 Vaccine, Sanofi-Pasteur's Human Diploid Cell Rabies Vaccine","Kilifi - Kenya, Amani, Tanga - Tanzania",2008-08-15,2006-09-26,2018-07-03,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,malaria
NCT02282293,Unknown,COMPLETED,2014-12-09,"Malaria, Human Immunodeficiency Virus","Monthly dihydroartemisinin-piperaquine (DP) + daily trimethoprim/sulfamethoxazole (TS), Monthly placebo + daily trimethoprim/sulfamethoxazole (TS)",Tororo - Uganda,2016-05-26,2014-11-04,2019-03-05,INTERVENTIONAL,PHASE3,"University of California, San Francisco",OTHER,malaria
NCT01184911,SP IPTp,WITHDRAWN,2010-10,"Intermittent Preventive Treatment, Placental Malaria",Sulfadoxine-pyrimethamine,Tororo - Uganda,2011-09,2010-08-19,2015-03-05,INTERVENTIONAL,PHASE4,"University of California, San Francisco",OTHER,malaria
NCT04969185,DRUMARS,COMPLETED,2021-08-16,"Malaria,Falciparum",No interventions listed,"Bobo-Dioulasso - Burkina Faso, Bobo-Dioulasso - Burkina Faso",2021-11-30,2021-07-20,2023-08-14,OBSERVATIONAL,Not Available,"University of California, San Francisco",OTHER,malaria
NCT00811356,Unknown,TERMINATED,2008-12-11,Malaria,GSK932121; Rosiglitazone; Rosuvastatin,Melbourne - Australia,2009-03-30,2008-12-19,2017-08-03,INTERVENTIONAL,PHASE1,GlaxoSmithKline,INDUSTRY,malaria
NCT05978037,Unknown,ACTIVE_NOT_RECRUITING,2023-08-18,"Malaria, Malaria,Falciparum, Parasitic Disease, Vector Borne Diseases, Infections",RH5.1 and/or RH5.2-VLP with Matrix-M,Oxford - United Kingdom,2026-01-10,2023-08-07,2024-11-06,INTERVENTIONAL,PHASE2,University of Oxford,OTHER,malaria
NCT00243737,Unknown,COMPLETED,2005-10,Malaria,Artesunate-Mefloquine,"Lambarene - Gabon, Libreville - Gabon",Unknown Date,2005-10-25,2013-01-24,INTERVENTIONAL,PHASE2,Albert Schweitzer Hospital,OTHER,malaria
NCT05044637,CHILDPRIM,COMPLETED,2021-08-26,"Malaria, Vivax","Primaquine, Primaquine, Primaquine","Cruzeiro Do Sul - Brazil, Manaus - Brazil",2024-07-29,2021-09-16,2025-02-20,INTERVENTIONAL,PHASE2,Fundação de Medicina Tropical Dr. Heitor Vieira Dourado,OTHER,malaria
NCT03960632,Unknown,UNKNOWN,2021-06,Malaria,Abbott SD Bioline Malaria Pf Plus (05FK150) and Abbott SD Bioline Malaria Pf/Pv Plus (05FK160)),No locations listed,2021-09,2019-05-23,2020-09-16,OBSERVATIONAL,Not Available,"Foundation for Innovative New Diagnostics, Switzerland",OTHER,malaria
NCT05905432,PamTBVac,NOT_YET_RECRUITING,2023-07-25,Malaria,Vaccine AnAPN1,Lambaréné - Gabon,2023-12-31,2023-06-15,2023-07-24,INTERVENTIONAL,PHASE1,Centre de Recherche Médicale de Lambaréné,OTHER,malaria
NCT03462615,Unknown,UNKNOWN,2018-04,"Plasmodium Falciparum Malaria, Pregnancy Malaria, Diagnoses Disease",HS-RDT,No locations listed,2018-10,2018-03-12,2018-03-12,OBSERVATIONAL,Not Available,"Foundation for Innovative New Diagnostics, Switzerland",OTHER,malaria
NCT06618885,SUM-101,NOT_YET_RECRUITING,2025-04-01,"Malaria,Falciparum",SUM-101,Ouagadougou - Burkina Faso,2025-10-31,2024-10-01,2024-10-01,INTERVENTIONAL,PHASE1,European Vaccine Initiative,OTHER,malaria
NCT01255215,Unknown,COMPLETED,2011-07,Severe Malaria,Inhaled Nitric Oxide,Jinja - Uganda,2013-07,2010-12-07,2014-02-20,INTERVENTIONAL,PHASE2,"University Health Network, Toronto",OTHER,malaria
NCT00157885,Unknown,COMPLETED,2005-07,"Malaria, Falciparum, Malaria, Vivax",Amodiaquine plus artesunate; Artekin,Timika - Indonesia,Unknown Date,2005-09-12,2006-06-26,INTERVENTIONAL,NA,Menzies School of Health Research,OTHER,malaria
NCT00870987,DNA-Ad,COMPLETED,2009-05,Malaria,"DNA vaccine prime, adenovirus type 5 vaccine boost",Silver Spring - United States,2014-04,2009-03-30,2021-02-11,INTERVENTIONAL,PHASE2,U.S. Army Medical Research and Development Command,FED,malaria
NCT00885287,InterACT,COMPLETED,2009-07,"Malaria, Falciparum, HIV Infections",Artemether-lumefantrine (AL),Muheza - Tanzania,2012-10,2009-04-21,2013-01-16,INTERVENTIONAL,PHASE4,University of Copenhagen,OTHER,malaria
NCT01002833,TIP1,COMPLETED,2010-04,"Plasmodium Falciparum, Malaria",Exposure to Plasmodium falciparum infected mosquitoes,Leiden - Netherlands,2010-11,2009-10-27,2010-11-09,INTERVENTIONAL,NA,Radboud University Medical Center,OTHER,malaria
NCT04546633,KALUMI,COMPLETED,2021-02-16,Uncomplicated Plasmodium Falciparum Malaria,"KAF156, LUM-SDF, Coartem","Banfora - Burkina Faso, Bobo Dioulasso - Burkina Faso, Ouagadougou - Burkina Faso, Sabou - Burkina Faso, Commune De La Kenya Lubumbashi - Congo, The Democratic Republic of the, Abidjan - Côte D'Ivoire, Lambarene - Gabon, Kati - Mali, Sotuba - Mali",2024-08-13,2020-09-14,2024-09-25,INTERVENTIONAL,PHASE2,Novartis Pharmaceuticals,INDUSTRY,malaria
NCT04858087,Unknown,COMPLETED,2015-03-24,"Malaria, Malaria,Falciparum, Anemia",Screening and treatment,No locations listed,2015-11-13,2021-04-26,2021-04-26,OBSERVATIONAL,Not Available,"University of Maryland, Baltimore",OTHER,malaria
NCT05958693,TES,COMPLETED,2015-01-05,"Malaria,Falciparum, Malaria Recrudescence","Artemether-lumefantrine, Primaquine",No locations listed,2015-12-30,2023-07-24,2023-07-24,OBSERVATIONAL,Not Available,"Research Institute for Tropical Medicine, Philippines",OTHER_GOV,malaria
NCT02504593,Unknown,COMPLETED,2015-07,Quality Assurance of Malaria Diagnosis,mHealth platform employing Fionet Deki Readers to ensure quality of community-based malaria diagnosis,Eldoret - Kenya,2016-04,2015-07-22,2016-05-25,INTERVENTIONAL,NA,Duke University,OTHER,malaria
NCT01218893,ZonMw1,COMPLETED,2011-04,Plasmodium Falciparum Malaria,"Chloroquine prophylaxis, Immunization, Plasmodium falciparum challenge, Malarone treatment",Leiden - Netherlands,2012-01,2010-10-11,2012-04-02,INTERVENTIONAL,NA,Radboud University Medical Center,OTHER,malaria
NCT05287893,Unknown,COMPLETED,2022-04-04,"Malaria,Falciparum, Malaria, Malaria Recrudescence, Parasitemia, Protozoan Infections, Parasitic Disease","Pyronaridine, P. falciparum IBSM infection","Brisbane - Australia, Brisbane - Australia",2022-09-26,2022-03-18,2022-11-04,INTERVENTIONAL,PHASE1,Medicines for Malaria Venture,OTHER,malaria
NCT00132561,Unknown,COMPLETED,2002-06,Malaria,Sulfadoxine/pyrimethamine and artesunate,Dakar - Senegal,Unknown Date,2005-08-22,2017-01-12,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT00341783,Unknown,TERMINATED,2002-07,Malaria,No interventions listed,Bethesda - United States,Unknown Date,2006-06-21,2009-01-07,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT00308061,Unknown,COMPLETED,2003-07,Malaria,"FMP1/AS02A, Imovax Rabies Vaccine",Bandiagara - Mali,2004-09,2006-03-28,2017-07-31,INTERVENTIONAL,PHASE1,U.S. Army Medical Research and Development Command,FED,malaria
NCT00454961,C3,COMPLETED,2007-04,Malaria,artemether-lumefantrine,Kibaha - Tanzania,Unknown Date,2007-04-02,2007-10-25,INTERVENTIONAL,PHASE4,Karolinska University Hospital,OTHER,malaria
NCT00701961,Unknown,COMPLETED,2008-10,Plasmodium Falciparum Malaria,Mefloquine-artesunate,Nanoro - Burkina Faso,2009-07,2008-06-19,2010-09-14,INTERVENTIONAL,PHASE3,"Institute of Tropical Medicine, Belgium",OTHER,malaria
NCT03375983,Unknown,RECRUITING,2017-11-23,Advanced Cancers,Blood-stage infection of P.vivax,Guangzhou - China,2023-03-31,2017-12-18,2024-02-20,INTERVENTIONAL,PHASE2,"CAS Lamvac Biotech Co., Ltd.",INDUSTRY,malaria
NCT00149383,Unknown,COMPLETED,2004-12,Falciparum Malaria,"Rosiglitazone, Placebo",Bangkok - Thailand,2005-11,2005-09-08,2015-04-13,INTERVENTIONAL,PHASE2,Mahidol University,OTHER,malaria
NCT04724161,Unknown,COMPLETED,2020-12-09,Malaria,ANC surveillance,Maputo - Mozambique,2022-09-30,2021-01-26,2022-12-12,OBSERVATIONAL,Not Available,PATH,OTHER,malaria
NCT04230161,Unknown,COMPLETED,2020-02-24,Malaria,"Standard long-lasting insecticidal net, Chlorfenapyr insecticide treated net, Indoor residual spraying",Kigali - Rwanda,2022-11-18,2020-01-18,2023-01-25,OBSERVATIONAL,Not Available,PATH,OTHER,malaria
NCT02672228,MalariaSense,COMPLETED,2015-10,Malaria,MalariaSense device,"Basse, Upper River Region - Gambia",2015-12,2016-02-03,2018-03-22,INTERVENTIONAL,NA,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT04250428,AIFASMaP,UNKNOWN,2020-02,Antenatal Care,"Demand intervention, Supply intervention",No locations listed,2021-05,2020-01-31,2020-02-05,INTERVENTIONAL,NA,Centre Suisse de Recherches Scientifiques en Cote d'Ivoire,OTHER,malaria
NCT04558528,Unknown,COMPLETED,2020-10-01,Malaria,Novel in vitro diagnostics and medical applications,"Jakarta - Indonesia, Kigali - Rwanda",2021-07-31,2020-09-22,2023-11-18,OBSERVATIONAL,Not Available,"Foundation for Innovative New Diagnostics, Switzerland",OTHER,malaria
NCT00375128,Unknown,COMPLETED,2006-09,"Malaria, Falciparum, Malaria","FP9-PP (FP9 polyprotein), MVA-PP (Modified Virus Ankara polyprotein)","London - United Kingdom, Oxford - United Kingdom",Unknown Date,2006-09-12,2007-10-19,INTERVENTIONAL,PHASE2,European Vaccine Initiative,OTHER,malaria
NCT02001428,Unknown,COMPLETED,2014-07-21,"Plasmodium Falciparum Malaria, Plasmodium Vivax Malaria",dihydroartemisinin-piperaquine,Timika - Indonesia,2016-03-31,2013-12-04,2018-08-02,INTERVENTIONAL,NA,Gadjah Mada University,OTHER,malaria
NCT06225297,Unknown,SUSPENDED,2024-01-19,Malaria,Intervention package,Touba - Senegal,2024-12-23,2024-01-25,2025-02-17,INTERVENTIONAL,PHASE4,PATH,OTHER,malaria
NCT01624961,Unknown,COMPLETED,2012-06,Malaria,PfSPZ Challenge,Tübingen - Germany,2012-10,2012-06-21,2016-04-04,INTERVENTIONAL,PHASE1,Sanaria Inc.,INDUSTRY,malaria
NCT00140361,Unknown,COMPLETED,2000-01,Malaria (Uncomplicated),"Sulfadoxine-pyrimethamine, sulfadoxine-pyrimethamine plus artesunate, lumefantrine plus artemether, Sleeping under insecticide-treated bednet","Ngere Ngere - Tanzania, Ikwiriri - Tanzania, Lupiro - Tanzania",2008-01,2005-09-01,2012-09-11,INTERVENTIONAL,PHASE4,Centers for Disease Control and Prevention,FED,malaria
NCT02364583,Unknown,UNKNOWN,2010-06,Plasmodium Vivax,Primaquine,Madang - Papua New Guinea,2016-06,2015-02-18,2015-10-14,INTERVENTIONAL,PHASE4,Papua New Guinea Institute of Medical Research,OTHER_GOV,malaria
NCT01546961,KCP,COMPLETED,2011-06,Vivax Malaria,Chloroquine,Tak - Thailand,2016-11,2012-03-07,2019-01-08,INTERVENTIONAL,NA,University of Oxford,OTHER,malaria
NCT01364883,Unknown,COMPLETED,2011-07,Malaria,"Vaccination Schedule One, Vaccination Schedule Two, Vaccination Schedule Three, Vaccination Schedule Four, Vaccination Schedule Five, Vaccination Schedule Six, Vaccination Schedule Seven",Oxford - United Kingdom,2013-07,2011-06-03,2013-07-29,INTERVENTIONAL,PHASE1,University of Oxford,OTHER,malaria
NCT00158561,Unknown,COMPLETED,2004-02,"Malaria, Vivax Malaria",sulfadoxine-pyrimethamine and chlorproguanil-dapsone,Peshawar - Pakistan,Unknown Date,2005-09-12,2017-01-12,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT04816461,SMC-RST,COMPLETED,2021-07-07,"Malaria, Malaria Prophylaxis, Mass Testing and Treatment","Amodiaquine Sulfadoxine-Pyrimethamin administration, Dihydroartemisinin-Piperaquine, Standard HRP2-RDT",Nanoro - Burkina Faso,2023-06-30,2021-03-25,2025-01-22,INTERVENTIONAL,PHASE4,"Institut de Recherche en Sciences de la Sante, Burkina Faso",OTHER_GOV,malaria
NCT05025761,Unknown,UNKNOWN,2022-01-01,Plasmodium Falciparum Infection,Personal protection package,No locations listed,2022-06,2021-08-27,2021-11-04,INTERVENTIONAL,NA,Macfarlane Burnet Institute for Medical Research and Public Health Ltd,OTHER,malaria
NCT01002183,JP015,WITHDRAWN,Unknown Date,Malaria,Fosmidomycin,Bangkok - Thailand,Unknown Date,2009-10-27,2011-09-27,INTERVENTIONAL,PHASE2,Jomaa Pharma GmbH,INDUSTRY,malaria
NCT06590597,Unknown,COMPLETED,2024-03-05,Malaria,EDUCATIONAL INTERVENTION FOR MALARIA PREVENTION,Monteria - Colombia,2024-05-20,2024-09-19,2024-09-19,INTERVENTIONAL,NA,Universidad de Antioquia,OTHER,malaria
NCT04695197,MALCOV,COMPLETED,2021-01-08,"Covid-19, Malaria","Artemether-lumefantrine (AL), Pyronaridine-artesunate (PA)","Ouagadougou - Burkina Faso, Kisumu - Kenya",2022-11-01,2021-01-05,2024-02-23,INTERVENTIONAL,PHASE3,Liverpool School of Tropical Medicine,OTHER,malaria
NCT01814683,Unknown,COMPLETED,2014-07,Uncomplicated Vivax Malaria,"Primaquine, Primaquine, Placebo","Jalalabad - Afghanistan, Laghman - Afghanistan, Metahāra - Ethiopia, Ārba Minch - Ethiopia, Bandar Lampung - Indonesia, Medan - Indonesia, Binh Phuoc - Vietnam, Krông Pa - Vietnam",2018-02-28,2013-03-20,2019-09-17,INTERVENTIONAL,NA,University of Oxford,OTHER,malaria
NCT02198807,FOSPIP,UNKNOWN,2014-03,Oral Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria,Fosmidomycin-Piperaquine,No locations listed,2014-07,2014-07-24,2015-06-15,INTERVENTIONAL,PHASE2,Jomaa Pharma GmbH,INDUSTRY,malaria
NCT02348788,PRIMAL,UNKNOWN,2015-01,Plasmodium Vivax Malaria Without Complication,"Artemether-lumefantrine + Primaquine, Chloroquine + Primaquine","Kota Marudu - Malaysia, Kudat - Malaysia, Pitas - Malaysia",2017-12,2015-01-28,2017-02-01,INTERVENTIONAL,PHASE3,Menzies School of Health Research,OTHER,malaria
NCT01906788,Unknown,UNKNOWN,2013-05,Malaria Transmission,"Artemether Lumefantrine, Artemether Lumefantrine 6 dose regimen & single dose of Primaquine on day 0, Artemether Lumefantrine 6 dose regimen and single dose Primaquine on day 2",Bagamoyo - Tanzania,2013-10,2013-07-24,2013-07-24,INTERVENTIONAL,PHASE4,Kilimanjaro Clinical Research Institute,OTHER,malaria
NCT06083688,Unknown,RECRUITING,2024-10-14,"Malaria,Falciparum, Anemia in Children","Dihydroartemisinin-Piperaquine, Chloroquine, Sulfadoxine-pyrimethamine-amodiaquine",Blantyre - Malawi,2025-07,2023-10-16,2024-10-18,INTERVENTIONAL,PHASE4,Liverpool School of Tropical Medicine,OTHER,malaria
NCT05380388,MIST3,NOT_YET_RECRUITING,2024-12-01,"Plasmodium Vivax Infection, Malaria Vaccine","Malaria Vaccine, HBV vaccine",Bangkok - Thailand,2025-12-30,2022-05-18,2024-05-09,INTERVENTIONAL,PHASE2,University of Oxford,OTHER,malaria
NCT00126971,Unknown,SUSPENDED,2005-07,Malaria,chlorproguanil-dapsone,Faladje - Mali,Unknown Date,2005-08-05,2006-08-15,INTERVENTIONAL,PHASE1,Centers for Disease Control and Prevention,FED,malaria
NCT03483571,Unknown,COMPLETED,2018-07-26,Malaria,No interventions listed,Yangon - Myanmar,2019-09-03,2018-03-30,2021-06-01,OBSERVATIONAL,Not Available,Duke University,OTHER,malaria
NCT05874271,SCOPE,RECRUITING,2023-07-10,"Vivax Malaria, G6PD Deficiency",Revised case management package,"Kokopo - Papua New Guinea, Wewak - Papua New Guinea, Vanimo - Papua New Guinea, Madang - Papua New Guinea",2025-05-31,2023-05-24,2023-07-11,INTERVENTIONAL,NA,Macfarlane Burnet Institute for Medical Research and Public Health Ltd,OTHER,malaria
NCT00497471,Unknown,TERMINATED,1995-02,"Malaria, Anemia","Deltaprim (3.125 mg pyrimethamine plus 25 mg dapsone), iron (2 mg/kg/daily)",Ifakara - Tanzania,Unknown Date,2007-07-06,2007-07-06,INTERVENTIONAL,NA,Hospital Clinic of Barcelona,OTHER,malaria
NCT05750628,PLATINUM,RECRUITING,2024-01-23,Uncomplicated Plasmodium Falciparum Malaria,"INE963, KAE609 (Cipargamin), SoC (Coartem), KLU156","Banfora - Burkina Faso, Nanoro - Burkina Faso, Abidjan - Côte D'Ivoire, Azaguie - Côte D'Ivoire, Lambarene - Gabon, Libreville - Gabon, Kintampo - Ghana, Navrango - Ghana, Ahero - Kenya, Kisumu - Kenya, Kampala - Uganda, Tororo - Uganda",2026-06-05,2023-03-02,2025-01-16,INTERVENTIONAL,PHASE2,Novartis Pharmaceuticals,INDUSTRY,malaria
NCT02118428,AIMS,COMPLETED,2014-03,Malaria,"Mirasol-treated Whole Blood, Untreated Whole Blood",Kumasi - Ghana,2014-12,2014-04-21,2019-05-10,INTERVENTIONAL,NA,Terumo BCTbio,INDUSTRY,malaria
NCT01862783,Unknown,TERMINATED,2013-02-10,Malaria,No interventions listed,Rakai District - Uganda,2015-10-19,2013-05-24,2019-11-25,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT05045547,CAM-VMW,UNKNOWN,2022-02-17,Febrile Illness,No interventions listed,Battambang - Cambodia,2023-12-31,2021-09-16,2023-04-07,OBSERVATIONAL,Not Available,University of Oxford,OTHER,malaria
NCT05689047,Unknown,COMPLETED,2023-03-29,Acute Malaria,"M5717 330 mg, M5717 500 mg, M5717 660 mg, Pyronaridine 360 mg, Pyronaridine 360 mg, Pyronaridine 540 mg, Pyronaridine 720 mg, Pyronaridine-artesunate (Pyramax) 360 mg/120 mg, Pyronaridine- artesunate (Pyramax) 540 mg/180 mg, Pyronaridine-artesunate (Pyramax) 720 mg/240 mg","Nanoro - Burkina Faso, Ouagadougou - Burkina Faso, Lambarene - Gabon, Maputo - Mozambique, Tororo - Uganda",2024-05-28,2023-01-18,2025-01-03,INTERVENTIONAL,PHASE2,"Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany",INDUSTRY,malaria
NCT01081847,Fase1B,COMPLETED,2005-07,"Malaria, Vivax","Peptides (N,R&C) formulated in Montanide ISA 720, Peptides (N,R&C) formulated in Montanide ISA 51, Peptides (N,R&C) formulated in Montanide ISA 720, Peptides (N,R&C) formulated in Montanide ISA 51, Placebo","Cali - Colombia, Cali - Colombia",2006-03,2010-03-05,2010-03-08,INTERVENTIONAL,PHASE1,Malaria Vaccine and Drug Development Center,OTHER,malaria
NCT01635647,Unknown,COMPLETED,2012-11,Malaria,"ChAd63 ME-TRAP and MVA ME-TRAP, Rabies vaccine",Ouagadougou - Burkina Faso,2014-08,2012-07-09,2016-02-15,INTERVENTIONAL,PHASE2,University of Oxford,OTHER,malaria
NCT00677833,Unknown,COMPLETED,2008-06,"Malaria, Falciparum","Azithromycin plus Chloroquine, Artemether-lumefantrine","Nouna - Burkina Faso, Ouagadougou 01 - Burkina Faso, Ouagadougou - Burkina Faso, Abidjan 13 - Côte D'Ivoire, Navrongo - Ghana, Kisumu - Kenya, Bamako - Mali, Sikasso - Mali",2010-09,2008-05-15,2014-06-26,INTERVENTIONAL,PHASE3,Pfizer,INDUSTRY,malaria
NCT00744133,Unknown,COMPLETED,2009-03,Plasmodium Falciparum Infection,NF54 P. falciparum isolate,Baltimore - United States,2010-12,2008-08-29,2014-08-08,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT05086887,MMS,UNKNOWN,2019-04-15,"Malaria, Parasitic Infection",Malaria diagnostic tests (RDT and PCR) and serology for malaria and other parasitic diseases,Stockholm - Sweden,2023-01-01,2021-10-21,2021-10-21,OBSERVATIONAL,Not Available,Region Stockholm,OTHER_GOV,malaria
NCT05829187,MCHUPF,COMPLETED,2022-11-01,Uncomplicated Plasmodium Falciparum,"Dihydroartemisinin, Piperaquine, Primaquine, Momordica Charantia Extract",Tambolaka - Indonesia,2022-12-31,2023-04-25,2023-05-16,INTERVENTIONAL,PHASE2,"Syamsudin Abdillah,Ph.D, Pharm D",OTHER,malaria
NCT04716387,Unknown,COMPLETED,2020-08-18,Malaria,"Standard LLIN, Piperonyl butoxide ITN, Pyriproxyfen ITN, Chlorfenapyr ITN",Maputo - Mozambique,2022-09-30,2021-01-20,2022-12-15,OBSERVATIONAL,Not Available,PATH,OTHER,malaria
NCT02013687,Unknown,COMPLETED,2013-10,Malaria,Pfs25 VLP- FhCMB,Rockville - United States,2014-08,2013-12-17,2017-03-08,INTERVENTIONAL,PHASE1,"Fraunhofer, Center for Molecular Biotechnology",INDUSTRY,malaria
NCT00757887,Unknown,COMPLETED,2009-10,P. Falciparum Malaria,Exposure to 5 P. falciparum infected mosquitoes,Nijmegen - Netherlands,2010-08,2008-09-23,2010-11-09,INTERVENTIONAL,NA,Radboud University Medical Center,OTHER,malaria
NCT01407887,Unknown,COMPLETED,2011-08,Uncomplicated Falciparum Malaria,artesunate (AS) - amodiaquine (AQ) - methylene blue (MB),Nouna - Burkina Faso,2011-08,2011-08-02,2012-12-05,INTERVENTIONAL,PHASE2,Heidelberg University,OTHER,malaria
NCT01697787,Unknown,COMPLETED,2012-10,Malaria,"Amodiaquine-Artesunate, Artemether-lumefantrine",Nanoro - Burkina Faso,2014-09,2012-10-02,2015-07-31,INTERVENTIONAL,PHASE4,Centre Muraz,OTHER,malaria
NCT01640587,RDM,TERMINATED,2013-11,P. Falciparum Malaria,"Mefloquine+Artesunate, Dihydroartemisinin-Piperaquine",Mae Sot - Thailand,2017-03,2012-07-13,2023-01-10,INTERVENTIONAL,NA,University of Oxford,OTHER,malaria
NCT05426187,PRIMVACLongT,ACTIVE_NOT_RECRUITING,2022-02-18,Malaria in Pregnancy,No interventions listed,Ouagadougou - Burkina Faso,2024-12-31,2022-06-21,2024-04-18,OBSERVATIONAL,Not Available,Groupe de Recherche Action en Sante,OTHER,malaria
NCT03083847,Unknown,COMPLETED,2017-06-05,Malaria,"Chloroquine Phosphate, Pyrimethamine, Sanaria PfSPZ Challenge",Bethesda - United States,2019-06-26,2017-03-20,2021-06-01,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT00374998,Unknown,COMPLETED,2006-04,"Malaria, Falciparum, Malaria","FP9-PP (FP9 polyprotein), MVA-PP (Modified Virus Ankara polyprotein)",Oxford - United Kingdom,Unknown Date,2006-09-12,2007-03-01,INTERVENTIONAL,PHASE1,European Vaccine Initiative,OTHER,malaria
NCT05676645,MILK Malaria,ACTIVE_NOT_RECRUITING,2023-03-20,"Malaria,Falciparum",Artemether-lumefantrine,Kampala - Uganda,2024-12-10,2023-01-09,2025-02-26,OBSERVATIONAL,Not Available,University of Liverpool,OTHER,malaria
NCT03648411,Unknown,COMPLETED,2019-01-12,"Drug Resistant Malaria, Asymptomatic Infections, Migrant Workers",Drug resistance molecular markers,Yangon - Myanmar,2019-12-30,2018-08-27,2020-07-22,OBSERVATIONAL,Not Available,"Department of Medical Research, Lower Myanmar",OTHER,malaria
NCT00902811,ACT,UNKNOWN,2008-12,Uncomplicated Falciparum Malaria,"AM(FDC), AM(LT), AL, DP, AA(FDC)","Sittwe - Myanmar, Kachin - Myanmar, Maungdaw - Myanmar, Shan - Myanmar",2009-10,2009-05-15,2009-05-15,INTERVENTIONAL,PHASE4,"Medecins Sans Frontieres, Netherlands",OTHER,malaria
NCT05796193,Unknown,ACTIVE_NOT_RECRUITING,2023-10-02,Malaria,"Alpha-cypermethrin and PBO LLIN, Alpha-cypermethrin and Clorfenapyr LLIN, Alpha-cypermethrin only LLIN",Bouaké - Côte D'Ivoire,2024-10,2023-04-03,2024-10-15,INTERVENTIONAL,NA,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT05304611,L9LS,COMPLETED,2022-03-18,"Plasmodium Falciparum Infection, Malaria","L9LS (VRC-MALMAB0114-00-AB) Subcutaneous injection, L9LS (VRC-MALMAB0114-00-AB) intravenous injection, Placebo","Kalifabougou - Mali, Torodo - Mali",2023-01-31,2022-03-31,2024-07-10,INTERVENTIONAL,PHASE2,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT01450293,Unknown,COMPLETED,2011-10,Malaria,"AdCh63 ME-TRAP, MVA ME-TRAP, AdCH63 ME-TRAP, MVA ME-TRAP",Banjul - Gambia,2013-03,2011-10-12,2013-12-12,INTERVENTIONAL,PHASE1,University of Oxford,OTHER,malaria
NCT06599593,INSPIRE,NOT_YET_RECRUITING,2025-06-01,"Malaria Incidence, Seasonal Malaria Chemoprevention, Nutrition Assessment, Acute Malnutrition in Childhood, Acute Malnutrition, Integrated Community-based Intervention Package","SQ-LNS, Integrated Nutritional Screening",Nouna - Burkina Faso,2025-11-01,2024-09-19,2024-09-19,INTERVENTIONAL,NA,"University of California, San Francisco",OTHER,malaria
NCT04300309,CALINA,TERMINATED,2020-12-21,Plasmodium Falciparum Malaria,artemether:lumefantrine (2.5 mg:30 mg),"Nanoro - Burkina Faso, Ouagadougou - Burkina Faso, Kisantu - Congo, The Democratic Republic of the",2023-07-02,2020-03-09,2024-11-12,INTERVENTIONAL,PHASE3,Novartis Pharmaceuticals,INDUSTRY,malaria
NCT04428307,Unknown,COMPLETED,2021-01-11,"Malaria, Febrile Illness","Conditional artemisinin combination therapy subsidy, Testing incentive",Eldoret - Kenya,2022-08-31,2020-06-11,2024-02-20,INTERVENTIONAL,NA,Duke University,OTHER,malaria
NCT00118807,Unknown,COMPLETED,2003-08,Malaria,"Amodiaquine plus artesunate (AQ/AS), Sulfadoxine-pyrimethamine plus chloroquine (SP/CQ), Sulfadoxine-pyrimethamine plus amodiaquine (SP/AQ)",Banjul - Gambia,Unknown Date,2005-07-12,2006-01-09,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT00988507,FARM,TERMINATED,2009-10,Plasmodium Falciparum Infection,"Ferroquine (SSR97193), Placebo, artesunate","Cotonou - Benin, Bobo-Dioulasso 01 - Burkina Faso, Nouna - Burkina Faso, Ouagadougou - Burkina Faso, Yaounde - Cameroon, B.P. 118 Lambarene - Gabon, Libreville - Gabon, Kilifi - Kenya, Kisumu - Kenya, Korogwe - Tanzania",2010-11,2009-10-02,2011-06-28,INTERVENTIONAL,PHASE2,Sanofi,INDUSTRY,malaria
NCT02572388,Unknown,COMPLETED,2015-10-15,Malaria,"R21, Matrix-M1","Oxford - United Kingdom, London - United Kingdom",2017-08-29,2015-10-08,2019-11-12,INTERVENTIONAL,PHASE1,University of Oxford,OTHER,malaria
NCT06806956,SEMA ReACT,ENROLLING_BY_INVITATION,2024-03-10,Severe Malaria,Treatment of severe malaria with rectal artesunate + Artemisinin based Combination Therapy is not inferior to rectal artesunate + injectable artesunate + ACT in terms of effectiveness in remote areas,"Kinshasa - Congo, The Democratic Republic of the, Ndola - Zambia",2027-03,2025-02-04,2025-02-04,OBSERVATIONAL,Not Available,"Tropical Diseases Research Centre, Zambia",OTHER_GOV,malaria
NCT02627456,Unknown,COMPLETED,2015-12-09,Malaria,"PfSPZ Vaccine, PfSPZ Challenge Material, PBS and HSA Diluent, Normal Saline, Coartem, ASAQ",Bamako - Mali,2018-03-31,2015-12-11,2021-04-21,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT02914145,MDAM,COMPLETED,2015-11,Malaria,Dihydroartemisinin-piperaquine,No locations listed,2017-12,2016-09-26,2018-02-06,INTERVENTIONAL,NA,Centro de Investigacao em Saude de Manhica,OTHER,malaria
NCT01075945,Unknown,UNKNOWN,2010-02,Malaria,"Dihydroartemisinin- piperaquine, artemether- lumefantrine",Cinnar - Sudan,2010-04,2010-02-25,2010-02-25,INTERVENTIONAL,PHASE4,University of Khartoum,OTHER,malaria
NCT03384498,Unknown,UNKNOWN,2016-10,Plasmodium Falciparum and Plasmodium Vivax,No interventions listed,"Phnom Penh - Cambodia, Vientiane - Lao People's Democratic Republic, Qui Nhon - Vietnam",2023-01-31,2017-12-27,2022-03-23,OBSERVATIONAL,Not Available,University of Oxford,OTHER,malaria
NCT04416945,COMBAT,UNKNOWN,2020-09-20,"Plasmodium Falciparum Malaria, Plasmodium Vivax Malaria","Household Reactive Case Detection, RACD of cases' co-workers/co-travelers, Case Management and Follow-up",Vientiane - Lao People's Democratic Republic,2021-09-30,2020-06-04,2021-09-16,INTERVENTIONAL,NA,"University of California, San Francisco",OTHER,malaria
NCT05252845,R21/Matrix-M,COMPLETED,2023-01-04,"Malaria,Falciparum","R21/Matrix-M vaccination, DHA-PIP, PQ",Bangkok - Thailand,2023-06-08,2022-02-23,2023-10-27,INTERVENTIONAL,PHASE2,University of Oxford,OTHER,malaria
NCT04238845,SMC-NUT,UNKNOWN,2020-07-13,"Malaria, Malnutrition, Child","AQSP Administration, Supplementation with Plumpy'Doz, Supplementation with Vitamin A, Supplementation with Zinc",Ouagadougou - Burkina Faso,2021-07-04,2020-01-23,2022-03-08,INTERVENTIONAL,NA,"Institut de Recherche en Sciences de la Sante, Burkina Faso",OTHER_GOV,malaria
NCT02612545,Unknown,COMPLETED,2015-11-20,Acute Falciparum Malaria,"Dihydroartemisinin-piperaquine (DHA-PPQ), Mefloquine (MQ)",Phnom Penh - Cambodia,2018-10-12,2015-11-24,2019-10-10,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT01365598,Unknown,COMPLETED,2011-12,Falciparum Malaria,Primaquine,Jinja - Uganda,2013-03,2011-06-03,2013-06-12,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT01120145,Unknown,COMPLETED,2010-03,Malaria in Pregnancy,No interventions listed,Liwonde - Malawi,2011-01,2010-05-10,2013-02-06,OBSERVATIONAL,Not Available,Centers for Disease Control and Prevention,FED,malaria
NCT01634945,Unknown,COMPLETED,2012-04,Anemia,"SP/amodiaquine, FeFum fortified porridge, SP/Amodiaquine + FeFum fortified porridge, Ferric pyrophosphate fortified porridge, Placebo",Taabo Cite - Côte D'Ivoire,2013-05,2012-07-06,2013-09-24,INTERVENTIONAL,NA,Swiss Federal Institute of Technology,OTHER,malaria
NCT01204411,Unknown,WITHDRAWN,Unknown Date,"Malaria, Falciparum, Malnutrition, Child",Artesunate-amodiaquine fixed-dose combination,Madaoua - Niger,Unknown Date,2010-09-17,2012-11-30,INTERVENTIONAL,PHASE4,Epicentre,OTHER,malaria
NCT03726593,APACT,UNKNOWN,2018-10-04,Plasmodium Falciparum Malaria (Drug Resistant),"Artesunate and Pyronaridine, Atovaquone Proguanil and Artesunate Pyronaridine, Atovaquone Proguanil and Artesunate Mefloquine","Kratie - Cambodia, Stung Treng - Cambodia, Ânlóng Vêng - Cambodia",2022-08-30,2018-10-31,2021-03-02,INTERVENTIONAL,PHASE4,"Armed Forces Research Institute of Medical Sciences, Thailand",OTHER_GOV,malaria
NCT02637128,Unknown,COMPLETED,2014-03,"MALARIA, FALCIPARUM","artemether-lumefantrine (AL), artesunate-amodiaquine (ASAQ)",Blantyre - Malawi,2014-07,2015-12-22,2015-12-22,INTERVENTIONAL,PHASE4,Centers for Disease Control and Prevention,FED,malaria
NCT05911828,ZYFER-1,RECRUITING,2024-08-30,"Uncomplicated Malaria, Asymptomatic Condition, Falciparum Malaria","ZY19489 + Ferroquine (FQ), Placebo",Lambaréné - Gabon,2025-02-01,2023-06-22,2024-10-01,INTERVENTIONAL,PHASE1,Zydus Lifesciences Limited,INDUSTRY,malaria
NCT03882528,Unknown,COMPLETED,2019-03-04,"Malaria,Falciparum",Plasmodium falciparum malaria parasite,Silver Spring - United States,2019-04-25,2019-03-20,2021-03-30,INTERVENTIONAL,PHASE1,U.S. Army Medical Research and Development Command,FED,malaria
NCT02213211,Unknown,COMPLETED,2014-04,Malaria,Artemether lumefantrine,Blantyre - Malawi,2015-03,2014-08-11,2017-01-04,INTERVENTIONAL,NA,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT00197028,Unknown,COMPLETED,2005-08-23,Malaria,"RTS,S/AS02D, TETRActHib™, Engerix-B®",Maputo - Mozambique,2007-12-27,2005-09-20,2018-08-20,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,malaria
NCT01074905,VHX,COMPLETED,2010-05,Vivax Malaria,"Artesunate, Chloroquine, Chloroquine/Primaquine",Mae Sot - Thailand,2012-10,2010-02-24,2013-08-28,INTERVENTIONAL,PHASE3,University of Oxford,OTHER,malaria
NCT05060198,Unknown,COMPLETED,2016-06-17,"Malaria,Falciparum","Artemether-lumefantrine (AL), Dihydroartemisinin-piperaquine (DP)",No locations listed,2017-03-13,2021-09-29,2021-09-29,INTERVENTIONAL,NA,Kenya Medical Research Institute,OTHER,malaria
NCT02653898,Unknown,UNKNOWN,2016-01,"Malaria, Parasitic Diseases","DHA-PIP, Primaquine, Artesunate + Mefloquine, Permethrin (Insecticide treated uniform)",Anlong Veng - Cambodia,2016-08,2016-01-13,2021-03-02,INTERVENTIONAL,PHASE4,"Armed Forces Research Institute of Medical Sciences, Thailand",OTHER_GOV,malaria
NCT02044198,Unknown,COMPLETED,2014-03,Plasmodium Falciparum Malaria,FMP2.1/AS01B,"Southampton - United Kingdom, Oxford - United Kingdom, London - United Kingdom",2014-12,2014-01-23,2015-01-09,INTERVENTIONAL,PHASE2,University of Oxford,OTHER,malaria
NCT02394197,EMTM,COMPLETED,2008-02,Malaria,"Chloroquine phosphate, primaquine",No locations listed,2010-09,2015-03-20,2015-03-20,INTERVENTIONAL,PHASE4,LILIA GONZALEZ CERON,OTHER,malaria
NCT01082705,Unknown,COMPLETED,2010-04,P. Falciparum Malaria,"artemether-lumefantrine, Dihydroartemisinin-piperaquine",Bagamoyo - Tanzania,2011-06,2010-03-09,2012-01-31,INTERVENTIONAL,PHASE3,Centers for Disease Control and Prevention,FED,malaria
NCT00356005,Unknown,COMPLETED,2006-08,Uncomplicated Falciparum Malaria,"azithromycin plus artesunate, Artesunate",Bandarban - Bangladesh,2007-08,2006-07-25,2012-11-01,INTERVENTIONAL,PHASE2,Medical University of Vienna,OTHER,malaria
NCT04241705,Unknown,UNKNOWN,2020-01-20,Malaria,"Treatment of positive individuals per national treatment guidelines, Presumptive treatment with artemether-lumefantrine (AL) plus 14 days of primaquine (PQ), Optimized malaria control interventions","Alemaya - Ethiopia, Babile - Ethiopia, Fedis - Ethiopia, Girawa - Ethiopia, Golo oda - Ethiopia, Gursum - Ethiopia, Kersa - Ethiopia, Kombolcha - Ethiopia, Kurfa chele - Ethiopia, Midega Tola - Ethiopia",2022-01-20,2020-01-27,2020-06-12,INTERVENTIONAL,NA,"Armauer Hansen Research Institute, Ethiopia",OTHER,malaria
NCT01902797,Unknown,COMPLETED,2013-07,Malaria,Questionnaire,Mae Sot - Thailand,2013-12,2013-07-18,2016-04-28,INTERVENTIONAL,NA,University of Oxford,OTHER,malaria
NCT01157897,Unknown,COMPLETED,2010-07,"Malaria, Plasmodium Vivax","VMP001, P. vivax sporozoite challenge",Silver Spring - United States,2012-01,2010-07-07,2019-05-29,INTERVENTIONAL,PHASE2,U.S. Army Medical Research and Development Command,FED,malaria
NCT04545905,Unknown,COMPLETED,2020-09-22,Malaria,ANC surveillance,Ouagadougou - Burkina Faso,2022-07-31,2020-09-11,2022-12-12,OBSERVATIONAL,Not Available,PATH,OTHER,malaria
NCT04844905,MATAMAL,UNKNOWN,2021-05-03,"Malaria,Falciparum, Neglected Tropical Diseases, Strongyloidiasis, Lymphatic Filariasis, Scabies, Hook Worm, Soil Transmitted Helminths","Ivermectin, Placebo, Dihydroartemisinin-piperaquine",Bissau - Guinea-Bissau,2023-03,2021-04-14,2022-02-24,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT01255605,Unknown,COMPLETED,2010-09,"Malaria, Pregnancy",No interventions listed,Bobo-Dioulasso - Burkina Faso,Unknown Date,2010-12-07,2012-06-18,OBSERVATIONAL,Not Available,Université Polytechnique de Bobo-Dioulasso,OTHER,malaria
NCT03035305,Unknown,COMPLETED,2016-08,Malaria,"Lipid-based Nutrient Supplement (LNS), Seasonal malaria chemoprevention",Kolokani Circle - Mali,2016-11,2017-01-30,2017-01-30,INTERVENTIONAL,NA,Alliance for International Medical Action,OTHER,malaria
NCT05958797,TES,COMPLETED,2016-01-04,"Malaria, Vivax Malaria, Recrudescence","Chloroquine, Primaquine",No locations listed,2016-12-29,2023-07-25,2023-07-25,OBSERVATIONAL,Not Available,"Research Institute for Tropical Medicine, Philippines",OTHER_GOV,malaria
NCT01556945,MAL019,COMPLETED,2001-04,"Malaria, Falciparum","FMP1/AS02, RTS,S/AS02, AS02 adjuvant alone, Malaria challenge",Silver Spring - United States,2002-02,2012-03-19,2014-05-02,INTERVENTIONAL,PHASE2,U.S. Army Medical Research and Development Command,FED,malaria
NCT01107145,PAACT-PV,TERMINATED,2011-02,Plasmodium Vivax Malaria,"Mefloquine- Artesunate, Artemether-Lumefantrine, Chloroquine","Cruzeiro do Sul - Brazil, Anajas - Brazil, Porto Velho - Brazil",2012-01,2010-04-20,2012-04-13,INTERVENTIONAL,PHASE4,Centers for Disease Control and Prevention,FED,malaria
NCT01449045,Unknown,COMPLETED,2011-07,Malaria,"IPTc+CCM, Community Case Management with artemether-lumefantrine (AL)",Dakar - Senegal,2011-12,2011-10-07,2012-04-26,INTERVENTIONAL,PHASE3,"Cheikh Anta Diop University, Senegal",OTHER,malaria
NCT00119145,Unknown,COMPLETED,2005-06,Malaria,"artesunate-amodiaquine, coartem, artesunate-lapdap",Kintampo - Ghana,Unknown Date,2005-07-13,2017-01-12,INTERVENTIONAL,PHASE4,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT02927145,Unknown,COMPLETED,2016-10-17,Malaria,RH5.1/ ASO1,"London - United Kingdom, Southampton - United Kingdom",2019-06-27,2016-10-06,2022-02-18,INTERVENTIONAL,PHASE2,University of Oxford,OTHER,malaria
NCT06166498,Unknown,COMPLETED,2024-07-24,Malaria,"SP (Macleods Pharmaceuticals Ltd), AS (Guilin Pharmaceuticals)",Nchelenge - Zambia,2024-12-19,2023-12-12,2025-03-12,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT04412005,MiPMon,COMPLETED,2016-11-01,P. Falciparum,No intervention,No locations listed,2019-10-31,2020-06-02,2020-06-09,OBSERVATIONAL,Not Available,Barcelona Institute for Global Health,OTHER,malaria
NCT00343005,Unknown,COMPLETED,2004-04-23,Plasmodium Falciparum Malaria,"AMA1-C1, AMA1-C1/alhydrogel Malaria Vaccine",Bamako - Mali,Unknown Date,2006-06-21,2017-07-02,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT00374205,Unknown,TERMINATED,2006-09,"Malaria, Falciparum","Artesunate plus Amodiaquine, Artemether-Lumefantrine",Agogo - Ghana,Unknown Date,2006-09-11,2007-11-27,INTERVENTIONAL,PHASE4,Bernhard Nocht Institute for Tropical Medicine,OTHER_GOV,malaria
NCT05801198,Unknown,NOT_YET_RECRUITING,2024-03-01,"Malaria,Falciparum",Artemisia afra or Annua 10g oral infusion/tea per day for 14 days,No locations listed,2026-04-30,2023-04-06,2023-10-17,INTERVENTIONAL,PHASE2,King Faisal Hospital Rwanda,OTHER,malaria
NCT02297477,ASAP,UNKNOWN,2014-12,Malaria,"atovaquone-proguanil, artesunate-atovaquone-proguanil",Anlong Veng - Cambodia,2015-12,2014-11-21,2021-03-02,INTERVENTIONAL,PHASE4,"Armed Forces Research Institute of Medical Sciences, Thailand",OTHER_GOV,malaria
NCT04370977,MEFI_III,COMPLETED,2018-03-21,Malaria,"Coartem™ (Artemether-lumefantrine combination), Winthrop™ (Amodiaquine-artesunate combination)","Montepuez - Mozambique, Massinga - Mozambique, Manhiça - Mozambique, Manhiça - Mozambique, Moatize - Mozambique, Mopeia - Mozambique",2018-09-29,2020-05-01,2020-05-01,INTERVENTIONAL,PHASE4,Centro de Investigacao em Saude de Manhica,OTHER,malaria
NCT01169077,Unknown,COMPLETED,2010-08,Plasmodium Falciparum Malaria,"Placebo, EP-1300",Atlanta - United States,2012-07,2010-07-23,2012-11-16,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT03707353,Unknown,COMPLETED,2018-10-30,Malaria,ChAd63 ME-TRAP and MVA ME-TRAP vaccination,"London - United Kingdom, Oxford - United Kingdom, Oxford - United Kingdom, Southampton - United Kingdom",2019-06-10,2018-10-16,2019-09-26,INTERVENTIONAL,PHASE2,University of Oxford,OTHER,malaria
NCT00137553,Unknown,COMPLETED,2001-05,"Malaria, Falciparum",Sulfadoxine-pyrimethamine (Fansidar),Apartado 861 - Guinea-Bissau,Unknown Date,2005-08-30,2010-03-16,INTERVENTIONAL,PHASE4,Bandim Health Project,OTHER,malaria
NCT00367653,Unknown,COMPLETED,2006-11,Malaria,"Azithromycin plus Chloroquine, Mefloquine","Ouagadougou - Burkina Faso, Nouna - Burkina Faso, Navrongo - Ghana, Kisumu - Kenya, Bamako - Mali, Bamako - Mali, Senegal - Senegal, Ndola - Zambia",2007-09,2006-08-23,2008-09-16,INTERVENTIONAL,PHASE3,Pfizer,INDUSTRY,malaria
NCT02942277,Unknown,COMPLETED,2016-10-21,Malaria,"Pfs25M-EPA, Pfs230D1M-EPA, AS01, Engerix-B, Menactra, Normal Saline, Coartem",Bamako - Mali,2020-07-15,2016-10-24,2024-12-10,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT06862453,LARC-Tu,NOT_YET_RECRUITING,2025-07-30,Malaria Falciparum,"Normal Saline (Placebo), PfSPZ-LARC2 Vaccine, PfSPZ Challenge (NF54)",Wilhelmstraße 27 - Germany,2026-01-30,2025-03-06,2025-03-06,INTERVENTIONAL,PHASE1,Sanaria Inc.,INDUSTRY,malaria
NCT05340153,Unknown,UNKNOWN,2022-04-11,Malaria,"Artemether-Lumefantrine Drug Combination, Dihydroartemisinin-Piperaquine drug combination",No locations listed,2022-12-31,2022-04-22,2022-04-22,INTERVENTIONAL,PHASE4,University of Yaounde 1,OTHER,malaria
NCT01163877,Unknown,COMPLETED,2010-04,"Malaria, Falciparum, Hookworm Infections, Schistosoma Haematobium","Fe-57 orally, Fe-58 intravenously",Taabo - Côte D'Ivoire,2013-09,2010-07-16,2013-10-14,INTERVENTIONAL,NA,Swiss Federal Institute of Technology,OTHER,malaria
NCT02206451,Unknown,COMPLETED,2014-07-16,Malaria,No interventions listed,Bamako - Mali,2014-07-16,2014-08-01,2019-12-17,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT02758353,MIPP-NG,COMPLETED,2015-04,"Malaria, Stillbirths",Community distribution of SP,No locations listed,2015-11,2016-05-02,2016-05-02,INTERVENTIONAL,NA,"JSI Research & Training Institute, Inc.",OTHER,malaria
NCT01603251,ACTIVE,COMPLETED,2013-01,Malaria,"Artemether-lumefantrine combination, Artemether-lumefantrine combination + single dose Ivermectin, Artemether-lumefantrine combination + repeated dose Ivermectin",Ouagadougou - Burkina Faso,2013-04,2012-05-22,2013-04-18,INTERVENTIONAL,PHASE2,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT00465777,MTV,COMPLETED,2004-12,"Mortality, Malaria",Guideline adherence and financial incentive,Bissau - Guinea-Bissau,Unknown Date,2007-04-25,2007-04-25,INTERVENTIONAL,NA,Bandim Health Project,OTHER,malaria
NCT00857077,Unknown,COMPLETED,2000-09,"Anaemia, Malaria","Sulfadoxine-pyrimethamine, Placebo",Navrongo - Ghana,Unknown Date,2009-03-06,2017-01-26,INTERVENTIONAL,NA,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT02658253,PRIMALVAC,COMPLETED,2016-01,Malaria,"PRIMVAC, GLA-SE, Alhydrogel, Placebo","Ouagadougou - Burkina Faso, Paris - France",2018-09-19,2016-01-18,2025-02-28,INTERVENTIONAL,PHASE1,"Institut National de la Santé Et de la Recherche Médicale, France",OTHER_GOV,malaria
NCT00725777,Unknown,COMPLETED,2008-07,Acute Non-falciparum Malaria,artemether-lumefantrine,Lambaréné - Gabon,2011-12,2008-07-30,2012-02-17,INTERVENTIONAL,NA,Albert Schweitzer Hospital,OTHER,malaria
NCT02163447,PROMOTE-BC1,COMPLETED,2014-06-23,Malaria,"Monthly dihydroartemisinin-piperaquine (DP) for adult women during pregnancy, 3 dose dihydroartemisinin-piperaquine (DP) for adult women during pregnancy, 3 dose sulfadoxine-pyrimethamine (SP) for adult women during pregnancy, Monthly dihydroartemisinin-piperaquine (DP) for infants, 3-monthly dihydroartemisinin-piperaquine (DP) for infants",Tororo - Uganda,2018-05-14,2014-06-13,2024-12-18,INTERVENTIONAL,PHASE3,"Grant Dorsey, M.D, Ph.D.",OTHER,malaria
NCT04672577,ITIT,NOT_YET_RECRUITING,2021-01-30,"Travel-Related Illness, Malaria, Dengue, Chikungunya, Zika, SARS-CoV Infection, MERS, Influenza, Diarrhea",Observational study,Zürich - Switzerland,2024-12-31,2020-12-17,2020-12-17,OBSERVATIONAL,Not Available,Patricia Schlagenhauf,OTHER,malaria
NCT04020653,Unknown,WITHDRAWN,2019-09-06,Malaria,"5-aminolevulinic acid hydrochloride (5-ALA HCl) 600 mg QD, Sodium ferrous citrate (SFC) 472 mg QD, Artemisinin-based combination (ACT), Placebo, 5-aminolevulinic acid hydrochloride (5-ALA HCl) 300 mg BID, Sodium ferrous citrate (SFC) 236 mg BID",No locations listed,2020-05-31,2019-07-16,2020-03-03,INTERVENTIONAL,PHASE2,"Neopharma Japan Co., Ltd.",INDUSTRY,malaria
NCT00217451,Unknown,COMPLETED,2002-06,Malaria,Fosmidomycin-clindamycin,Lambaréné - Gabon,Unknown Date,2005-09-22,2005-09-22,INTERVENTIONAL,PHASE2,Albert Schweitzer Hospital,OTHER,malaria
NCT06337253,Unknown,NOT_YET_RECRUITING,2024-03-26,"Malaria,Falciparum, Chemoprevention",Sulfadoxine/pyrimethamine plus amodiaquine,No locations listed,2024-05-26,2024-03-29,2024-03-29,INTERVENTIONAL,PHASE4,Malaria Consortium,OTHER,malaria
NCT03217851,Unknown,COMPLETED,2017-09-18,Malaria,"Blood Collection, Dried Blood Spot",Mae Sot - Thailand,2021-12-24,2017-07-14,2022-06-28,OBSERVATIONAL,Not Available,University of Oxford,OTHER,malaria
NCT04783051,ULTRAPYRAPREG,COMPLETED,2021-05-06,Malaria in Pregnancy,"Sulfadoxine pyrimethamine, Pyramax","Kinshasa - Congo, The Democratic Republic of the",2022-06-22,2021-03-04,2022-11-04,INTERVENTIONAL,PHASE3,University of Kinshasa,OTHER,malaria
NCT02511353,IVERMAL,COMPLETED,2015-07,Malaria,"ivermectin, placebo, dihydroartemisinin-piperaquine",Kisumu - Kenya,2016-07,2015-07-30,2018-08-23,INTERVENTIONAL,PHASE2,Liverpool School of Tropical Medicine,OTHER,malaria
NCT00469651,MSP3TN,UNKNOWN,2007-10,Malaria,"MSP 3 Long Synthetic Peptide, MSP3 vaccine, Hepatitis B vaccine, MSP3 candidate vaccine, Hepatitis B control vaccine",Korogwe - Tanzania,Unknown Date,2007-05-04,2007-12-14,INTERVENTIONAL,PHASE1,African Malaria Network Trust,NETWORK,malaria
NCT03420053,Unknown,COMPLETED,2018-02-07,"Malaria, Malaria,Falciparum","PfSPZ Vaccine, Normal Saline Placebo, PfSPZ Challenge",Bagamoyo - Tanzania,2018-08-25,2018-02-05,2019-04-05,INTERVENTIONAL,PHASE1,Sanaria Inc.,INDUSTRY,malaria
NCT01397851,Outgrowers,COMPLETED,2010-12,Malaria,Insecticide-treated net (BASF Incerceptor),Lusaka - Zambia,2011-12,2011-07-20,2023-12-15,INTERVENTIONAL,NA,PATH,OTHER,malaria
NCT05197751,MSP3CRMV4All,UNKNOWN,2021-12-01,"Malaria,Falciparum",MSP3-CRM-Vac4All/ Alhydrogel®,Bamako - Mali,2022-08-03,2022-01-19,2023-02-28,INTERVENTIONAL,PHASE1,Vac4All,INDUSTRY,malaria
NCT00808951,Unknown,COMPLETED,2008-12,Malaria,"Artesunate-amodiaquine, Artemether-lumefantrine",Bobo-Dioulasso - Burkina Faso,2010-10,2008-12-16,2015-08-03,INTERVENTIONAL,PHASE4,Centre Muraz,OTHER,malaria
NCT04494854,PREPAP,COMPLETED,2020-09-01,"Malaria, Disease, Infectious, Travel-Associated Infections",No interventions listed,Villeneuve-Saint-Georges - France,2020-10-01,2020-07-31,2023-06-07,OBSERVATIONAL,Not Available,Centre Hospitalier Intercommunal Creteil,OTHER,malaria
NCT05244954,Unknown,COMPLETED,2022-02-01,"Malaria,Falciparum, Anemia in Children","Dihydroartemisinin-Piperaquine, Chloroquine",Blantyre - Malawi,2022-08-26,2022-02-17,2022-11-15,INTERVENTIONAL,PHASE4,"University of Maryland, Baltimore",OTHER,malaria
NCT01627951,TIP3,COMPLETED,2012-08,Malaria,"NF54, NF135, NF166","Nijmegen - Netherlands, Rotterdam - Netherlands",2012-10,2012-06-26,2012-11-27,INTERVENTIONAL,NA,Radboud University Medical Center,OTHER,malaria
NCT02511054,Unknown,COMPLETED,2015-07-21,Malaria,"Chloroquine (CQ), Pyrimethamine (PYR), Sanaria PfSPZ Challenge (NF54)",Bethesda - United States,2016-10-21,2015-07-29,2017-07-02,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT00509015,MDATRANS,COMPLETED,2008-02,"Malaria, Falciparum","Sulphadoxine-pyrimethamine (day 1: 500mg S&25mg P/20 kg), Artesunate (day 1,2,3: 4 mg/kg), Primaquine-base (day 3: 0.75 mg/kg), placebo tablets",Moshi - Tanzania,2008-08,2007-07-31,2008-08-13,INTERVENTIONAL,NA,Radboud University Medical Center,OTHER,malaria
NCT05058885,VIBRANT,RECRUITING,2022-05-02,"Malaria, Vivax, Malaria,Falciparum, Malaria",No interventions listed,Dschang - Cameroon,2024-06-30,2021-09-28,2023-04-13,OBSERVATIONAL,Not Available,University of Dschang,OTHER,malaria
NCT00941785,Unknown,COMPLETED,2009-07,Malaria,"DHA-PQ, SP-AQ",Bobo-Dioulasso - Burkina Faso,2009-12,2009-07-20,2011-03-21,INTERVENTIONAL,PHASE3,London School of Hygiene and Tropical Medicine,OTHER,malaria
NCT06044805,CQ+PQ,COMPLETED,2022-12-19,"Efficacy, Malaria, Chloroquine, Vivax Malaria","Chloroquine, Primaquine",Arba Minch - Ethiopia,2023-03-13,2023-09-21,2023-09-22,INTERVENTIONAL,PHASE4,Dinka Dugassa,OTHER,malaria
NCT02527005,Unknown,COMPLETED,2015-09,"Malaria, Pregnant, HIV","Sulphadoxine-pyrimethamine, Azithromycin",Ibadan - Nigeria,2016-08,2015-08-18,2017-12-11,INTERVENTIONAL,PHASE1,University of Ibadan,OTHER,malaria
NCT00612547,Unknown,COMPLETED,2008-02,"Fever, Suspected Malaria",Artesunate + Amodiaquine Fixed Dose Combination (CoArsucam),Paris - France,2009-02,2008-02-11,2009-02-26,OBSERVATIONAL,Not Available,"National Malaria Control Programme, Madagascar",OTHER_GOV,malaria
NCT03334747,Unknown,COMPLETED,2017-11-16,Malaria,"KAE609, Coartem","Lambarene - Gabon, Kintampo - Ghana, Navrango - Ghana, Bamako - Mali, Sotuba - Mali, Kigali - Rwanda, Bushenyi - Uganda, Kampala - Uganda, Tororo - Uganda",2019-11-23,2017-11-07,2021-10-11,INTERVENTIONAL,PHASE2,Novartis Pharmaceuticals,INDUSTRY,malaria
NCT00133393,Unknown,TERMINATED,2002-01,Plasmodium Falciparum Malaria,Pentoxifylline,Kilifi - Kenya,Unknown Date,2005-08-23,2010-08-27,INTERVENTIONAL,PHASE2,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT01585077,ChallengeIII,COMPLETED,2012-10,Malaria,P. vivax infected mosquito bites,Cali - Colombia,2013-06,2012-04-25,2014-01-15,INTERVENTIONAL,PHASE2,Socrates Herrera Valencia,OTHER,malaria
NCT04251351,PROTECtS,RECRUITING,2021-12-13,"Severe Malaria, Malaria,Falciparum, Acute Kidney Injury, Paracetamol","Paracetamol, Mechanical antipyresis","Kinshasa - Congo, The Democratic Republic of the",2024-06-01,2020-01-31,2023-06-13,INTERVENTIONAL,PHASE3,University of British Columbia,OTHER,malaria
NCT00385047,Unknown,COMPLETED,2006-09,Malaria,"Group A FMP2.1/AS01B, Group B FMP2.1/AS02A",Silver Spring - United States,2007-04,2006-10-06,2015-06-08,INTERVENTIONAL,PHASE2,U.S. Army Medical Research and Development Command,FED,malaria
NCT00299247,Unknown,WITHDRAWN,Unknown Date,Plasmodium Falciparum Malaria,sulfadoxine/pyrimethamine,"Cali - Colombia, Cali - Colombia",2006-12,2006-03-06,2019-01-30,INTERVENTIONAL,PHASE3,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT02696928,BlueAL,WITHDRAWN,2016-04,Vivax Malaria,"Artemeter-Lumefantrine and MB (combination therapy), Artemeter-Lumefantrine (combination therapy), Artemeter-Lumefantrine and Primaquine (combination therapy)",No locations listed,2017-10,2016-03-02,2020-03-25,INTERVENTIONAL,PHASE2,Heidelberg University,OTHER,malaria
NCT03168854,Unknown,COMPLETED,2017-07-26,Plasmodium Falciparum Infection,"Genetically-attenuated p52-/p36-/sap1- Plasmodium falciparum parasite (GAP3KO) strain, Malaria challenge",Seattle - United States,2019-08-16,2017-05-30,2025-02-24,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT02780154,Unknown,COMPLETED,2016-08-25,Plasmodium Falciparum Infection,"PfSPZ (7G8) Challenge, PfSPZ (NF54) Challenge",Baltimore - United States,2016-12-15,2016-05-23,2019-01-28,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT03967054,RIMDAMAL II,ACTIVE_NOT_RECRUITING,2019-07-13,Malaria,"Ivermectin, Placebo oral tablet",Diebougou - Burkina Faso,2020-11-08,2019-05-30,2024-01-11,INTERVENTIONAL,PHASE3,Brian Foy,OTHER,malaria
NCT00157833,Unknown,COMPLETED,2004-07,"Falciparum Malaria, Vivax Malaria",Artekin / Coartemther,Timika - Indonesia,Unknown Date,2005-09-12,2006-06-26,INTERVENTIONAL,NA,Menzies School of Health Research,OTHER,malaria
NCT05125133,ITENs,UNKNOWN,2021-07-09,"Malaria,Falciparum",ITENs + ITWS,Bagamoyo - Tanzania,2022-08-31,2021-11-18,2021-12-02,INTERVENTIONAL,NA,Ifakara Health Institute,OTHER,malaria
NCT00845533,Unknown,COMPLETED,2007-08,Uncomplicated Malaria,Dihydroartemisinin-Piperaquine,No locations listed,2007-12,2009-02-18,2014-01-16,INTERVENTIONAL,PHASE4,"University of California, San Francisco",OTHER,malaria
NCT02704533,Unknown,COMPLETED,2016-08-29,Malaria,"PfSPZ Vaccine, PfSPZ Challenge (NF54), PfSPZ Challenge (7G8), Normal saline",Tübingen - Germany,2018-10-19,2016-03-10,2019-02-01,INTERVENTIONAL,PHASE1,Sanaria Inc.,INDUSTRY,malaria
NCT00832754,RDT-ACT,COMPLETED,2009-03,Malaria,"RDT, Clinical Judgement as basis for treatment of malaria with ACT",Kintampo - Ghana,2012-08,2009-01-30,2012-12-21,INTERVENTIONAL,PHASE4,"Kintampo Health Research Centre, Ghana",OTHER,malaria
NCT04245033,IPTsc,COMPLETED,2020-07-20,Malaria,Dihydroartemisinin-Piperaquine (DP),Tanga - Tanzania,2021-05-31,2020-01-28,2024-11-20,INTERVENTIONAL,PHASE4,"National Institute for Medical Research, Tanzania",OTHER_GOV,malaria
NCT02783833,Unknown,COMPLETED,2016-05,Malaria,"MMV390048 40mg, MMV390048 dose to be determined mg",Herston - Australia,2017-01-16,2016-05-26,2017-02-08,INTERVENTIONAL,PHASE2,Medicines for Malaria Venture,OTHER,malaria
NCT01828333,MATIAS,COMPLETED,2013-04,Severe Malaria,No intervention,"Kimpese - Congo, The Democratic Republic of the, Kimpese - Congo, The Democratic Republic of the, Kimpese - Congo, The Democratic Republic of the, Kisantu - Congo, The Democratic Republic of the, Kisantu - Congo, The Democratic Republic of the, Maluku - Congo, The Democratic Republic of the, Maluku - Congo, The Democratic Republic of the, Maluku - Congo, The Democratic Republic of the, Kinshasa - Congo, The Democratic Republic of the",2013-06,2013-04-10,2013-09-13,OBSERVATIONAL,Not Available,Swiss Tropical & Public Health Institute,OTHER,malaria
NCT01645254,Unknown,UNKNOWN,2012-09,Malaria,Argemone mexicana,Bamako - Mali,2012-10,2012-07-20,2012-10-03,INTERVENTIONAL,PHASE1,University of Bamako,OTHER,malaria
NCT00301054,Unknown,COMPLETED,2005-06,Anaemia in Children,"Ferrous sulphate, Sulphadoxine-Pyrimethamine",Berekum - Ghana,Unknown Date,2006-03-10,2006-05-29,INTERVENTIONAL,NA,Ghana Health Services,OTHER_GOV,malaria
NCT03341754,Unknown,COMPLETED,2018-09-15,Malaria,"D/ChAd63-CA, D/ChAd63-CAT, Infectivity Control (IC) Group","Bethesda - United States, Silver Spring - United States",2019-10-28,2017-11-14,2020-05-06,INTERVENTIONAL,PHASE1,U.S. Army Medical Research and Development Command,FED,malaria
NCT05478954,Unknown,ACTIVE_NOT_RECRUITING,2022-07-15,Malaria,"Sulfadoxine pyrimethamine, Amodiaquine",Nanoro - Burkina Faso,2022-10-01,2022-07-28,2023-11-01,INTERVENTIONAL,PHASE4,Malaria Consortium,OTHER,malaria
NCT00442377,Unknown,COMPLETED,2007-01,Falciparum Malaria,exposure to malaria sporozoites,Nijmegen - Netherlands,Unknown Date,2007-03-01,2007-08-16,INTERVENTIONAL,NA,Radboud University Medical Center,OTHER,malaria
NCT03917654,Unknown,COMPLETED,2019-04-24,Malaria,"Pfs230D1M-EPA/AS01, HAVRIX, TYPHIM Vi (Salmonella typhi vaccine), Menactra, AVAXIM",Bamako - Mali,2021-07-30,2019-04-17,2024-10-22,INTERVENTIONAL,PHASE2,National Institute of Allergy and Infectious Diseases (NIAID),NIH,malaria
NCT00197054,Unknown,COMPLETED,2005-07,Plasmodium Falciparum,"RTS, S/AS01B, RTS, S/AS02A, Rabipur (Rabies) Vaccine",Kisumu - Kenya,2006-09,2005-09-20,2021-02-12,INTERVENTIONAL,PHASE2,U.S. Army Medical Research and Development Command,FED,malaria
NCT01326754,Unknown,COMPLETED,2011-08,"Malaria, Falciparum","Artemether-lumefantrine combination, Artesunate-amodiaquine combination, Dihydroartemisinin-piperaquine",Liwonde - Malawi,2012-06,2011-03-31,2013-02-25,INTERVENTIONAL,NA,Centers for Disease Control and Prevention,FED,malaria
NCT01213433,ASAQ-MAL,COMPLETED,2010-10,Uncomplicated Malaria,Artesunate-Amodiaquine,Nanoro - Burkina Faso,2010-11,2010-10-04,2015-07-31,INTERVENTIONAL,PHASE4,Centre Muraz,OTHER,malaria
NCT05842954,KALUMA,RECRUITING,2024-03-07,Uncomplicated Plasmodium Falciparum Malaria,"KLU156, Coartem","Bobo Dioulasso - Burkina Faso, Nanoro - Burkina Faso, Ouagadougou - Burkina Faso, Sabou - Burkina Faso, Kimpese - Congo, The Democratic Republic of the, Kisantu - Congo, The Democratic Republic of the, Abidjan - Côte D'Ivoire, Agboville - Côte D'Ivoire, Azaguie - Côte D'Ivoire, Lambarene - Gabon, Libreville - Gabon, Kintampo - Ghana, Navrango - Ghana, Bhubaneswar - India, Jaipur - India, Darjeeling - India, Sotuba - Mali, Niamey - Niger, Bagamoyo - Tanzania, Korogwe Tanga - Tanzania, Tanga - Tanzania, Tororo - Uganda",2025-07-07,2023-05-06,2024-12-31,INTERVENTIONAL,PHASE3,Novartis Pharmaceuticals,INDUSTRY,malaria
NCT06232954,Mossie-GO,RECRUITING,2024-06-05,"Malaria, Mosquito-Borne Disease","Mossie-Go containing treated transfluthrin disc, Mossie-Go containing untreated blank disc",Jinja - Uganda,2025-09,2024-01-31,2024-06-21,INTERVENTIONAL,NA,Africa Power Limited,INDUSTRY,malaria
NCT01422954,Unknown,COMPLETED,2012-01,"Malaria, Plasmodium Falciparum","Chloroquine prophylaxis, Mefloquine prophylaxis, Immunization, Controlled Human Malaria Infection, Malarone",Leiden - Netherlands,2012-12,2011-08-25,2013-04-29,INTERVENTIONAL,NA,Radboud University Medical Center,OTHER,malaria
NCT00113854,Unknown,UNKNOWN,2004-10,Cerebral Malaria,Mannitol,Kampala - Uganda,Unknown Date,2005-06-13,2005-06-24,INTERVENTIONAL,PHASE3,Makerere University,OTHER,malaria
NCT01916954,ALN5P,COMPLETED,2013-07,Malaria,"3-day artemether-lumefantrine, 5-day artemether-lumefantrine",Kinshasa - Congo,2014-03,2013-08-06,2014-03-26,INTERVENTIONAL,PHASE3,University of Oxford,OTHER,malaria
